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ABSTRACT
NAOMI C. BROWNSTEIN: Analysis of Time-to-event Data, Intermediate
Phenotypes, and Sparse Factors in the OPPERA Study
(Under the direction of Drs. Eric Bair and Jianwen Cai)
Motivated by the Orofacial Pain: Prospective Evaluation and Risk Assessment
(OPPERA) project, a large study of temporomandibular disorders (TMD), this dissertation
develops statistical methods applicable to three facets of chronic pain.
First, we propose a method for parameter estimation in survival models with missing
censoring indicators. These result because conducting multiple invasive examinations
for incidence on all participants in large prospective studies is infeasible. We estimate
the probability of being an incident case for those lacking a gold standard” examination
using logistic regression. Multiple imputations of case status for each missing examination
are generated using these estimated probabilities. Imputed and observed data are
combined in Cox models to estimate the incidence rate and associations with putative
risk factors. The variance is estimated using multiple imputation. Our method performs
as well as or better than competing methods and highlighted new discoveries for
OPPERA.
Secondly, we propose a general method to analyze secondary phenotypes and apply
it to the OPPERA baseline case-control study. Traditional case-control genetic association
studies examine relationships between case-control status and one or more covariates.
Investigators now commonly study additional phenotypes and their association with
the original covariates as secondary aims. Assessing these associations is statistically
challenging, as participants do not form a random sample from the population of
iii
interest. Standard methods may be biased and lack coverage and power. Utilizing
inverse probability weighting and bootstrapping for standard error estimation, our
method performs as well as competitors when they are applicable and provides promising
results for outcomes to which other methods do not apply.
Third, we propose a method for sparse factor analysis. Psychometric studies frequently
measure numerous variables that may be noisy manifestations of a few underlying
constructs. Aims include identifying these latent variables and their relationship to
the observed variables and reducing the data to a few key variables that explain the
majority of variance. While variable reduction methods exist for principal component
analysis, none have been proposed to date for factor analysis. Our method retains
predictive accuracy for many thresholds in simulations while providing sparse loadings.
Competing methods had less predictive accuracy or less sparsity.
iv
To my little sister, Shira Brownstein, in loving memory. Both her presence and
absence have shaped my progress throughout the program and continue to inspire me
to work hard and never give up.
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CHAPTER 1: INTRODUCTION
Time-to-event analyses are frequently conducted in medicine, actuarial science, and
numerous other fields of applied science. Actuaries study the time until death of
individuals for the purpose of calculating and offering fair life insurance rates. In
clinical trials, researchers note whether and when participants experience the event of
interest and compare the times between the treatment and control groups. Similarly,
in cohort studies, researchers compare survival times and want to know if survival time
is related to a risk factor of interest. Additionally, it may be of interest to study the
hazard of death over time.
There is a well-developed set of standard time-to-event analysis methods implementable
in standard statistical software packages. Logrank tests allow testing of differences of
survival times between a finite number of groups. The survival distribution may be
eassily estimated non-parametrically and plotted using SAS or R. Semi-parametric
methods, such as the Cox proportional hazards model, allow robust estimation of the
hazard function in the presence of covariates. Yet, these methods require knowledge
of both the event time and status for all individuals. The event status may not be
known for all individuals, especially when one is interested in studying death due to a
particular cause.
Additionally, current methods do not work for secondary time-to-event outcomes
in case-control studies, in which study participants are sampled based on the primary
outcome, because the study does not constitute a simple random sample of the population
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of interest. In fact, arbitrary analysis of one or more secondary phenotypes is a non-
trivial problem and has spawned a great deal of research in recent years.
Often, the outcome of interest may be difficult to ascertain. For example, an
autopsy by expert medical examiner may be needed to determine if a death was due
to myocardial infarction, a cancer tumor, or other factors. In order to mitigate this
problem, some studies employ delayed event adjudication. That is, possible cases are
identified using simple, but possibly error-prone methods. Then, one or more experts
examines the possible cases using a more accurate, but also more costly and time-
consuming method to determine the true event status. For example, a specialized
dental examination is required for accurately diagnosing temporomandibular disorders
(TMD). It is impractical to subject large number of subjects to such an examination,
especially if they are unlikely to have the condition. Instead, the “gold standard”
examination is performed only on subjects who screen positive on a simpler assessment,
such as a questionnaire designed to measure recent orofacial pain. However, some
subjects do not receive the “gold standard” examination due to inability or unwillingness
to attend research centers. A time-to-event analysis would then have some subjects
with self-reported symptoms but missing censoring indicators. This setting presents
statistical challenges, which require care in order to avoid bias and maintain efficiency.
In other settings, cause of death may be unknown or death certificates may be
missing entirely. This frequently arises when there are multiple failure types. In
oncology studies, for example, researchers may want to differentiate between deaths
due to cancer and deaths due to car accidents or other unrelated causes. For such
studies, a death certificate is insufficient to classify a subject. Moreover, it may be
impossible to determine if a death occurred if a subject dies abroad or national death
registries are incomplete.
While there have been a few methods developed in this area, each has drawbacks.
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There is a clear need for new methodology to handle this challenging situation. In
the first paper, we propose a method for parameter estimation in the case of missing
censoring indicators. In the second paper, we seek an unbiased and efficient method to
model the relationship between a genotype and a secondary phenotype in case-control
studies. The third paper extends the framework of the first paper to allow for Cox
regression with both missing covariates and missing censoring indicators.
3
CHAPTER 2: LITERATURE REVIEW
Our methods, detailed in chapters 3-5, rely on basic knowledge of survival analysis,
missing data, imputation, bootstrapping, joint-modeling, case-control genetic studies
and factor analysis. This chapter reviews the literature pertaining to these fields.
2.1 Survival Analysis
Actuaries, medical experts, and statisticians alike are frequently confronted with
failure time data. One important quantity of interest is the survival function. The
nonparametric maximum likelihood estimate of the survival distribution is given by
(60). Nonparametric estimation in the accelerated failure time model is discussed in
(72). The shape of the survival function is instructive in studying the progression of
the event of interest over time.
Yet, it is often of interest to model the relationship between the failure times and
a set of covariates. A parametric model with one covariate assuming that the failure
time has an exponential distribution is proposed in (36). Unfortunately, the stringent
distributional assumption and limit of one covariate prevent this method from being
useful in most situations. Instead, the classic semi-parametric model of the hazard
function in the presence of covariates is defined in (10). The field of survival analysis
in the past forty years has been centered around this model. In fact, in prospective
cohort studies of risk factors for disease, hazards ratios are beneficial because they
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approximate the incident rate ratio. The pervasiveness of this model is evident in, for
example, (40), a review of developments in survival analysis in clinical trials through
the turn of the century.
2.1.1 Cox Proportional Hazards Model
One of the most popular statistical tools today, the Cox model combines the ability
to handle covariates with the flexibility resulting from leaving the baseline hazard
unspecified. Cox defines a partial likelihood, which allows for maximum likelihood
estimation of the regression parameters, and extends results for bivariate life table
data. Further details on the partial likelihood are provided in (11).
The Fisher information matrix for the regression parameter from the standard
likelihood is calculated in (26) and shown under broad conditions to be asymptotically
equal to the information based on the partial likelihood. Thus, the Cox likelihood is
asymptotically efficient. Efron also estimates the hazard rate and connects it to the
Kaplan-Meier estimate of the survival function. Accelerated failure time model and
inference and parameter estimation in the Cox model is discussed in (59) as well as
extensions to multivariate failure data, time-dependent covariates, and case control
studies. A heuristic method for computing the asymptotic variance of the estimated
survival function is proposed in (68) and used it to construct confidence intervals, which
are shown in simulations to have adequate coverage.
The applicability of Cox models continued to grow. Methodology were generalized
to competing risks and multivariate outcomes. The framework for competing risks is
detailed in (81), (50) and (94).
Another important question is how robust the Cox model is to mis-measured or
missing data and what modifications are appropriate in the presence of such data.
Effects of covariate measurement error are investigated in (93) and (52). Cox models
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with missing data are discussed in section 2.4. Specifically, the setting of uncertain
outcomes are discussed in section 2.4.2.
2.2 Bootstrapping
Bootstrapping is an estimation method that may be applied in a wide variety of
situations with or without missing data. The goal is to estimate a statistical quantity
and its variability. Bootstrapping is especially useful for quantities whose standard
error is difficult or impossible to calculate mathematically. Over the past 30 years, the
original method has evolved dramatically, with new methods applicable to frequentist,
Bayesian, parametric, nonparametric, and semiparametric situations alike.
The nonparametric bootstrap was originally proposed in (27) as a modification of
the jackknife. The first step is to find the empirical distribution function of the data.
Next, one creates a large number of boostrap samples by sampling with replacement
from this empirical distribution function. Third, one combines the results from each of
the replications. The estimate of the quantity of interest is the mean of the R estimates
from the replicates and the estimated standard error is the standard deviation of the
estimates from the replicates. Details may be found in (27) and (29).
This simple procedure, available in standard statistical software, originally allowed
estimation of the parameter of interest and of bias, but now also routinely provides
several confidence intervals. Asymptotic properties, including second order accuracy,
are discussed in (111), (5) and (112). Literature on standard errors and confidence
interval estimation is discussed in more detail in section 2.2.1.
In its classical form, bootstrapping is a nonparametric frequentist method, though
it has been adapted to the parametric and Bayesian frameworks as well. One example
of parametric bootstrapping is found in (29). Instead of substituting the empirical
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distribution for the unknown sampling distribution, Efron substitutes a normal distribution
with mean and variance equal to the sample mean and sample variance. This procedure
is called the normal smoothed bootstrap. (102) first described the Bayesian bootstrap.
Weighted bootstrapping, which is applicable to hypothesis testing, is discussed in (62).
Bootstrapping has emerged as a useful tool for practitioners and the foundation of
numerous papers on its theoretical properties, scope, and limitations.
In his silver anniversary review paper, (31) stresses that boostrapping is founded
on the “plug-in principle”, which he defines as the act of simply “plugging in” the
empirical distribution function for the unknown distribution function. He notes that
while the literature as of 2003, (19), indicates that this is generally valid to the second
order, there are notable situations where it can be problematic. According to a similar
review paper by (14), it is the simplicity of the bootstrap and its connection with other
methods, such as the jackknife, that make it both widely utilized in applications and
extensively studied from a theoretical standpoint.
2.2.1 Standard Error and Confidence Intervals
One important benefit of bootstrap methods is the ability to calculate standard
errors and confidence intervals. For many estimators of interest in practice, standard
errors are, at best, difficult to calculate, or worse, impossible to evaluate analytically.
Moreover, even when the standard error can be found, standard confidence intervals
based on the central limit theorem may be inadequate for statistics whose distribution
are non-normal. On the other hand, according to (32), the bootstrap can always provide
numerical standard error estimates. A simple example of the bootstrapping in the Cox
proportional hazards model can be found in (32).
Three methods of bootstrap confidence intervals are discussed in the literature,
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namely percentile, bias corrected and acclerated (BCa), approximate bootstrap confidence
intervals (ABC) and bootstrap ‘t’. The percentile method simply reports the estimated
percentiles of the bootstrap distribution. A quick theoretical justification for percentile
intervals is provided in (28). BCa intervals are motivated by the assumption that a
simple monotone transformation of the parameter of interest is normally distributed
with slight bias with respect to the transformed mean and a variance that may not
be constant for all possible parameter values. The user does not need to specify the
transformation. In order for BCa confidence intervals to be accurate, it is only required
that such a transformation exists. Monte Carlo sampling yields adequate estimates of
the standard error in about 50-200 replications for most statistics and adequate BCa
confidence intervals in about 1000 replications (32, 19). The bootstrap ‘t’ interval is
conceptually simpler than BCa intervals. However, unlike percentile intervals, they are
not transformation invariant and can result in confidence intervals that are much too
wide. ABC intervals do not require Monte Carlo simulations at all, relying instead on
an analytic approximation to the BCa interval.
2.3 Missing Data: General Theory and Methods
The problem of missing data is nearly ubiquitous in practical statistical problems.
Consequently, there is a rich body of research on analysis with missing data, including
methods such as the EM algorithm, single imputation, and multiple imputation. There
are also a wide variety of ad-hoc techniques that may introduce severe bias. This section
summarizes the literature on missing data and proper data analyses.
In the classic paper, (101) defines three missing data mechanisms and ignorability.
Before proceeding, necessary definitions from Rubin’s work are introduced. Additional
details may be found in (70). The missing data mechanism refers to the probability
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of having missing data. Data are called missing completely at random (MCAR) if
the probability of having a missing value is independent of the data, both observed
and missing. Data are called missing at random (MAR) if the probability of having a
missing value is independent of the missing values, but may depend on the observed
values or on observed covariates. Under MAR or MCAR, the missing data mechanism
is said to be ignorable. If the probability of having a missing value depends on that
unobserved value, then the data is missing not at random (MNAR) and the mechanism
is non-ignorable.
When confronted with missing data, data users face a dilemma. They may know
that, in theory, disregarding observations that are not fully observed is inefficient, at
best. The loss in efficiency increases with the proportion of missing data. It may
bias inference and lead to misleading conclusions. Yet, most software is not equipped
to handle missing observations. Typically, observations with any missing values are
dropped. This can be problematic in studies with a large number of covariates of
interest. Subjects with one or more of the covariates missing would be excluded.
Denoted a “complete-case” analysis, the results may be severely biased when the
missing data mechanism is non-ignorable. Similarly, “available-case” analyses, which
use all cases with observed values for at least one of the variables under consideration,
may be invalid. Mean-imputation, in which missing values are imputed by the mean of
observed values, may also introduce bias, (103). While it may be tempting to use these
or other more convenient approaches, it is usually not appropriate. There is a rich set
of methodology for handling missing data without introducing bias and maintaining as
much efficiency as possible. A selection of relevant methods are included below.
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2.3.1 The EM Algorithm
One common method for handling missing data is the Expectation-Maximization
(EM) Algorithm. There are three steps: first, finding the expected value of the
full log-likelihood given the observed data and current parameter estimate, second
maximizing the expectation to update the parameter estimates, and third, iterating
until convergence. The method was formally introduced in (16) with details of the E-
step and M-step. The authors demonstrate why the EM algorithm works, that is, the
fact that the likelihood always increases with each iteration. They also give examples
and suggest the ability to generalize the EM algorithm in a Bayesian framework.
The EM-algorithm in some form is instrumental in most papers that develop new
methods for analysis of data with missingness. One noteworthy example is in the
context of logistic regression with uncertain outcomes. The EM-algorithm and known
or estimated values of sensitivity and specificity are used in (74) to improve upon
parameter estimates in standard logistic regression. Section 2.4 discusses additional
examples of methods that employ the EM-algorithm for missing data in survival analysis.
2.3.2 Multiple Imputation
Multiple imputation, discussed in section 2.3, is a Bayesian method for analyzing
data with some degree of missingness. It was first presented as a way to handle non-
response in sample surveys. The framework is summarized in (103) as containing
a database constructor often separate from the person who will analyze data. He
states that multiple imputation is a statistically valid method within this framework.
Multiple imputation definitions and equations are reviewed. He defines proper multiple
imputation and urges users to include available covariate information in the imputation.
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Finally, Rubin compares multiple imputation to competing methods, i.e. single imputation,
jackknife, bootstrapping.
Missing data mechanisms are discussed in (155) from frequentist and Bayesian
points of view as well as the consequent challenges under various assumptions and
appropriate missing data analysis methods. Imputation in general is explored in (155),
specifically two multiple imputation methods – propensity score and predictive model
– under monotone missingness, and one method of multiple imputation under non-
monotone missingness utilizing Markov Chain Monte Carlo (MCMC). Readily vailable
multiple imputation software procedures, such as PROC MI and PROC MIANALYZE
in SAS, frequently assume data are MAR.
Often, especially for binary data, values generated with multiple imputation are
rounded. Yet, rounding can cause excessive bias, as shown in (51). One solution is
to keep the raw imputed values, as they introduce less bias than the rounded values.
They urge instead to posit a more appropriate posterior, for example to refer to Rubin’s
detailed instructions for how to impute missing binary data.
2.3.3 Bootstrapping and Missing Data
For missing data problems, (30) provides a comparison of three bootstrapping
methods and multiple imputation. Non-parametric bootstrapping, the simplest form
of bootstrapping, requires no knowledge of the missing data mechanism. It may be
applied to virtually any reasonable estimator. However, nonparametric bootstrapping
may be too slow or infeasible to use in practice due to the comparatively large number
of replications required. This is especially true when BCa confidence intervals are of
utmost interest.
Full mechanism bootstrapping is less computationally intensive, but requires modeling
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of the missing data mechanism. Thus, it is most appropriate for non-ignorable missing
data, when this is required anyway. The multiple-imputation bootstrap begins with
the Bayesian bootstrap and calculates confidence intervals via the ABC method. It is
most appropriate for Bayesian settings, because it requires knowledge of the conditional
density of the full data given the observed data. Note that the requirement to know the
conditional density is less stringent than the requirement of full-mechanism bootstrapping
to know the missing data mechanism. For censored surival data, full mechanism and
nonparametric bootstrapping are identical (29, 30).
An important type of partially incomplete data is censored failure-time data. Under
the assumption of random censoring, (29) argues that bootstrapping is valid for survival
data. Similarly, it is straightforward to use bootstrapping to estimate the survival
function and its standard error.
2.4 Missing Data Methods and Survival Analysis
This section discusses specific developments in missing data methods for time-to-
event data. As discussed previously, survival analysis already has incomplete data in
the sense that the failure time is unknown for censored individuals. Most methods
assume that data are censored randomly. In the literature, this is termed as ignorable
censoring. When this assumption is not tenable, censoring is termed non-ignorable and
adjustments must be made.
When modeling time-to-event data with covariates, there are additional types of
missing data that may arise. Most commonly, some subjects may have one or more
unobserved covariates. A less studied situation is when the censoring indicator is
missing for a subset of the observations. While it is possible for a single dataset to
have missing covariates and missing censoring indicators, no papers on that problem
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have been found to date.
The following subsections detail, respectively, the literature for survival analysis
with missing covariates and missing censoring indicator models.
2.4.1 Cox Models with Missing Covariates
There have been numerous papers on modeling proportional hazards with missing
covariates. Estimating equations are propposed in (65) to yield what they call an
“approximate partial likelihood estimator” (APLE), which is consistent and asymptotically
normal under MCAR covariates. The assumption is relaxed to MAR by (89) and
impute the covariates using the conditional expectation based on observed information.
Through simulations, they demonstrate the superiority of their method to that of
Lin and Ying in terms of efficiency under MCAR and consistency under MAR. A
nonparametric model for estimation of relative risk with the missing covariates is given
in (156) based on additional auxiliary covariates. An EM-type algorithm for missing
covariates in Cox models is detailed in (49). Additional papers include the inverse
selection probability weighted estimator of (139), among others.
2.4.2 Cox Models with Missing Censoring Indicators
Missing censoring indicators frequently arise when there are multiple failure types.
Investigators may easily record the mortality of all subjects, but it may be extremely
difficult or costly to find out exactly why each subject died. Consequently, there has
been much more work done on missing censoring indicators in the context of competing
risks than when there is only one type of failure. Over the past three decades, authors
have produced a variety of methods of estimating the hazard and survival function
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for the missing censoring indicator model. The logrank test has been generalized for
missing censoring indicators. Yet, there have been fewer papers on the more difficult
problem of Cox regression.
First, (20) uses the EM algorithm to estimate the survival function under various
types of partially observed competing risk data. Observations may be either fully
observed, censored, or observed failures with unobserved causes. He estimates the
information matrix and provide clear examples of the method applied in practice. The
survival function is estimated non-parametrically in (96) when death status is known
but its cause is uncertain for some subjects, while the Kaplan-Meier estimate may be
biased for such data. Causes of failure are said to be masked when it is unknown but
at least one type of cause may be eliminated from consideration. For competing risks
data with masked causes of failure, (39) estimate the survival function.
A modified logrank test for competing risk data for which cause of failure is unknown
and missing at random, (44). A slight modification to their partial likelihood is
proposed in (17) to increase the information and improve the test. Multiple imputation
of the cause of failure and a corresponding asymptotically valid modified log-rank test
is detailed in (133).
For standard survival data, there have been a number of methods proposed for
estimating the survival function under the missing censoring indicator model. An
asymptotically efficient estimator of the survival function under missing at random,
or more generally, “coarsening at random” censoring indicators, is proposed by (136).
Namely, they use the nonparametric MLE of the survival function based on reduced
data produced by a discretization of the failure time. A comparable alternative is
proposed by (123) that requires less computational resources and time. Kernel estimation
is employed in (124) to provide a weakly convergent estimator of the survival function.
As in the case with fully observed censoring indiators, kernel estimation depends on
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the choice of bandwidth sequence. It follows that clever estimation of the bandwidth
would improve the kernel estimation performance. Three methods of bootstrapping the
bandwidth are compared to each other and to existing methods, (129). Semiparametric
random censorship models for hazard function estimatiors, both nonparametric and
semiparametric, are given in (128). In addition, they compute and minimize the
asymptotic mean squared error to find the optimal bandwidth. An augmented inverse
probability weighted estimator of the survival function under MAR is proposed in
(127) and shown that it is robust even under partial model misspecification. Improving
the survival function estimate in the missing censoring indicator model via multiple
imputation is discussed in (125) and (126).
An important research question is how Cox models are affected when case status
is uncertain. Competing risks proportional hazards regression models are proposed
in (45) using estimating equations assuming that observations are known either to be
censored or to have failed by some cause. They assume proportional hazards for each
failure type and between the two failure types. For the linear transformation model,
An augmented inverse probability weighted estimator and algorithm are proposed in
(41) along with asymptotic and double robustness properties.
Time-to-event data which may not be classified and confirmed is modeled in (8)
by weighting each subject by their estimated probability of being a true case. Their
methods include estimation of the survival function, Cox models, and a logrank test.
They propose an asymptotic variance expression which may be used as an approximation
for finite samples. Alternatively, they suggest estimating the variance by bootstrapping.
Empirical processes are employed to prove consistency and weak convergence of the
estimators to Gaussian processes.
For the usual survival setting with only one cause of failure, (43) estimate the
survival function by modifying and combining estimates of the hazard function, discuss
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estimation in the Cox model and prove consistency and asymptotic normality of the
estimators. The survival function is also estimated without covariates and Cox proportional
hazards models are proposed in (78) by modifying the Nelson-Aelen estimator and
taking the product-integral. The advantage of their method is that it does not require
discretization of the failure times or estimation of the unconditional probability of
having an observed censoring indicator. Simulations demonstrate that the (78) is
superior to previous estimators, such as the earlier version of (43). Yet, the methods
of (78) and (43) both depend on the MCAR assumption, which they state that it is
non-trivial to relax. Parameter estimation in the Cox model under the assumptions of
proportional censorship and MCAR censoring indicators is conducted in (122).
Weights are recommended for each potential event, of which individuals may have
more than one, along with a weighted partial likelihood, (116). That is, he suggests
screening out observations that are unlikely to be true events, and weighting each
observation by the probability that the subject had first failed at the observed time. The
weights may be known or estimated using auxiliary covariates. Taking this uncertainty
into account reduces bias and increases power. However, estimating the weights depends
upon the presence of a normally distributed diagnostic variable and either knowing or
having experts guess the relative frequency of true endpoints to false endpoints. In
addition, the variance of the method is mentioned but not described in detail.
Adjusting a proportional hazards model based on discrete survival times and measurement
error of case status is discussed in (79). They show that mis-measured outcomes can
bias the usual proportional hazards model parameter estimates toward the null and poor
coverage probability for confidence intervals, but this can be mitigated by incorporating
information about sensitivity and specificity.
Estimators for the regression parameters in the Cox proportional hazards model
with missing censoring indicators are derived in (6) using the EM algorithm and
16
their consistency is established under basic regularity conditions. The authors then
estimate the non-missing rate of censoring indicators with the kernel estimator and use
it to estimate the information matrix. Their approach depends on the assumption of
piecewise constant hazard functions and proportional hazards for not only the event
time, but also for the censoring time.
Multiple imputation is also discussed for repeated failure times where the event is
known to have occurred at a certain time but the event type is missing (107). The
method is compared to multiple imputation under the Cox proportional hazards model
without repeated events.
2.5 Genetics and Case-Control Data
Investigators are frequently interested in reusing case-control data to evaluate associations
between measured risk factors and outcomes other than the outcome to define case
status. These other outcomes are often referred to as secondary phenotypes, which may
be associated with the primary disease used to define case status. Utilizing one study
to investigate more than one outcome is important for financial reasons, as the process
of attaining genetic information and other putative risk factors for all participants is
time-consuming and expensive. While logistic regression is known to be invariant to
the sampling method for primary analyses, this does not hold for secondary phenotype
analyses. Simple logistic and linear regression may be severely biased. Restricting
analyses to cases only or controls only results in decreased efficiency. These methods
are considered “naive” methods. There has been a great deal of recent interest in
developing unbiased and efficient methodology for analyzing secondary phenotypes in
case-control studies.
Two methods for analyzing associations are proposed in (97). The first is to use a
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standard logistic regression model with a covariate adjusting for original case status.
The second is to use stratum-weighted logistic regression, i.e. logistic regression in
which cases and controls are weighted by the reciprocal of their sampling fractions.
For population studies, it is often easier to estimate the ratio of the sampling fractions
than to estimate the sampling fractions for cases and controls separately. Hence, (97)
proposes using a unit weight for the cases and the ratio of the sampling fractions for
controls. In a nested case-control study, the ratio is the number of cases in the whole
study divided by number of controls.
Simulations are conducted in (82) to estimate size and power for the naive methods
and the inverse probability weighting (IPW) method and dummy variable adjustment
method in (97). They conclude that IPW has adequate type I error but has increased
variance and sometimes decreased power compared to the naive approaches. Note,
however, that the simple unweighted analysis and the analyses that adjust for case
status with a binary variable or restrict to either cases or controls have slightly inflated
type I error when the primary disease is not rare and both the genetic profile and
secondary phenotype are related to the primary disease. There are also situations in
which the IPW method is more efficient than the method that adjusts for case-control
status with an indicator variable for case status.
A rigorous likelihood based approach is derived in (66). However, (63) points out
that (66) assumes no interaction between the covariate information (genotypes) and the
secondary phenotype and that in the case of interaction in modeling the probability
of having the primary disease, the results may be biased. They propose an adaptive
weighting parameter estimate motivated by a Bayesian shrinkage estimator for gene-
environment interaction when the disease is rare.
The bias may be corrected by solving iterated non-linear equations relating regression
coefficients to estimates of prevalence of the disease and phenotype from the literature
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and using bootstrapping to calculate confidence intervals via the percentile method,
(140). Their method assumes that the secondary phenotype may be modeled by logistic
regression given a set of binary covariates and the primary disease may be model by
logistic regression given the covariates and the secondary phenotype but no interaction.
They describe the IPW method in (97) and extend it to retrospective case-control
studies using an estimate of disease prevalence. They also adapt their bias correction
method to the frequency-matched case-control study design. Their method produced
narrower confidence intervals than the IPW method.
In their second paper, (141) conduct simulations, which show that the method
in (140) has adequate size and is more powerful than the naive logistic regression
approaches. A joint model based on a Gaussian copula is proposed by (47) for one
or more secondary phenotypes in the exponential family and the disease of interest
given the covariate, i.e. genotype. Their simulations confirm that their method is more
powerful than the IPW method. Unlike other methods, this one allows joint modeling of
multiple secondary phenotypes that is more powerful than multiple univariate analyses.
2.6 Sparse Factor Analysis
Latent variable models are frequently used in statistics. In certain situations, it
is reasonable to assume that observed variables are random variations of one or more
unobserved random variables. Within the field of psychometrics, studies often consist
of a large number of correlated measured variables, which may be manifestations
of a smaller number of underlying constructs. Factor analysis is commonly used
for this purpose. In factor analysis models, the observed data is assumed to be
a linear combination of the unobserved factors, plus random error. See (9) for an
excellent description and illustration of some simple factor analysis models. A more
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theoretical description of the problem of factor analysis is provided in (3) along with a
demonstration that it may fall into the Bayesian framework.
Factor analysis may be either exploratory or confirmatory in nature. Exploratory
factor analysis (EFA) aims to discover underlying relationships between the observed
variables and is more commonly used (91). Confirmatory factor analysis (CFA) begins
with an a priori structure and tests hypotheses about those structures using the factor
analysis setting. Researchers such as (137, 55) have debated quite heatedly about when
each type of factor analysis is appropriate.
Principal component analysis (PCA) is more frequently used in statistics than
is factor analysis. In principal component analysis, instead of assuming that there
are unobserved variables driving the observed data, it is desired to extract linear
combinations of the observed variables. The first linear combination, or component,
explains the largest amount of variability in the data. The second component explains
the next largest amount of variance, and so on. Traditionally, principal component
analysis extracts the same number of components as there are observed variables.
However, since data reduction is commonly a goal of PCA, usually the analyst selects
a smaller number of components that explains a sufficient amount of variance.
It is desired to have sparse loadings, meaning that many of the loadings are equal to
zero. Unfortunately, neither principal component analysis nor factor analysis produce
sparse loadings. This can be problematic, especially in genetic settings, where the
number of variables present in the study can be very large. Two methods (157,
147) have recently been proposed for sparse principal component analysis. (147)
uses a penalized matrix decomposition to produce more sparse results than traditional
principal component analysis.
The aforementioned sparse principal component analysis methods do not immediately
generalize to factor analysis models. To date, the author of this dissertation has not
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found any articles on sparse factor analysis.
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CHAPTER 3: PARAMETER ESTIMATION IN COX
PROPORTIONAL
HAZARD MODELS WITH MISSING CENSORING
INDICATORS
3.1 Introduction
Time-to-event analyses are frequently conducted in medicine, actuarial science, and
numerous other fields of applied science. There is a well-developed set of survival
analysis methods implemented in standard software. Semi-parametric methods, such as
the Cox proportional hazards model, allow robust estimation of the effects of covariates
on the hazard function. However, these methods require the analyst to know the
censoring status of each participant, which may not always be available.
In some cases the outcome of interest may be difficult to ascertain. For example, in
oncology studies, researchers may want to differentiate between deaths due to cancer
and deaths due to car accidents or other unrelated causes. Investigators may easily
record the mortality of all subjects, but it may be extremely difficult or costly to find
out exactly why each subject died. One possible solution to this problem is delayed
event adjudication (8). This means that possible cases are not identified immediately
but screened using simple methods that may have poor sensitivity or specificity. Later,
the screened candidate cases are re-examined using a more precise, but also more costly
and time-consuming, method to determine the true event status.
The study that motivates our work is Orofacial Pain: Prospective Evaluation and
Risk Assessment (OPPERA), a prospective cohort study to identify risk factors for the
onset of temporomandibular disorders (TMD). Each (initially TMD-free) OPPERA
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study participant was followed for a median of 2.8 years to identify cases of first-
onset TMD. However, it was impractical to perform a physical examination on every
participant. It would also have been inefficient given that most study participants did
not develop the condition. Instead, this “gold standard” examination was performed
only on participants who screened positively on a quarterly screening questionnaire
that was designed to assess recent orofacial pain (1). However, some participants
who screened positively were lost to follow-up before receiving the “gold standard”
examination. Thus a time-to-event analysis would have some participants with missing
censoring indicators.
Cook and Kosorok (8) estimate parameters in Cox proportional hazard models with
missing censoring indicators by weighting observations according to their probability
of being a true case. They show that the estimators are consistent and asymptotically
normally distributed. However, the standard error of their proposed estimate cannot
be easily obtained using existing software without bootstrapping. For the OPPERA
data, a separate Cox model was calculated for each putative risk factor of interest,
including approximately three thousand genetic markers. Consequently, applying this
method to the OPPERA genetic data would be computationally intractable.
In the OPPERA study, the likelihood that a participant who screened positively
was examined was associated with demographic variables such as gender, race, or
socioeconomic status (1). This indicated that the censoring indicators in the OPPERA
study were not missing completely at random (MCAR). Application of models that
assume MCAR censoring indicators may result in biased estimates of hazard ratios for
covariates of interest. More importantly, a participant’s responses to their screening
questions are predictive of whether or not they are an incident case of TMD. This
setting presents statistical challenges, which require care in order to avoid bias and
maintain efficiency. Additionally, incidence rate estimates are desired, and none of the
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methods currently available allow for estimation of the incidence rate. There is a clear
need for new methodology to effectively answer the research questions of the OPPERA
study.
In this paper, we propose a method for parameter and variance estimation in
Cox regression models with missing censoring indicators. The motivating data set
is introduced in section 3.2. We describe our method in section 3.3. In section 3.4, we
report the results of simulations. Finally, in section 3.5 we apply our method to the
OPPERA study. We conclude with a discussion in section 3.6.
3.2 Motivating Data Set: The OPPERA Study
OPPERA is a prospective cohort study designed to identify risk factors for first-
onset TMD. A total of 3,263 initially TMD-free subjects were recruited at four study
sites between 2006 and 2008. TMD status was confirmed by physical examination of
the jaw joints and muscles using the Research Diagnostic Criteria for TMD (25), which
is the gold standard for diagnosing TMD.
Upon enrollment in the study, each OPPERA participant was evaluated for a wide
variety of possible risk factors for TMD, including psychological distress, previous
history of painful conditions, and sensitivity to experimental pain. For a brief overview
of the risk factors of interest in the OPPERA study, see Section 6 in the Web Appendix.
See Ohrbach et al. (86), Fillingim et al. (37), Greenspan et al. (46), and Maixner et al.
(76) for a complete description of the baseline measures that were collected in OPPERA.
After enrollment, each participant was asked to complete questionnaires to evaluate
recent orofacial pain once every three months. These questionnaires (hereafter referred
to as “screeners”) evaluated the frequency and severity of pain in the orofacial region
during the previous three months. The purpose of the screener was to identify participants
who were likely to have recently developed TMD. For a complete description of the
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screener, see Slade et al. (114). Participants who screened positively were asked to
undergo a follow-up physical examination by a clinical expert to diagnose presence or
absence of TMD.
Of the 3,263 subjects, 2,737 filled out at least 1 screener, and the remaining 521 did
not fill out any screeners. The total number of screeners was 26,666. There were 717
positive screeners, 486 (about 68%) of which were followed by a clinical examination.
As reported in Bair et al. (1), case classifications made by one examiner (hereafter,
“Examiner #4”) were deemed unreliable because the examiner diagnosed a much higher
percentage of individuals with TMD compared to other examiners. We therefore set
all of Examiner #4’s physical examination findings to be missing and imputed them
using the methods in this paper. This left 404 positive screeners (56%) resulting in
valid clinical exams. On the individual level, after setting the exams from Examiner
#4 to missing, there were 404 people who had one positive screener, and 114 people
who had two or more positive quarterly screening questionnaires.
3.3 Model
3.3.1 Notation and Assumptions
Assume there are n independent participants. For each participant i (i = 1, . . . , n),
let Ci and Ti denote the potential times until censoring and failure, respectively, let
Vi = min(Ti, Ci), ∆i = I(Ti ≤ Ci), Ni(t) = I(Ti < t). Let Zi a p×1 vector of covariates
measured at baseline and let Xi be a q× 1 vector of covariates measured at the time of
the putative event. We assume the hazard for participant i follows a Cox proportional
hazards model
λ(t|zi) = λ0(t) exp(β′zi) (3.1)
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where λ0(t) is an unspecified baseline hazard function. Let ξi denote the indicator that
∆i is observed and σi = ξi∆i. We observe (Vi, ξi, σi) for i = 1, . . . , n.
In the OPPERA study, Vi is the length of time for participant i between enrollment
in the study and either of two events
(a) a screener which resulted in a diagnosis of incident TMD
(b) the last-completed screener before loss-to-follow-up.
If participant i either screened positively and subsequently was diagnosed with TMD,
then ∆i = 1. If participant i either screened negatively on the last quarterly screener
before loss-to-follow up or screened positively and was diagnosed to be free of TMD,
then ∆i = 0. If participant i screened positively on the last screener but was not
examined, then ∆i is missing and ξi = 0. The putative risk factors for TMD that were
assessed at enrollment are denoted by the vector Zi. Responses to the screener for
participant i at time Vi are denoted by the vector Xi. For OPPERA, we also define
Qi = 1 if participant i screens positively on the last screener before either a positive
diagnosis of TMD or loss to follow-up and Qi = 0 otherwise.
We assume the censoring indicators are missing at random (MAR) as follows:
P (ξi = 0|Xi, Vi,∆i, Qi = 1) = P (ξi = 0|Xi, Vi, Qi = 1) (3.2)
In other words, the probability of having a missing censoring indicator may depend on
measured factors, but it does not depend on whether or not an event occurred. We will
denote the probability in (3.2) by ρ(Xi, Vi).
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3.3.2 Estimating Event Probabilities
We model the probability that participant i with a missing censoring indicator is a
case by a logistic regression model based on Xi and Vi:
P (∆i = 1|Xi, Vi, Zi, ξi = 0, Qi = 1)
= P (∆i = 1|Xi, Vi, Qi = 1)
=
exp(α′Xi + γVi)
1 + exp(α′Xi + γVi)
I(Qi = 1) (3.3)
That is, we estimate the probability of examiner-diagnosed TMD in a participant
who was not examined as intended. (Here I(x) denotes an indicator function.) The
probability was estimated using the time between enrollment and their last positive
screener as well as their answers on that screener. Then, for those individuals who
screened positively on the last screener (i.e. those with Qi = 1) and were not examined,
the estimated probability of being a case is estimated by (3.3) with the parameters
replaced by their respective estimates based on individuals who were examined.
Note that if there are repeated measures, we may use a generalized linear mixed
effects logistic regression model rather than a standard univariate logistic regression
model. For example, if some participants screen positively on more than one screener
and are examined at least once, then we have multiple observations per participant.
In that case, fitting a generalized linear mixed effects logistic regression model rather
than a standard logistic regression model would account for correlations between the
responses of the same participant.
3.3.3 Multiple Imputation
One popular method for handling missing data is multiple imputation. For a
comprehensive review on multiple imputation, see (103). Our imputation procedure
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is as follows:
(i) Estimate predicted probabilities as described in the previous section for observations
with missing censoring indicators. These are the individuals who screen positively
but are not examined by a clinician.
(ii) For each observation with a missing censoring indicator, generate a Bernoulli
random variable with success probability equal to the predicted probability found
in step (i).
(iii) Combine the raw data and imputed data from step (ii) to form a completed data
set.
(iv) Fit the Cox proportional hazards model to the completed data set.
(v) Record each parameter estimate βˆj and covariance matrix Uˆj.
(vi) Repeat steps (ii)-(v) for a total of m times, where m is the desired number of
imputations.
Next, we combine all of the estimates. The average parameter estimate is
β¯ =
1
m
m∑
j=1
βˆj, (3.4)
the within-imputation variance estimate is
U¯ =
1
m
m∑
j=1
Uˆj, (3.5)
and the between-imputation variance
Bˆ =
1
m− 1
m∑
j=1
(βˆj − β¯)(βˆj − β¯)′. (3.6)
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Finally, the estimated covariance matrix is
ˆV ar(β¯) = U¯ + (1 +
1
m
)Bˆ. (3.7)
3.3.4 Estimation of Incidence
Previous sections of this paper described how to estimate hazard ratios in the
presence of missing censoring indicators. It may also be of interest to estimate incidence
rates for the same event using Poisson regression instead of Cox regression. For example,
one of the aims of the OPPERA study is to estimate the incidence rate of first-onset
TMD.
In order to estimate incidence rates, we estimate the case probabilities as described
previously based on participants who screened positively and were examined. Then we
impute case status as described in section 3.3.3 for those who screened positively but
were not examined. However, in this case we fit Poisson regression models, rather than
Cox models, to the completed data sets. Finally, we calculate the incidence rate based
on the estimates of the regression coefficients in the Poisson model. Specifically, we use
the data from imputation j to fit the model
log(E(∆ij|Zi, Vi)) = α + β′Zi + log(Vi) (3.8)
where ∆ij denotes the j
th imputation for observation i, j = 1, . . . ,m. We combine the
m imputations using equation (3.4) and
α¯ =
1
m
m∑
j=1
αˆj. (3.9)
The estimated incidence rate for an individual with covariate Z∗ is given by exp(α¯ +
β¯Z∗).
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3.4 Simulations
Data with missing censoring indicators were simulated, and several possible methods
were compared with respect to bias, coverage, and confidence interval width. Survival
times for 1,000 individuals were generated with exponentially distributed failure times
under a proportional hazards model with covariates as proposed by Bender et al. (4).
That is, the survival time for each individual was distributed according to (3.1) where
λ0(t) = 1 is the baseline hazard. For our simulations, Zi = Xi1 was a single baseline
covariate following a normal distribution with mean 2 and unit variance. In other words,
the failure times Ti followed an exponential distribution with hazard exp(β
′Xi1) where
β ∈ {−0.5,−1.5,−3}. The censoring times Ci followed an exponential distribution
with mean 5. This yielded about 35%, 75% and 90% censoring for β = −0.5, β = −1.5,
and β = −3, respectively.
Covariates are represented by Xi1, a risk factor for TMD measured at enrollment,
and Xi2, a measurement collected on the last screener. For each observation, a normally
distributed covariate Xi2 was generated with mean ∆i and standard deviation 0.3,
representing a continuous measure of the likelihood of being identified as an incident
case of TMD. This was used to generate Qi = I(Xi2 > 0.5), an indicator of whether
participant i screened positive on their last screener. Also, ξi = I(∆i is observed)
corresponds to the indicator of whether participant i came in for their clinical exam if
Qi = 1. In all simulations, we set ∆i = 0 if Qi = 0 (i.e. the participant’s final screener
was negative). This decision was made to reflect the fact that OPPERA participants
who screened negatively were not examined.
We created missing censoring indicators under the following classical missing data
mechanisms of Rubin (101):
(I) The probability of having a missing censoring indicator is independent of the
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data. This is known as missing completely at random (MCAR).
(II) The probability of having a missing censoring indicator depends on an observed
covariate. This is known as missing at random (MAR).
(III) The probability of having a missing censoring indicator depends on the (potentially
unobserved) censoring indicator. This is known as missing not at random (MNAR).
Our method assumes that the data are MAR, which includes MCAR as a special
case. Our simulations under MAR and MNAR parallel the study protocol in that
censoring indicators can only be missing for those with positive screeners. In other
words, observations were potentially missing if and only if Qi = 1. (Individuals with
negative screeners have Qi = 0 and are assumed to be censored. Those with positive
screeners have Qi = 1 and may have missing clinical examinations.) Details and results
for MCAR and MNAR data are shown in Sections 6 and 6 in the Web Appendix.
We also considered several simulation scenarios where the logistic regression model for
predicting the censoring indicator was misspecified; see Section 6 in the Web Appendix.
For MAR data, we set censoring indicators to be missing with probability
ρi(Xi, Vi) = P (ξi = 0|Xi, Vi, Qi = 1) (3.10)
=
exp(−0.2− 0.3Xi1 + 0.1Vi)
1 + exp(−0.2− 0.3Xi1 + 0.1Vi) . (3.11)
In each simulated data set, all observations with observed censoring indicators who
had screened positively were used to fit a logistic regression model for case status with
covariates Xi1, Xi2 and Vi. That is, using the complete data (i.e. observations with
Qi = 1 and ξi = 1), we fit the logistic regression model for the event probability
conditional on X ′i = (1, Xi1, Xi2) and Vi, namely
logit{P (∆i = 1|Xi, Vi, Qi = 1, ξi = 1)} = α′Xi + γVi (3.12)
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The estimated probabilities pˆi =
exp(αˆ′Xi+γˆVi)
1+exp(αˆ′Xi+γˆVi)
were calculated for individuals with
Qi = 1.
To evaluate the performance of our method, multiple imputation was employed
to calculate 100 imputed estimates of β for each simulation as described in Section
3.3.3. For each observation i with Qi = 1 and ξi = 0, we estimated failure indicators
∆ˆij ∼ Bernoulli(pˆi) independently for each imputation j.
A Cox proportional hazards model was fit for each imputed data set, and the
imputed estimates of the regression coefficient and their variances were recorded. These
were aggregated using equations (3.4) and (3.7) to create confidence intervals for the
multiple imputation estimates.
The performance of our method was compared with that of the method of Cook and
Kosorok (8). To obtain the estimates of (8), for each simulated data set, we estimated
the probabilities pˆi that the (potentially unobserved) event for participant i is a true
event, as described previously. We then fit a weighted Cox proportional hazards model
to the data set. Two new observations were generated for observations with missing
censoring indicators. Each such pair of observations had the same failure time and
covariates, but different failure indicators and weights. The first observation had weight
pˆi and ∆ˆi = 1, and the second observation had weight 1− pˆi and ∆ˆi = 0. Participants
with fully observed data had unit weight. The estimated regression coefficient, βˆ was
recorded. The variance of this estimate was estimated by generating 1000 bootstrap
replicates of each simulated data set and refitting the model for each bootstrap replicate.
The average parameter estimate,
¯ˆ
β and percentile confidence intervals (β0.025, β0.975)
were all recorded, where βα is the α
th quantile among the 1000 bootstrap replicates.
We also compared our method to the ideal situation in which all data were observed,
complete case analysis (meaning that we exclude from the data set all observations with
missing censoring indicators), and two ad hoc methods in which we treat the missing
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indicators either all as censored or all as failures. Results under the assumption of MAR
are shown in Table 3.1. We estimated the bias of each method by calculating the mean
difference between the estimated Cox regression coefficient and the true coefficient over
the 1000 simulations. We also calculated the mean width of the confidence intervals
produced by each method over the 1000 simulations. Similarly, we calculated the
empirical coverage probability for the confidence intervals produced by each method by
dividing the number of times that the confidence intervals contained the true value of
the parameter by 1000. Finally, we report the Monte Carlo error for the coverage rate,
which is the error in the empirical coverage probability due to conducting only a finite
number of simulations (which would be
√
α(1− α)/n for n simulations).
The empirical coverage probability of the imputed confidence intervals is close to
the nominal level (0.95) in all simulations. Our multiple imputation method and the
method of Cook and Kosorok (8) produced approximately unbiased estimates and valid
confidence intervals in all the scenarios we considered. The estimates produced by the
other methods showed a larger amount of bias and did not always achieve the desired
coverage level. Our multiple imputation method also yielded the narrowest confidence
intervals in each scenario, although the method of Cook and Kosorok (8) produced
confidence intervals that were only slightly wider. Moreover, for most parameter values,
the coverage probabilities for the complete case and ad hoc methods were significantly
different (p < 0.01) from the nominal rate.
In addition, we examined the performance of our proposed methods when we
changed the logistic regression model for ∆i. We investigate two additional types
of models: one in which the model contained a variable unrelated to case status
and another in which the model does not include one variable related to case status.
As in the previous simulations, the failure times were generated by (3.1), censoring
was exponential with mean 5, failure indicators were set to be missing completely at
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random or missing at random with probability given in equation (3.10), Xi1 ∼ N(2, 1),
Xi2 ∼ N(∆i, 0.3) and Qi = I(Xi2 > 0.5) for i = 1, . . . , n. We also generated
Xi3 ∼ N(0, 1) where Xi1, Xi2, Xi3 were mutually independent.
In the previous simulations, we fit the data to (3.12) with Xi = {Xi1, Xi2}. The
additional simulations instead used the covariates and parameters as follows:
(A) X˜i = {1, Xi1, Xi2, Xi3}, α˜ = {α˜0, α˜1, α˜2, α˜3}
(B) X˜i = {1, Xi1} α˜ = {α˜0, α˜1} .
That is, rather than fitting model (3.12) to the data, we modeled the case probability
with
logit{P (∆i = 1|Xi, Vi, Qi = 1)} = α˜′X˜i + γVi. (3.13)
The results, which are shown in Section 6 in the Web Appendix, remained similar
under both alternative models. This indicates that the proposed methods are robust to
misspecification of the logistic regression model. Most notably, leaving out one covariate
that was weakly related to case status did not markedly decrease the performance of
the method.
Finally, we conducted simulations to evaluate the method’s ability to estimate
incidence rates. A similar multiple imputation strategy was applied to Poisson regression.
Our method produced estimates much closer to the true incidence rates than the
complete case estimate. In fact, the complete case method underestimated incidence
rates by as much as a factor of 3. See Section 6 in the Web Appendix for details.
3.5 Analysis of the OPPERA Study
In this section, we apply our method to estimate hazard ratios and incidence rates
in the OPPERA study.
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3.5.1 Hazard Ratios
We applied our method to the OPPERA cohort to adjust for the effect of participants
with missing clinical examinations. (Note that examinations for participants evaluated
by Examiner #4 were also treated as missing.) First, we estimated the probability
that a participant would be diagnosed as an incident case of TMD given a positive
screener. Due to the rich body of information collected in each screener, we carefully
selected a small number of predictor variables. Specifically, we fit a generalized linear
mixed model with a logistic link function to predict the result of the clinical exam based
on each item in the screener. A mixed model was used because a significant (n=113)
minority of participants screened positive more than once. All models were adjusted
for study site and included a random effect term for each participant.
The majority of the variables measured on the screener were not associated with
the result of the clinical examination. The strongest predictor of being diagnosed with
TMD was a count of non-specific orofacial symptoms (e.g stiffness, fatigue) in the
previous three months. The time elapsed since enrollment and OPPERA study site
were also important covariates, as shown in (1). Several other possible predictors of
being diagnosed with TMD were identified, but including these additional predictors
in the model did not significantly improve the predictive accuracy of the model. Thus,
we estimated the probability of being diagnosed with TMD based on the count of
non-specific orofacial symptoms, time since enrollment, and OPPERA study site. This
model was used to perform multiple imputation for those with no clinical examination.
These imputed data sets were used to fit a series of Cox proportional hazards models
to estimate the hazard ratio (and associated confidence interval and p-value) for each
predictor using the methods described in section 3.3.3. Examples of predictors include
perceived stress, history of comorbid chronic pain conditions, and smoking status.
In addition, Bair et al. (1) examined univariate relationships between examination
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attendance and numerous possible predictor variables. Differences between examined
and non-examined participants were small and most were not statistically significant.
However, this indicates that the data were not missing completely at random.
Table 3.2 shows the results of applying our method to a subset of the putative risk
factors of TMD measured in OPPERA. Due to the large number of putative risk factors
measured in OPPERA, we only report the results for a selected subset of the variables.
All continuous variables were normalized to have mean 0 and standard deviation 1
prior to fitting the Cox models. (Thus, the hazard ratios for the continuous variables
represent the hazard ratios corresponding to a one-standard deviation increase in the
predictor variable.) In Table 3.2, all the quantitative sensory testing and psychosocial
variables were continuous, while all of the clinical variables were dichotomous (and
hence were not normalized). For a more detailed description of the OPPERA domains,
see Section 6 in the Web Appendix, (75), and (113).
Compared to the unimputed results, which treated missing censoring indicators as
censored observations, imputation slightly reduced the hazard ratios for most of the
psychosocial variables that were measured in OPPERA. For instance, Table 3.2 shows
the (standardized) hazard ratios for the Pennebaker Inventory of Limbic Languidness
(PILL) score, the neuroticism subscale of the Eyesenk Personality Questionnaire (EPQ),
the Spielberger Trait Anxiety Inventory score, the Perceived Stress Scale, and the
somatization subscale of the Symptom Checklist-90, Revised (SCL-90R). In each case,
the hazard ratios were reduced after imputation.
A similar pattern was observed after applying our imputation method to the measures
of experimental pain sensitivity. The mechanical pain aftersensation ratings were
strongly associated with first-onset TMD before imputation, but they were only weakly
associated with first-onset TMD after imputation. The pressure pain algometer ratings
were also more weakly associated with TMD after imputation (and two of three ratings
36
in Table 3.2 were no longer significantly associated with first-onset TMD at the p < 0.05
level).
Interestingly, the hazard ratios for the presence of one or more palpation tender
points at the temporalis and masseter muscles were also attenuated after imputation.
These tender points were evaluated as part of the clinical examination using a different
protocol than the quantitative sensory testing algometer pain ratings. However, both
pain measures (algometer and palpation) were measured at the same facial locations.
While the palpation ratings were more strongly associated with first-onset TMD than
the algometer ratings both before and after imputation, it is interesting that different
pain sensitivity measures using different protocols at the same anatomical location were
both attenuated by imputation.
The effects of other clinical variables were also attenuated after imputation. For
example, the hazard ratios associated with being unable to open one’s mouth wide in
the past month and having two or more comorbid pain conditions were both noticeably
attenuated after imputation. However, other clinical variables were more strongly
associated with first-onset TMD after imputation. For example, having a history of
respiratory illness was only weakly associated with first-onset TMD before imputation
(HR=1.38, p=0.04), but the association was much stronger after imputation (HR=1.43,
p=0.004). Also, being a current smoker was not significantly associated with first-
onset TMD before imputation (HR=1.26, p=0.24) but was associated after imputation
(HR=1.49, p=0.02).
3.5.2 Incidence Rates
In Table 3.3, the incidence rate of first-onset TMD was estimated using two different
approaches. First, all missing censoring indicators were treated as censored. Second,
the multiple imputation method in this paper was used to estimate the incidence rate.
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The estimated TMD incidence rate using multiple imputation was 66% greater than
the unimputed estimate. The estimated incidence rate increased by 64% for females
and 72% for males. Estimated incidence rates for whites and Hispanics were 99% and
193% higher, respectively, with imputation. Thus, the incidence rate is likely to be
underestimated without imputation.
3.6 Discussion
We have developed a computationally efficient method to adjust for missing censoring
indicators in time-to-event data using logistic regression and multiple imputation.
Logistic regression is used to estimate the failure probability for participants with
missing censoring indicators. The missing values are imputed, and the standard errors
are estimated using our multiple imputation method. This framework is important in
studies where failure status may be measured in stages, which may lead to missing
censoring status indicators. This is a common occurrence in studies of diseases that
are difficult or expensive to diagnose, such as TMD.
The present method is similar to the method of Magder and Hughes (74), who
use an iterative procedure for parameter estimation based on the EM algorithm. Our
assumption of MAR data renders their iterative method unnecessary. Other methods
(78, 43, 122) depend on the MCAR assumption, which does not hold for the OPPERA
study. Chen et al. (6) estimate Cox regression parameters using the EM algorithm
and establish their consistency under basic regularity conditions, including missing
at random (MAR) censoring indicators. However, their approach depends on the
assumptions of piecewise constant proportional hazard functions for the censoring time
as well as for the failure time.
In each simulation scenario, our multiple imputation method produced the narrowest
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valid confidence intervals and no significant bias. In particular, the method of Cook and
Kosorok (8) produced slightly wider confidence intervals in all but one of the simulations
we considered. The differences were extremely small, so the performance of the two
methods appear to be comparable for most practical purposes. However, we believe
that our method has several possible advantages over the method of Cook and Kosorok
(8). First, bootstrapping is much more intensive computationally than our multiple
imputation approach. Calculating bootstrap confidence intervals generally requires
at least 1000 bootstrap replicates (33), whereas as few as 10 imputed data sets may
be sufficient for multiple imputation (70). Although the difference in the computing
time of the two methods is small for a single fitted model, many such models will be
required in the course of the OPPERA study. OPPERA has already collected data on
approximately 3000 genetic markers and has plans to collect data on approximately a
million genetic markers in a genome-wide association study. Thus, at least 3000 (and
potentially as many as a million) Cox models will need to be fit, and our proposed
method may allow for a significant decrease in computing time. Moreover, our method
can also be easily implemented in popular statistical software packages (such as SAS)
without additional programming.
Additionally, our methodology may easily be extended to other models, such as
Poisson regression. We conducted simulations (Table A1.10 in the Web Appendix) that
showed that our proposed method can be used to estimate incidence rates using Poisson
regression, which is one of the research aims of the OPPERA study. In particular,
estimates of the failure rates were biased when missing censoring indicators were treated
as censored or when the complete case method was used, but they were unbiased when
we employed the methodology in this paper. The method of Cook and Kosorok (8)
cannot be used for incidence rate estimation.
Our method may yield increased bias and decreased coverage if the logistic regression
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model for predicting case status is inaccurate, as observed in the simulations in Section
6 in the Web Appendix. However, this would also be true for competing methods,
including the method of (8).
In the OPPERA study, the hazard ratios associated with some variables were
noticeably different after imputation. Although other results remained qualitatively
unchanged, we note that even small changes in hazard ratios are important. In addition,
estimated incidence rates were significantly increased after imputation. Since the results
of OPPERA may become normative in the orofacial pain literature, precise calculation
of the incidence rate of TMD and the hazard ratios associated with putative risk factors
is important. Thus, imputation is recommended.
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Table 3.1: Simulation Results for MAR
β Method Bias SE (Bias) Width SE (Width) Coverage*
-0.5 Full Data -0.0005 0.0006 0.1668 0.0001 0.938
Complete Case 0.0018 0.0007 0.2155 0.0001 0.951
Treat all as Censored 0.1053 0.0007 0.2131 0.0001 0.494
Treat all as Failures 0.0018 0.0006 0.1701 0.0001 0.941
Cook & Kosorok -0.0010 0.0006 0.1738 0.0001 0.943
Multiple Imputation -0.0010 0.0006 0.1716 0.0001 0.938
-1.5 Full Data -0.0008 0.0010 0.3185 0.0002 0.966
Complete Case -0.0626 0.0015 0.4343 0.0003 0.930
Treat all as Censored 0.1215 0.0014 0.4229 0.0003 0.778
Treat all as Failures 0.0680 0.0010 0.3160 0.0002 0.852
Cook & Kosorok 0.0002 0.0011 0.3412 0.0004 0.951
Multiple Imputation 0.0002 0.0011 0.3309 0.0002 0.961
-3 Full Data -0.0301 0.0025 0.7627 0.0009 0.957
Complete Case -0.1996 0.0037 1.0840 0.0017 0.913
Treat all as Censored 0.0987 0.0035 1.0417 0.0016 0.919
Treat all as Failures 0.5875 0.0024 0.6307 0.0006 0.104
Cook & Kosorok -0.0275 0.0027 0.9112 0.0017 0.946
Multiple Imputation -0.0282 0.0027 0.8057 0.0011 0.947
*: The Monte Carlo error is 0.007.
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Table 3.2: Results from the OPPERA Study
Treat All MCIs as Censored Multiple Imputation
HR LCL UCL P HR LCL UCL P
Clinical Variable
In the last month
3.26 1.83 5.84 <0.0001 2.45 1.42 4.22 0.0012
could not open mouth wide
Has two or more comorbid 3.08 2.26 4.21 <0.0001 2.50 1.90 3.29 <0.0001
chronic pain disorders
History of 5 respiratory conditions 1.38 1.01 1.87 0.0408 1.45 1.13 1.87 0.0040
Smoking: current 1.26 0.86 1.84 0.2403 1.49 1.07 2.09 0.0199
Smoking: former 1.87 1.22 2.87 0.0041 1.65 1.12 2.43 0.0106
One or more palpation tender
1.83 1.32 2.52 0.0002 1.54 1.18 2.02 0.0017
points: right temporalis
One or more palpation tender
1.60 1.14 2.25 0.0064 1.48 1.12 1.97 0.0060
points: left temporalis
One or more palpation tender
1.85 1.35 2.53 0.0001 1.63 1.25 2.12 0.0003
points: right masseter
One or more palpation tender
1.70 1.23 2.35 0.0013 1.53 1.17 2.01 0.0021
points: left masseter
Quantitative Sensory Testing Variable
Pressure pain threshold: temporalis 1.26 1.07 1.49 0.0065 1.16 1.01 1.33 0.0335
Pressure pain threshold: masseter 1.23 1.04 1.45 0.0170 1.15 1.00 1.32 0.0576
Pressure pain threshold: TM joint 1.25 1.05 1.48 0.0106 1.14 1.00 1.30 0.0555
Mechanical pain aftersensation:
1.23 1.09 1.38 0.0006 1.15 1.03 1.28 0.0123
512mN probe, 15 s
Mechanical pain aftersensation:
1.20 1.07 1.34 0.0020 1.12 1.01 1.25 0.0328
512mN probe, 30 s
Psychosocial Variable
PILL Global Score 1.52 1.35 1.71 <0.0001 1.46 1.31 1.62 <0.0001
EPQ-R Neuroticism 1.39 1.21 1.60 <0.0001 1.26 1.12 1.42 0.0002
Trait Anxiety Inventory 1.43 1.25 1.64 <0.0001 1.35 1.21 1.52 <0.0001
Perceived Stress Scale 1.35 1.17 1.55 <0.0001 1.30 1.16 1.47 <0.0001
SCL 90R Somatization 1.44 1.31 1.58 <0.0001 1.40 1.29 1.52 <0.0001
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Table 3.3: Estimated TMD Incidence Rates With and Without Imputation
No MI MI Percent Change
Overall 2.23 3.70 66
Males 1.87 3.22 72
Females 2.46 4.03 64
White 1.70 3.37 99
Black 4.20 5.32 27
Hispanic 1.17 3.44 193
Other 1.10 1.80 63
Incidence rates are given in cases per 100 person-years.
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CHAPTER 4: MODELING SECONDARY PHENOTYPES
CONDITIONAL ON GENOTYPES IN
CASE-CONTROL STUDIES
4.1 Introduction
Prospective studies are more straightforward and less prone to confounding than
other study designs. However, they may require either extremely long follow-up periods
or large sample sizes and lack power. For rare diseases, in particular, the sample
sizes required in a prospective cohort study to have adequate statistical power to test
hypotheses of interest may be prohibitively large. This can be especially problematic in
genetic association studies, which may cost thousands of dollars per participant just to
extract their genetic profiles. Retrospective case-control studies are more cost-effective.
The number of case-control studies focusing on the relationship between genetics and
disease outcomes has grown astronomically in recent years.
It is well known that when modeling the probability of case status in a case control
design, simple logistic regression may be used to model the primary outcome as if
the study were prospective (95). However, researchers may design studies based on
one outcome but study outcomes of secondary interest simultaneously or via a new
follow-up study. Without proper care, analysis of secondary phenotypes in case-control
studies may be problematic. Standard methods, such as logistic regression, may be
biased, inefficient, or lead to misleading inference. The standard method of unweighted
regression on the full case control sample and the method of adjusting for case status
with an indicator variable have inflated type I error when the disease is not rare, (82).
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The popular practices of restricting to cases or restricting to controls greatly reduce
efficiency and may be subject to bias.
This methodological work arose in consideration with data from the Orofacial
Pain: Prospective Evaluation and Risk Assessment (OPPERA) Study (113). The
OPPERA study was primarily designed to identify risk factors for temporomandibular
disorders (TMD). In addition to the cohort of initially-TMD-free adults enrolled in
the prospective cohort study, people with examiner-verified chronic TMD were were
enrolled to create an unmatched, case-control study. A large number of putative risk
factors were collected at enrollment (75). In particular, investigators seek to explain
relationships between TMD and other chronic pain conditions. One putative risk factor
of interest in its own right is the (ordinal) number of comorbid pain conditions a
subject experiences. The genetic information collected may be predictive of comorbid
conditions as well as of TMD. There currently are no readily available methods to assess
the relationship between comorbid conditions, a secondary phenotype, and individual
candidate genes.
Over the past five years, some methods have been proposed for analyzing secondary
phenotypes in case-control studies. For logistic regression, (97) recommends weighting
subjects from a nested prospective case-control study by the reciprocal of their probability
of selection. This stratum-weighted logstic regression method, also called inverse probability
weighting (IPW), achieves the nominal type I error rate but can be less efficient than
the standard unadjusted method or the method of adjusting for case status (82). (Yet,
in light of the fact that the method of adjusting for case status may have inflated type I
error, the lower power of IPW is less alarming.) More significantly, the IPW estimator
of (97) may merit a correction factor for the standard error. (82) provides a robust
sandwich estimator for the variance based on generalized estimating equations (GEE),
which applies to both continuous and binary outcomes.
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(66) propose a likelihood based method for both continuous and binary outcomes
that is more powerful than the IPW method, but the results may be biased and
have inflated size when there is significant interaction between the genotypes and the
original outcome (63, 47). (140) propose a bootstrap estimate for binary outcomes.
They first derive non-linear equations relating the logistic regression coefficients to
known sample sizes and prevalence estimates for the primary disease and secondary
phenotype. Then they calculate the unadjusted parameter estimate and standard error,
resample parameter estimates from a normal distribution with that mean and standard
error, refine the estimate for each replication by solving the aforementioned non-linear
equations, and then using the percentile method for confidence intervals. They also
adapt their bias correction method to the frequency-matched case-control study design
and extend the IPW method to retrospective case-control studies using an estimate of
primary disease prevalence to calculate weights. (141) demonstrate that these methods
have greater efficiency than the IPW method, but they assume that the secondary
phenotype and covariates are binary and there is no gene-environment interaction.
When there is gene-environment interaction and the disease is rare (63) recommend
estimation with adaptive weighting motivated by a Bayesian shrinkage estimator. (47)
discuss joint modeling based on Gaussian copulas for the analysis of multiple secondary
phenotypes in the exponential family. The copula method has controlled type I error
and is more powerful than the IPW method.
The aforementioned methods may not be appropriate for all applications. First,
the IPW method of (97) may require an adjustment to the standard error and was
originally only designed to apply to binary outcomes. As far as we know, there are no
methods that can be applied to secondary phenotypes outside the exponential family.
Time-to-event outcomes, for example, may be of clinical interest, and may be present
in large studies, such as OPPERA. Sequencing studies also utilize more complicated
46
test statistics outside of the exponential family. Additionally, there is a lack of software
that may be easily implemented.
In this paper, we propose a method for analyzing secondary phenotypes in case-
control genetic association studies. We advocate using the IPW method of (97) for
parameter estimation, but estimating the standard error via bootstrapping. This
maintains the simplicity and intuitiveness of IPW and generalizes it to a wider variety of
situations than previously considered, while providing a valid estimate of the standard
error. Our method can handle arbitrary types of analyses, including time-to-event and
nonparametric methods, as well as logistic regression and linear models as described
in the current literature. Moreover, unlike other methods in the literature, IPW can
be easily generalized to outcomes for which no existing method applies. We describe
our methodology in detail in section 4.2. Simulations are presented in section 4.3. The
method is applied to the OPPERA study in section 4.4. We conclude with a discussion.
4.2 Proposed Method
Consider a case-control study consisting of n cases and m controls. Let Zi, a
p× 1 vector, denote covariate information, Di denote the case-control status (1=case,
0=control), and Yi denote the secondary phenotype for i = 1, . . . , n + m. In the
OPPERA study, Zi denotes the number of copies of the minor allele, Di is an indicator
of whether participant i is a chronic case of TMD, and Yi is the number (0,1,2+)
of comorbid pain conditions for participant i. If one were to ignore the case-control
study design and consider the data as a random sample from the population, then one
would use standard methodology to study the relationship between Yi = (Y1, . . . , Yn+m)
′
and Z = (Z1, . . . , Zn+m)
′. Denote the log-likelihood under the assumption of random
sampling as l(θ|Yi, Zi) where θ is a q × 1 vector of model parameters.
The IPW method of (97) simply weights standard analyses appropriately to account
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for over-sampling of cases. Specifically, in a prospective (nested) case-control study, if
we denote fca as the sampling fraction for cases and fco as the sampling fraction for
controls, we use wi = 1 as the weight for cases and wi =
fca
fco
as the weight for controls.
For retrospective case-control studies, the weights may be estimated as in (140) by
wi = 1 for cases and wi =
n(1−pe)
mpe
for controls. We may write wi(Di) = Di + (1−Di)wi.
The weighted log-likelihood is the weighted sum of the log-likelihood of each observation
lW (θ|Y, Z,D) =
m+n∑
i=1
wi(Di)l(θ|Yi, Zi) (4.1)
where l(θ|Yi, Zi) = log[f(Yi|Zi)] if Y is continuous or l(θ|Yi, Zi) = log[P (Yi|Zi)] if
Y is discrete. For example, if Yi is binary, one would typically use weighted logistic
regression with
lW (θ|Y, Z,D) =
m+n∑
i=1
log[P (Yi = 1|Zi, Di)] =
m+n∑
i=1
wi(Di){Yiα′Zi − log[1 + exp(α′Zi)]}
(4.2)
If Yi is continuous, a weighted linear model could be utilized,
lW (θ|Y, Z,D) =
m+n∑
i=1
log[f(Yi|Zi, Di)] =
m+n∑
i=1
wi(Di)[− log(2piσ
2)
2
− (Yi − α
′Zi)2
2σ2
] (4.3)
where V ar(Yi) = i ∼ N(0, σ2).
If (Yi,∆i) is a (possibly censored) time-to-event outcome with failure time Ti and
censoring time Ci and Yi = min(Ti, Ci) and ∆i = I(Ti < Ci), then one may use a
proportional hazards model,
λTi(t|Zi) = λ0(t)exp(β′Zi) (4.4)
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with weighted log-partial-likelihood given by
lW (Y |Z,D) =
m+n∑
i=1
wi(Di)∆i{β′Zi − log[
m+n∑
l=1
wl(Dl)I(Yi < Yl)exp(β
′Zl)]} (4.5)
We propose the use of bootstrapping to estimate the standard error of the estimate
of interest. We select R samples from the empirical distribution of the original data.
For each bootstrap replication, we apply the IPW method described above.
Specifically, let (D, Y, Z) denote the data with empirical cdf f , and let (D∗r , Y
∗
r , Z
∗
r )
denote bootstrap replications for r = 1, . . . , R. The first step is to fit a model to
(D∗r , Y
∗
r , Z
∗
r ) using the weighted log likelihood (4.1) for each replication. The variance of
the parameter estimate is given by the estimated variance of the R bootstrap parameter
estimates. Confidence intervals may be generated by the percentile method, BCa
method, bootstrap-t, or a normal approximation. Standard software, such as the boot
package in R, can easily generate these estimates.
4.3 Simulation Study
4.3.1 General Setup
We simulated data under the framework in (66). In order to have n cases and m
controls, we generated ns =
3max(m,n)
pe
observations where pe is the estimated prevalence
of cases in the population. This ensured there would be enough cases and controls
in each dataset. Next, we generated case status as detailed below. Lastly, we used
rejection sampling to select a subset of the cases and controls of the desired sample
size.
For all subjects in the large dataset, i = 1, . . . , ns, we assume that the relationship
between case-control status, Di, the number of copies of the minor allele, Zi, and
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the secondary phenotype, Yi, is given by a logistic regression model based on the
genetic profile and secondary phenotype. The distribution of each type of outcome
and corresponding specific form of the logistic regression model are given in sections
4.3.2, 4.3.3, and 4.3.4 for binary, ordinal, and time-to-event outcomes, respectively.
Each equation specifies that the probability of being a case of the primary disease
(rather than a control) depends on the status of the genetic profile and the secondary
phenotype. The inheritance model is assumed to be additive. We assumed an estimated
prevalence of D of 10% and a minor allele frequency of 30%.
Finally, we form a dataset consisting of the first n cases and m controls. For each of
these simulations, we generated 1000 datasets each with n = 1000 cases and m = 1000
controls. For each method and scenario, we estimated the value of the parameter
relating the secondary phenotype and the number of copies of the minor allele. (This
was the log-odds ratio or log-hazard ratio depending on the type of outcome.) Average
bias, empirical coverage, and average confidence interval width were compared between
our method, and the naive methods that restrict to cases, restrict to controls, or adjust
for case-control status using an indicator variable. We also compared performance to
the IPW with GEE method of (82) when applicable, i.e. for continuous outcomes.
4.3.2 Continuous Phenotypes
For continuous secondary phenotypes, we assume a standard linear model with
normally distributed errors, i ∼ N(0, σ2),
Yi = β0 + β1Zi + i. (4.6)
where Xi is defined in section 4.3.1, and case status is defined by
logit[P (Di = 1|Yi, Zi)] = γ0 + γ1Zi + γ2Yi. (4.7)
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Our simulations included the parameters β0 = 0, β1 = −0.12,−0.5,−1,−2 and
γ1 = log(2), log(3), log(5), log(10), γ2 = log(2) and σ
2 = 1.
In order to keep the prevalence approximately constant, we set the value of γ0
separately for each simulation, according to
γˆ0 = log(
peexp(−1 ∗ X˜)
1− pe ) (4.8)
where
X˜ = γ1Z¯ + γ2Y¯ . (4.9)
and Z¯ = 1
ns
∑ns
i=1 Zi and Y¯ =
1
ns
∑ns
i=1 Yi are the averages of the i = 1, . . . , ns Zi and Yi
values.
The parameter of interest was β1. Considering continuous outcomes facilitated
comparison to the IPW with GEE method of (82).
Simulations with continuous outcomes yielded the following results. In all scenarios,
our method had negligible bias and coverage rate near 95%, as desired. Performance
in terms of bias, coverage, and confidence interval width was comparable to that of
(82). The bootstrapping-IPW method had comparable bias to the method of (82) and
less bias than all other methods. Details are found in Table 4.1. This shows when
competing method are applicable, our method does at least as well as, if not better
than the competitors.
4.3.3 Ordinal Phenotypes
We tested four scenarios for ordinal phenotypes with 3 levels. For simplicity, we will
denote these Yi = 0, Yi = 1 and Yi = 2. In general, we generated the ordinal outcomes
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with the following probabilities
p0 = P (Yi = 0) = exp(ζ0 + βZi)/(1 + exp(ζ0 + βZi))
p1 = P (Yi = 1) = exp(ζ1 + βZi)/(1 + exp(ζ1 + βZi))− p0
p2 = P (Yi = 2) = 1− p1 − p0
For all subjects, i = 1, . . . ,m + n, we assume that the relationship between case-
control status, Di, the number of minor allele copies, Zi, and the secondary phenotype,
Yi, is given by the following logistic regression model
logit[P (Di = 1|Yi, Zi)] = γ0 + γ1Zi + γ2aI(Yi = 1) + γ2bI(Yi = 2). (4.10)
where
Y¯ = γ2a(
∑m+n
i=1 I(Yi = 1)
m+ n
) + γ2b(
∑m+n
i=1 I(Yi = 2)
m+ n
) (4.11)
is used to define the average outcome in equation (4.9) and thus the value of γ0 in (4.8).
For the four scenarios, we used the following parameters:
1. β = 0.5, ζ0 = 1.5, ζ1 = 2.5, and γ1 = γ2a = γ2b = log(2)
2. β = 1, ζ0 = 0, ζ1 = 1, and γ1 = γ2a = γ2b = log(2)
3. β = 0.75, ζ0 = 1, ζ1 = 2, and γ1 = γ2a = γ2b = log(2)
4. β = 0.5, ζ0 = 1.5, ζ1 = 2.5, γ1 = γ2a = log(2), and γ2b = log(3).
Our weighted bootstrap method has less bias than all other methods. None of the
other methods have adequate coverage for these ordinal simulations. Results are given
in Table 4.2.
53
4.3.4 Time-to-Event Phenotypes
Survival outcomes were generated as in (4) with exponential failure and censoring
times. The failure time Ti satisfies equation (4.4) where λ0(t) = 1 for all t, β = −1
and Zi is the minor allele frequency. The censoring time was exponential with shape
parameter 2. The parameter of interest was β and the outcome of interest was (Yi,∆i)
where Yi = min(Ti, Ci) and ∆i = I(Ti < Ci). This yielded about 84% censoring.
Case status in similar to equation (4.7) for continuous outcomes, but instead depended
on the true failure time rather than the observed time as follows
logit[P (Di = 1|Xi, Ti)] = γ0 + γ1Xi + γ2Ti. (4.12)
The value of γ0 was set by equation (4.8) with X˜ defined by equation (4.9) and X¯ and
Y¯ defined as in section 4.3.2. We used γ1 = γ2 = log(2).
For time-to-event outcomes, our method retained empirical coverage around 95%
and had less bias than all other methods. None of the other methods have adequate
coverage, except the method that adjusts for case status. However, the latter method
was overly conservative. See Table 4.3 for details. Other methods do not apply for this
type of outcome. Consequently, no comparison is made.
4.4 Data Application
We applied the method to baseline case-control genetic study within OPPERA.
The prospective cohort study consisted of 3263 healthy TMD-free volunteers and 186
volunteers determined at baseline to have TMD. All 186 cases were retained and 1633
controls were randomly selected into the baseline case-control study.
The covariates of interest were 2924 SNPs collected in a genetic association study
of 3037 participants (115). The outcome was the number of co-morbid conditions,
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categorized as either zero, one, or more than one co-morbid condition. Upon enrollment
in OPPERA, participants self-reported by checking experience with a list of 20 conditions
on the Comprehensive Pain and Symptom Questionnaire (CPSQ). Examples of chronic
pain conditions include arthritis, fibromyalgia, irritable bowel syndrome, include chronic
pelvic pain, among others. All cases and 1626 controls filled out the CPSQ, (87).
Combining these yielded 166 cases and 1435 controls with information available on
both their history of comorbid conditions and their genetic profiles. Recruited from 4
study sites and ranged from 18 to 44 years in age, these 1601 individuals comprise the
proceeding analysis. For more details on the OPPERA study design, see (113, 75, 115,
87).
For each SNP with less than 5% missing values, we fit a proportional odds model
to the data, adjusting for study site, age, gender, and two racial eigenvectors.
We collected the p-values and created QQ-plots of the negative logarithm of the
p-values for the standard unweighted method and for our weighted bootstrapping
method. The plots indicate that neither method found any SNPs that were significantly
associated with comorbid pain conditions after adjusting for multiple comparisons. See
Figures 4.1 and 4.2.
4.5 Discussion
Our proposed method for analysis of intermediate phenotypes in case-control studies
of genetic data is simple and easily implemented in standard software. The simulation
results indicate that it is approximately unbiased, has comparable coverage and confidence
interval width to the method of IPW with GEE by (82). Under situations in which the
method of (66) is applicable, their method should be more powerful than our proposed
method.
Our method is general enough to allow for analysis of multiple outcomes simultaneously
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and for outcomes for which previous methodology not applicable. Multiple outcomes
could be analyzed using standard multivariate methods but weighting each observation
as described in this paper, and bootstrapping to estimate the standard error. Currently,
our method is the only viable way to evaluate secondary time-to-event outcomes in
case-control studies. More importantly, the method can be applied to complicated test
statistics where there is no existing formula for the standard error, such as the many
test statistics employed in sequencing studies. It is worth noting that our procedure
is computationally non-trivial due to the use of bootstrapping, but the runtime is
reasonable for modern computers. For 1000 runs of the survival scenario with 100
bootstrap replications, for instance, the output of proc.time was 773.288 or about 13
seconds of elapsed time.
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Figure 4.1: QQ Plot for the Unweighted Method
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Figure 4.2: QQ Plot for the Weighted Bootstrap Method
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Table 4.2: Results of Simulations for Intermediate Ordinal Phenotypes
Method Result
Scenario 1 Scenario 2 Scenario 3 Scenario 4
Naive (Bias) -0.054 -0.068 -0.053 -0.069
Controls only (Bias) 0.075 0.051 0.063 0.093
Cases only (Bias) 0.805 -0.815 0.226 0.903
Adjusted for case status (Bias) 0.057 0.027 0.054 0.101
Bootstrap (Bias) 0.02 0.006 0.015 0.015
Naive (Coverage) 0.909 0.836 0.91 0.871
Controls only (Coverage) 0.937 0.937 0.948 0.933
Cases only (Coverage) 0 0 0 0
Adjusted for case status (Coverage) 0.904 0.937 0.913 0.824
Bootstrap (Coverage) 0.943 0.944 0.948 0.951
Bootstrap (Width) 0.519 0.399 0.477 0.512
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Table 4.3: Results of Simulations for Intermediate Time-to-Event Phenotypes
Method Result
Naive (Bias) -0.457
Controls only (Bias) 0.272
Cases only (Bias) -0.800
Adjusted for case status (Bias) 0.091
Bootstrap (Bias) -0.017
Naive (Coverage) 0.006
Controls only (Coverage) 0.396
Cases only (Coverage) 0.225
Adjusted for case status (Coverage) 1.000
Bootstrap (Coverage) 0.944
Bootstrap (Width) 0.439
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CHAPTER 5: SPARSE FACTOR ANALYSIS
5.1 Introduction
In many studies, we collect a large amout of data for each participant. The covariates
may be largely correlated and repetitive. Thus, it may be of interest to reduce the
covariates to a more manageable subset. Principal components analysis (PCA) and
exploratory factor analysis (EFA) are two classical methods designed for this purpose.
PCA calculates linear combinations of the variables which explain the maximal amout
of variance in the factors. EFA, by contrast, assumes that the observed variables are
a linear combination of a number of latent factors. However, the results of both PCA
and EFA are usually very difficult to interpret and may not be as sparse as desired.
It is desirable to have sparse loadings, meaning that most loadings are equal to zero
and only a small subset are nonzero. Sparse loadings facilitate solutions that are more
intuitive and make practical sense in real data applications.
Consequently, new methods have been proposed recently in the interest of sparsity.
(157) proposed an iterative method for sparse principal component analysis based on
elastic net. (147) proposed another iterative method for sparse principal component
analysis that maximizes the percentage of variance explained using penalized matrix
decomposition.
However, the aforementioned methods are not immediately applicable to the framework
of factor analysis. Factor analysis is commonly used for psychometric data, when it is
reasonable to assume that there are a small number of latent factors which drive the
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observed variables and simple interpretations are of the utmost importance. Compared
to principal component analysis, factor analysis by design sacrifices variance explained
for interpretability. Similarly, the increase in variance explained by iterating the method
of (147) may come with a decrease in interpretability.
Consider the Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA)
study, a large multicenter study of temporomandibular disorders (TMD). Researchers
measured a large number of covariates related to orofacial pain. Within the quantitative
sensory testing domain, (46) uses EFA to identify five underlying clinically meaningful
components of the data. Similar analyses (76, 37) were performed for data on the
autonomic nervous system function and psychosocial responses. Unfortunately, the
loadings are not sparse for any of these domains. Investigators would like to be able
to succintly explain latent factors that explain first-onset and chronic TMD, identify
variables that do not add additional information after accounting for the other variables,
and reduce the number of variables collected for follow-up studies.
We seek a method that generalizes EFA to have sparse loadings. However, because
we would like to use the loadings to predict TMD-related outcomes, we want to make
sure that the most important covariate information is not lost. In short, we propose
a method of sparse factor analysis that is predictive of first-onset and chronic TMD,
while minimizing the loss in variance explained compared to other methods. In section
5.2, we discuss our proposed method. In section 5.3, we show how the method performs
in simulations. In section 5.4, we apply the method to the OPPERA study.
5.2 Proposed Methodology
5.2.1 Notation
This paper generalizes the method of (147) to the EFA setting with sparse loadings.
Assume there are n subjects and p covariates. Let X = (Xi, . . . , Xn)
′ be an n×p matrix
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containing the covariate information, rank(X) = K ≤ min(n, p), and E[Xi] = µi. We
assume that there are k latent factors for each individual i, represented by the k × 1
vector Fi = (F1i, . . . , Fki)
′, Fji is a 1-dimensional unobserved random variable for all
i = 1, . . . , n and j = 1, . . . , k, and F = (F1, . . . , Fn)
′ is a n× k matrix of these factors.
Often Also, X − µ = FL′ + , where L is a p× k matrix of factor loadings,  is a n× p
matrix of random errors, µ = E[X], E(ij) = 0, V ar(ij) = σ
2
ij and Cov(ij, i′,j′) = 0
as long as i = i′ and j = j′ are not both true. We assume that E[F ] = 0, Cov(Fi) = I
for all i, and F and  are independent.
In the OPPERA study, X is the matrix of all p variables collected on n individuals
for a given domain, such as quantitative sensory testing (QST). The factors F denote a
matrix of unobserved variables that affect our measurements in that domain. We seek
to reduce the number of variables collected to a subset of k interpretable components
that explain a maximal amount of variance in our measurements within that domain.
The singular value decomposition (SVD) of X is given by X = UDV ′ where U is an
n× n matrix, V is a p× p matrix, D is a n× p rectangular diagonal matrix U ′U = In
and V ′V = Ip. Denote uj and vj as the jth columns of U and V , respectively. The
notation ||M ||F denotes the Frobenius norm of a matrix M .
The soft threshholding function is given by S(x, c) = sign(x)(|x| − c)+ where y+ =
yI(y > 0). In other words, if possible, softthresholding reduces each coefficient by c in
absolute value. Otherwise, it sets the coefficient to zero. Practically, this means that
coefficients whose values are nonzero but too small to be practically meaningful are set
exactly equal to zero.
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5.2.2 Background Information
The optimization problem in (147) is to
Minimize d,u,v||X−duv′||2F subject to P1(u) < c1, P2(v) < c2, ||u||22 = 1, ||v||22 = 1, d > 0
(5.1)
where P1 and P2 are convex penalty functions, u is a n×1 vector, and v is a p×1 vector.
Typically the Lasso penalty, P1(u) = ||u||1 is used. We may rewrite the optimization
using theorem 2.1 in (147), reproduced here:
Theorem 1. Let U and V be n×K and p×K orthogonal matrices and D a diagonal
matrix with diagonal elements d1, . . . , dk . Then,
1
2
||X − UDV ′||2F =
1
2
||X||2F −
K∑
k=1
ukXvkdk +
1
2
K∑
k=1
dk
2
Applying Theorem 1 with K = 1 reduces problem (5.1) to
Maximize uu
′Xv subject to P1(u) < c2, P2(v) < c2, ||u||22 = 1, ||v||22 = 1. (5.2)
where the sole diagonal element d1 = d is positive. In order to have a convex solution,
problem (5.2) is redefined as
Maximize uu
′Xv subject to P1(u) < c2, P2(v) < c2, ||u||22 ≤ 1, ||v||22 ≤ 1 (5.3)
Finally, (147) impose constant L-1 norm penalties on u and v to yield the following.
Maximize u′Xv subject to ||v||1 < c2, ||u||22 ≤ 1, ||v||22 ≤ 1 (5.4)
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and
Maximize u′Xv subject to ||u||1 < c1, ||u||22 ≤ 1, ||v||22 ≤ 1 (5.5)
In short, for the first factor, they propose an iterative algorithm, solving (5.4) for
u based on fixed v, solving (5.5) for v based on the esimate for u and repeating until
convergence. Specifically, in (147), see Algorithms 1 and 2 for the single and multiple
factor solutions, the special form given in Algorithm 3, and the notes about sparsity in
section 3.2 for more details.
5.2.3 Our Algorithm
First, we center and scale X, resulting in the matrix Xs. We perform traditional
factor analysis on Xs and extract the factor loadings vf1, . . . , vfk for k factors. We
perform soft threshholding on the k factors and normalize the results to yield v1, . . . , vk.
Next, for each factor, we update u based on Xs and v. Namely, u1 = Xsv1/||Xsv1||,
and for j = 2, . . . , k, uj = j where y˜j = Xsvj, X˜j = (u1, . . . , uj−1) denotes the first
j − 1 columns of U , and uj is the set of residuals from the least squares equation
y˜j = X˜jβj + j (5.6)
The following algorithm summarizes the method.
1. Find the initial estimate for v.
(a) Scale and center X to yield Xs.
(b) Perform traditional factor analysis on Xs.
(c) Extract the factor loadings vf1, . . . , vfk for k factors.
(d) vj =
S(vfj ,∆j)
||S(vfj ,∆j)||2 for j = 1, . . . , k
2. Update u based on v.
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(a) u1 ← Xsv1||Xsv1||2
(b) for j = 2, . . . , k, uj = j is the set of residuals from the fit of the data to the
model in (5.6).
Note that the thresholds, ∆1, . . . ,∆k, may vary for each component.
Finally, we use the formula in (109) to calculate the percentage of variance explained
by this procedure. Namely, the cumulative percentage of variance explained by first
j components is given by tr(Xj
′Xj) where Vj = [v1, . . . , vj] is the p × j matrix of the
first j loading vectors and Xj = XsVj(V
′
jVj)
−1V ′j is the n× j projection of Xs onto the
subspace generated by Vj.
Unlike the method of (147), our procedure does not iterate between these steps.
Consequently, the percentage of variance explained will be less than the variance
explained by their method. However, the trade off is that the results of our procedure
should be more sparse and lend to more concise interpretations, which are of interest in
the factor analysis setting. In addition, lack of iteration results in greater computational
efficiency.
5.3 Simulations
This section describes simulations that demonstrate our method and compare it
to a number of alternatives. Samples of size n = 1000 were generated with p = 30
covariates. For each individual, k = 5 factors were generated as independent normal
random variables with mean zero and standard deviations 10, 20, 30, 30, 30. That is,
for all i, Fi = (F1i, . . . , F5i)
′ is a 5 × 1 random normal variable with E[Fji] = 0 and
V ar[Fi] = Diag(100, 400, 900, 900, 900). This corresponds to having one factor with a
small amount of noise, a second factor with increased noise, and 3 additional factors
that are noisier than the first two. The full matrix of all factors is given by the n× k
matrix F = (F1, . . . , Fn)
′.
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We generated the p × k normally distributed loading matrix L. Loadings were
independent and each had standard deviation 0.1. The mean µij = E[Lij] varied based
on the row i and column j of the matrix L. Namely, µij = 0.8 if j = 1 and i = 1, ...6;
µij = 0.7 if j = 2 and i = 7, . . . , 12; µij = 0.6 if j = 3, and i = 13, ...18; µij = 0.5 if
j = 4, i = 19, ..., 24; or µij = 0.4 if j = 5, and i = 25, ..., 30. In other words, the first 6
elements of column 1 have mean 0.8, the second 6 elements of column 2 have mean 0.7,
the third six elements of column 3 have mean 0.6, the fourth six elements of column 4
have mean 0.5, and the last six elements of column 5 have mean 0.4; all other elements
have mean zero. The standard deviation of 0.1 for all elements means that all of the
loadings are nonzero, some are essentially just noise, and others are larger and more
meaningful but have a small amount of noise as well.
The elements of the n × 1 error vector  were also independent and normally
distributed with mean 0, variance 1. As in the methodology section, X = FL′ + .
For each individual, a binary outcome Yi was generated based on the scaled factors,
Fs. We used
logitP (Y = 1) = F˜α
where α is a (k + 1) × 1 vector of ones, Fs is an n × k matrix of the factors, scaled
to have mean zero and unit variance, and F˜ = (1, Fs) is a n × (k + 1) matrix with
the first column consisting of all 1’s and the remaining entries identical to Fs. Here,
Y = (Y1, . . . , Yn)
′.
We compared the performance of our method with traditional factor analysis, three
applications of (147), and two applications of (157). The different applications of the
competing methods varied based on level of sparsity specified. We used
c(0.06, 0.16, 0.1, 0.5, 0.5) and c(7, 4, 4, 1, 1) in the (157) function which corresponded to
low and high sparsity, respectively. The (147) applications varied based on 1,
√
(p)/2,
√
(p),
which correspond to high, medium, and low sparsity, where p denotes the number of
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variables under consideration. For our method, we also investigated softthreshold values
of 0.4, 0.5, 0.6, 0.7, and 0.8 for all components, as well as one scenario with increasing
thresholds for each components and one scenario with decreasing thresholds for the
components.
Simulations were run independently 1000 times. For each run, we fit logistic
regression models of the outcome based on each component separately for each method
and recorded the parameter estimate and corresponding p-value. We recorded the
average percent variance explained, and average parameter estimate (Table 5.1) and
average p-value (Table 5.2) for each of the five components. We also noted the number
of variables with nonzero loadings for each component and each method (Table 5.3).
We refer to our proposed method as Sparse Factor Analysis (SFA).
Our method captured a large percentage of the variance, around 71-82%, depending
on the thresholds used. Traditional factor analysis and the non-sparse methods of (147)
and (157) explained 91%. Sparse applications of (147) and (157) explained far less
variance (<40%).
For all thresholds, parameter estimates for all components were comparable in
magnitude to those for factor analysis but much larger than for the competing methods.
P-values were strongly significant for all methods. This indicates that the factor scores
from our method were more strongly related to the outcome than the competing method
scores were to the outcome. The associations were positive for our method, as intended,
and often negative for the other methods. Moreover, our method was clearly more
sparse than traditional factor analysis and all but the most sparse versions of (147)
and (157). We retained an average of about 6 variables per component with nonzero
loadings, compared to all or nearly all of the 30 variables for these other methods.
This was favorable, as we had generated only 6 variables to be meaningful for each
component and generated all others to represent noise.
68
In conclusion, the simulations show that for various thresholds, our method results
in sparse factor scores that still explain a majority of the variance and are correlated
with the outcome of interest. These were exactly the properties that were desired from
a practical standpoint.
5.4 Data Application
This section details the application to the OPPERA study. The OPPERA study
is comprised of a baseline case-control study (113) of chronic temporomandibular
disorders (TMD) and a prospective cohort study (1) of first-onset TMD. The prospective
cohort study consists of 3258 subjects who were free from TMD at basline. Officially,
the baseline case-control data consists of half of the controls, i.e. 1633 subjects who were
free from TMD at baseline, as well as 185 previously diagnosed cases of TMD. However,
for purposes of measuring predictability of chronic TMD, it makes sense to consider not
only the 1633 randomly selected controls, but the entire collection of 3258 controls as
well as the 185 cases. This yields the total sample size in OPPERA, n = 3443. Within
the prospective cohort, 2737 subjects had some follow-up data.
The goals of this analysis are to see which variables are most important in predicting
chronic and first-onset TMD, to establish a subset of the variables that may adequately
explain TMD status, and to see if the use of different thresholds in our methodology
changes the results. Percentage of variance explained is far less important than the
combination of interpretability and the predictive value of the model. Predictive value
of the components was examined via logistic regression models. For each component,
a model was fit to the cohort against the outcome. The outcomes of interest, chronic
TMD and first-onset TMD, are defined in (113) and (1). The parameter estimate,
standard error, odds ratio, and p-values were recorded and compared between various
applications of the methods in this paper and the results of traditional factor analysis.
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This paper presents results for the case control subjects and prospective cohort of
the OPPERA study described above. Whenever possible, we consider three domains
of the OPPERA study: quantitative sensory testing (QST), autonomic nervous system
function, and psychosocial factors. Details on the these domains are provided in (75).
Previous results (46, 76, 37) indicate that 5, 5, and 4 components, respectively are
optimal for these datasets. Results in this paper use the same number of components
as the authors did in the previous results. First, cases and controls are analyzed
separately when possible. Next, factor scores are generated for the entire OPPERA
cohort, consisting of both cases and controls. Finally, the results are compared for
predictability of chronic TMD and first-onset TMD.
5.4.1 The Baseline Case-Control Study of Chronic TMD
Intoduction
This portion of the paper discusses the loadings for cases and controls separately
for the QST dataset. For the autonomic dataset, the cases and controls were analyzed
together. The psychosocial domain was not considered because there was not a dataset
consisting of only the cases and controls in the official baseline case-control study as
discussed in (37).
QST Results
This baseline case-control data includes 1633 controls and 185 cases with information
on p = 33 variables measuring quantitative sensory testing. Loadings were generated
for cases and controls separately to facilitate comparison with the results of (46). For
these separate analyses, the only soft threshold considered for all components was 0.4,
as is commonly used as an arbitrary cut-off in factor analysis.
Results in this first analysis were compared with competing methods. Our method
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explained 66.4% of the variance in the data for controls. By comparison, the (147)
method explained between 15.1 % and 71.9% of the variance, depending on the sparsity
specified. The (157) method also explained between 31.8% and 71.9% of the variance.
Our sparse factors were highly correlated with the original factor scores. Suppose
that F0 represents the factor scores based on EFA, and F represents the factor scores
from our method. The diagonal of Cor(F0, F ) is d = (0.934, 0.945, 0.950, 0.977, 0.995).
Table 5.4 shows the loadings from our method. Compared to the results in (46),
the loadings in the present paper are smaller but occur in the same places. This means
sparse factor analysis uncovered the same components as standard factor analysis,
but the sparse factor analysis method rigorously achieved truly sparse loadings rather
than ignoring or artificially setting small loadings to zero. These components are
known as “heat pain ratings” (component 1), “heat pain aftersensations and tolerance”
(component 2), “mechanical cutaneous pain sensitivity” (component 3), “pressure pain
thresholds” (component 4), and “heat pain temporal summation (TS)” (component 5).
Results for cases, found in Table A2.14, are similar. The clinical interpretation of these
components is discussed further in (46)
Autonomic Results
This dataset consists of 1630 cases and 185 controls with 42 measured variables on
autonomic function.
In this analysis and for subsequent sections, we applied our method multiple times
with various soft thresholds. Here, we examine thresholds of 0.4 to 0.8 for all components.
Thresholds were identical for each component for results in this section. Using thresholds
of 0.4 for all 5 components yielded similar components to that in Maixner et al. (76),
but with true zero loadings which previously were only arbitrarily set to zero. The
components were Blood Pressure, Stroop Heart Rate Variability (HRV), Heart Rate,
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Resting HRV and Orthostatic HRV. See Maixner et al. (76) for a biological description
of these components.
As expected, increasing the threshold from 0.4 to 0.8 for all components increased
the sparsity. When we used a threshold of 0.8 for all components, there were only
24 variables with a nonzero loading on at least one component (Table A2.18). For
example, average systolic blood pressure and heart rate were no longer needed in the
model after measuring average resting systolic blood pressure and mean arterial blood
pressure (MAP). Similarly, the initial orthostatic measurements (SBP, DBP, MAP, and
HR) were no longer needed. By contrast, traditional factor analysis and the application
of our method with the threshold of 0.4 for all components yielded all 42 variables with
nonzero loadings.
Despite the increased sparsity, overall predictability remained similar for the thresholds
as shown in Tables 5.5-5.7, which report the parameter estimates and their p-values for
three components at various thresholds. The second component was highly predictive
of chronic TMD for thresholds up to 0.7 and then significant but less strongly so
for a threshold of 0.8. However, even at this high threshold, our component was
more strongly predictive of chronic TMD than was the corresponding component from
traditional factor analysis. Moreover, the third component was highly significant for
all thresholds. The fourth component was not predictive of chronic TMD using the
methods in this paper for any of the thresholds explored. While the fourth component
of a traditional factor analysis was predictive, it was only marginally so (p=0.0362),
and as the threshold increased, our parameters increased in magnitude and the p-
values dropped. Curiously, higher thresholds resulted in higher parameter estimates (in
magnitude) for components two and three, which were associated with chronic TMD.
This indicates that the components were more strongly predictive of TMD once soft
thresholding was implemented with higher thresholds. The first and fifth components
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are not discussed because they were not predictive of chronic TMD for either method.
In short, it can be argued that soft thresholding did not reduce the predictability of the
model for chronic TMD, even when we dramatically reduced the number of variables
under consideration within the autonomic domain.
We report thus the loadings for thresholds of 0.7 for all components in Table 5.8.
For the other thresholds, see Tables A2.15-A2.18.
5.4.2 Application to the Full OPPERA Cohort
For the full dataset, the same scores were reported in the context of both chronic
TMD and first-onset TMD. It is only the predictability that changes. The following
subsections detail the factor scores in general as well as their relationship to chronic
and first-onset TMD.
QST Loadings for the Full Cohort
The full OPPERA data consists of n = 3443 subjects with information on p = 33
variables measuring quantitative sensory testing.
Table 5.9 shows the factor loadings when our method is applied to this QST data
with a threshold of 0.8 for all components. Additional results are given for various
thresholds in Tables A2.1-A2.4. When the threshold of c = 0.4 was used for all
components, our method explained 68.9% of the variance, compared to 73.4% for
standard factor analysis. Higher thresholds, such as 0.8 for all components, correspond
to decreased variance explained, down to 44%. Fortunately, as discussed in sections
5.4.2 and 5.4.2, this does not negatively impact predictability with respect to the
outcomes of interest.
Loadings were qualitatively similar for each threshold examined with one logical
but notable exception. Larger thresholds resulted in fewer variables with nonzero
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loadings. For example, the mechanical cutaneous pain sensitivity component only had
one variable with a nonzero loading: the rating 15 seconds after being probed by a
256 mN probe. Additionally, the heat pain temporal summation component only had
3 nonzero variables, one of which was very small (0.08). By contrast, all 8 variables
in the mechanical cutaneous pain sensitivity component and all 6 variables in the heat
pain temporal summation component loaded nonzero (and exceeded 0.4) in (46).
Application to the QST Data for Chronic TMD
For standard factor analysis, the third and fourth component were predictive of
chronic TMD. The first four factors (i.e. all but heat pain temporal summation) for
our method were all highly predictive of chronic TMD. Moreover, especially for higher
thresholds, our loadings were sparse. Consider Table 5.9, which shows loadings when we
use a threshold of 0.8 for all components. The fourth component, measuring mechanical
cutaneous pain sensitivity, was weighted less heavily than previously. In fact, the only
variable remaining in this component was the after sensation rating (15 s, 256 mN
probe). The fifth component, temporal summation, was also not weighted as heavily,
nor was it predictive of chronic TMD.
Application to the QST Data for First-Onset TMD
None of the components were significantly associated with TMD, but none of the
components of a traditional EFA/PCA analysis were significantly associated with TMD
either. Thus, our method was no worse than the traditional method at predicting first-
onset TMD.
Results remained qualitatively similar for different threshold values. Decreasing
the threshold values rendered heat pain tolerance and the temporal summation single
stimulus variables nonzero in all components. For thresholds of 0.7 or 0.8 for all
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components, the temporal summation slope of the line for 46 degrees was set equal
to zero. When the threshold was 0.8 for all components, single stimulus and temporal
summation for either probe, ratings 30 seconds after exposure to either probe or 15
seconds after the 512 mN probe, Single Stimulus 46 and 50 degrees and all three
temporal summation slope variables were also zero. This left the after Sensation Rating
(15 s, 256 mN probe) as the sole nonzero loading on the 4th component and the two
remaining temporal summation slope variables as the only nonzero loadings on the 5th
component when c = 0.8. All other variables only had minor changes in the loadings
as the thresholds changed.
Autonomic Loadings for the Follow-up Cohort
Loadings are provided in Table 5.10 for the 2737 individuals in the prospective
cohort study with at least 1 QHU. This allowed examination of associations with first-
onset TMD. Because predictability in the case-control study was already examined for
those in the official base-line case control study, and because of the plethora of tables
already in this paper, additional analysis was not done to examine chronic TMD in the
larger cohort. Moreover, these results should be virtually identical as they were in the
multiple subsets analyzed for the QST domain. If desired, this additional analysis can
be added before we publish this paper.
Application to the Autonomic Data for First-Onset TMD
There are 42 variables measured in the autonomic domain. (76) previously fit
traditional EFA/PCA to the autonomic baseline case-control data. This paper applies
the SFA method to the autonomic follow-up cohort data. SFA explained 71.1% of the
data, compared to 74.7% for the EFA/PCA analysis. Moreover, the first component
(blood pressure) scores were predictive of first-onset TMD. We fit the model using
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c = 0.4, 0.5, 0.6, 0.7, 0.8. Results were quantitatively similar, with only
baseline heart rate variability and heart rate variability related to the Stroop questionnaire
having all components set to zero. The percent variance explained dropped very slightly
when the threshold for all components increased.
Predictive accuracy remained high for all thresholds but decreased as the threshold
decreased. In particular, logistic regression models were fit for each set of factor
scores to predict TMD. Parameter estimates and odds ratios were compared for the
different threshold values and for traditional factor analysis. As shown in Table 5.11,
the parameter estimates were higher for the sparse factor analysis method than for
the traditional factor analysis when c = 0.4 or c = 0.5. For higher thresholds, the
relationship reversed. Yet, differences were slight for all thresholds. Odds ratios were
similar for method compared to the traditional method and only dropped noticeably for
the highest threshold. P-values only increased appreciably for the two highest threshold
values, but were still under 0.05. This indicates that even with sparse loadings, the
blood pressure component is predictive of TMD.
Loadings for the Psychosocial Data
For the psychosocial domain, results were applied to the full dataset of 3443 participants.
The psychosocial data consists of 21 variables as previously analyzed in (37). Loadings
for the psychosocial dataset are provided in Table 5.12 for when the threshold is 0.6
for all components. Other loadings may be found in the appendix in Tables A2.19,
A2.20, and A2.21. In fact, for the psychosocial domain, we considered having different
thresholds for different components. See Tables A2.22-A2.24.
The components were Global Psychological Symptoms, Stress and Negative Affectivity,
Passive Pain Coping, and Active Pain Coping. These are the same components identified
in (37), except that the order of the first two components were swtiched. For a more
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detailed description of their meaning, please see (37).
Application to the Psychosocial Data for Chronic TMD
The first, third, and fourth psychosocial components were predictive of chronic
TMD regardless of the threshold. That is, global psychological symptoms, and both
active and passive pain coping were associated with chronic TMD. The magnitude
of the parameter estimate and p-value did not have a monotonic relationship with the
thresholds. In fact, when the threshold increased, the parameter estimate increased and
the p-value decreased for component 3, passive pain coping. This indicates that the
larger thresholds both made the loadings more sparse and increased the predictability
compared to traditional factor analysis.
Application to the Psychosocial Data for First-Onset TMD
The first two components, Global Psychological Symptoms, Stress and Negative
Affectivity, were predictive of first-onset TMD for all thresholds of our method as well
as for standard EFA. However, unlike ERA, the loadings using the method proposed in
this paper are sparse especially for larger thresholds. Notable variables that had zero
loadings for all components included KOHN global score, POMS Negative Affective
Score, CSQ Praying, EPQ N scale and EPQ E scale. In short, our method produced
sparse components that were predictive of first-onset TMD.
5.5 Discussion
This work proposes a method for factor analysis that allows for sparse factors,
motivated by the research questions in the OPPERA study. The use of soft thresholding
is employed to shrink coefficients, followed by a simple one step update. Our method is
similar to the sparse principal component analysis method of (147) but does not iterate.
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This results in increased computational efficiency and sparsity, while maintaining a
reasonable percentage of variance explained. Simulations showed that promising results,
namely, that even as the thresholds increase for one or more components, the parameters
are still significantly associated with the outcomes of interest.
We applied the method to various domains within the OPPERA study. Compared
to previous results, our loadings were more sparse yet remained predictive of both
chronic and first-onset TMD, where applicable. Moreover, the sparse results of our
method illuminate to investigators variables which may be redundant and may not be
needed in follow-up studies.
The method proposed in this paper is preferred to other methods, such as (147) and
(157), which are designed for principal component analysis. While factor analysis may
not be as desirable statistically, it provides much more easily interpretable components.
Thus, it is commonly used in the psychometric literature. A generalization such as ours
would improve their research by allowing them to consider sparse factors.
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Table 5.1: Parameters for Different Thresholds and Other Methods
Method Used PVE Parameter for Components
1 2 3 4 5
SFA (0.8,...,0.8) 0.7085 0.6169 0.6186 0.6194 0.6053 0.5911
SFA (0.7,...,0.7) 0.7750 0.6179 0.6220 0.6246 0.6017 0.5901
SFA (0.6,...,0.6) 0.7987 0.6191 0.6253 0.6293 0.5965 0.5870
SFA (0.5,...,0.5) 0.8110 0.6203 0.6287 0.6331 0.5914 0.5838
SFA (0.4,...,0.4) 0.8207 0.6211 0.6317 0.6360 0.5871 0.5809
SFA (0.4,...,0.8) 0.7721 0.6211 0.6289 0.6284 0.5921 0.5829
SFA (0.8,...,0.4) 0.7955 0.6169 0.6219 0.6298 0.6006 0.5890
EFA 0.9054 0.6169 0.6173 0.6224 0.6076 0.6044
Witten (Sparse) 0.1667 -0.0828 0.0126 0.1157 0.1568 0.0145
Witten (Full) 0.9054 -0.1970 0.0068 0.1787 0.2002 0.0697
Witten (Medium) 0.8564 -0.0707 0.0021 0.1219 0.1610 -0.0139
Zou (Full) 0.9054 -0.0300 -0.0061 -0.0224 -0.0017 -0.0178
Zou (Sparse) 0.3752 -0.0341 0.0001 0.0094 0.0168 -0.0126
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Table 5.2: P-Values for Different Thresholds and Other Methods
Method Used P-value for Components
1 2 3 4 5
SFA (0.8,...,0.8) <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
SFA (0.7,...,0.7) <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
SFA (0.6,...,0.6) <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
SFA (0.5,...,0.5) <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
SFA (0.4,...,0.4) <0.0001 0.0001 <0.0001 <0.0001 <0.0001
SFA (0.4,...,0.8) <0.0001 0.0001 <0.0001 <0.0001 <0.0001
SFA (0.8,...,0.4) <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
EFA <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
Witten (Sparse) 0.0192 0.0096 0.0138 0.0112 0.0116
Witten (Full) 0.0572 0.0557 0.0590 0.0630 0.0814
Witten (Medium) 0.0005 <0.0001 <0.0001 <0.0001 <0.0001
Zou (Full) 0.0572 0.0557 0.0590 0.0630 0.0814
Zou (Sparse) 0.0103 0.0041 0.0023 0.0065 0.0086
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Table 5.3: Number of Variables Retained for Different Thresholds and Other Methods
Method Used Variables Retained for Components
1 2 3 4 5 Total
SFA (0.8,...,0.8) 5.919 5.761 5.468 5.203 5.080 27.431
SFA (0.7,...,0.7) 6.030 6.009 5.934 5.761 5.699 29.433
SFA (0.6,...,0.6) 6.115 6.120 6.111 5.992 5.911 29.914
SFA (0.5,...,0.5) 6.318 6.256 6.268 6.179 6.051 29.992
SFA (0.4,...,0.4) 6.896 6.637 6.585 6.432 6.207 29.998
SFA (0.4,...,0.8) 6.896 6.256 6.111 5.761 5.080 29.420
SFA (0.8,...,0.4) 5.919 6.009 6.111 6.179 6.207 29.893
EFA 30.000 30.000 30.000 30.000 30.000 30.000
Witten (Sparse) 1.000 1.000 1.000 1.000 1.000 5.000
Witten (Full) 30.000 30.000 30.000 30.000 30.000 30.000
Witten (Medium) 10.900 11.820 12.612 13.638 14.193 30.000
Zou (Full) 29.973 29.925 29.956 29.747 29.741 30.000
Zou (Sparse) 7.000 4.000 4.000 1.000 1.000 16.986
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Table 5.4: PCA/SFA QST Results for Controls, c=0.4
Component 1 2 3 4 5
Pressure Pain Threshhold
Temporalis 0 0 0 0.47 0
Masseter 0 0 0 0.50 0
TMJ 0 0 0 0.47 0
Trapezius 0 0 0 0.39 0
Epicondyl 0 0 0 0.39 0
Mechanical Cutaneous Pain Threshhold 0 0 -0.01 0 0
Single Stimulus
256 mN Probe 0 0 0.34 0 0
512 mN Probe 0 0 0.35 0 0
After Sensation Ratings
15 s, 256 mN probe 0 0 0.48 0 0
30 s, 256 mN probe 0 0 0.41 0 0
15 s, 512 mN probe 0 0.00 0.42 0 0
30 s, 512 mN probe 0 0.01 0.38 0 0
Temporal Summation
256 mN probe 0 0 0.19 0 0
512 mN probe 0 0 0 0 0
Heat Pain Tolerance -0.05 0 0 0 0
Single Stimulus
46 0.33 0 0 0 0
48 0.42 0 0 0 0
50 0.43 0 0 0 0
Area Under the Curve
46 0.42 0 0 0 0
48 0.45 0 0 0 0
50 0.38 0 0 0 0
After Sensations
15 s, 46 0 0.36 0 0 0
30 s, 46 0 0.40 0 0 0
15 s, 48 0 0.41 0 0 0
30 s, 48 0 0.44 0 0 0
15 s, 50 0 0.41 0 0 0
30 s, 50 0 0.42 0 0 0
Temporal Summation: Highest Minus First Rating
46 0 0 0 0 0.47
48 0 0 0 0 0.50
50 0 0 0 0 0.32
Temporal Summation: Slope of Line for First 3 Ratings
46 0 0 0 0 0.33
48 0 0 0 0 0.44
50 0 0 0 0 0.36
Percent Variance Explained 0.15 0.30 0.44 0.55 0.66
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Table 5.5: Autonomic Parameter Estimates and Different Thresholds, Component 2
Method Details Parameter Estimate Standard Error Odds Ratio P-value
Traditional EFA/PCA -0.20445 0.09420 0.8151 0.03
SFA c = 0.8 -0.25411 0.10456 0.7756 0.0151
SFA c = 0.7 -0.30642 0.09836 0.7361 0.00184
SFA c = 0.6 -0.31278 0.09455 0.7314 0.000939
SFA c = 0.5 -0.31401 0.09242 0.7305 0.00068
SFA c = 0.4 -0.31515 0.09112 0.7297 0.000543
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Table 5.6: Autonomic Parameter Estimates and Different Thresholds, Component 3
Method Details Parameter Estimate Standard Error Odds Ratio P-value
Traditional EFA/PCA 0.23284 0.07621 1.2622 0.00225
SFA c = 0.8 0.28326 0.07356 1.3275 0.000118
SFA c = 0.7 0.24390 0.07376 1.2762 0.000944
SFA c = 0.6 0.22576 0.07402 1.2533 0.00229
SFA c = 0.5 0.21577 0.07422 1.2408 0.00365
SFA c = 0.4 0.20941 0.07436 1.2330 0.00486
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Table 5.7: Autonomic Parameter Estimates and Different Thresholds, Component 4
Method Details Parameter Estimate Standard Error Odds Ratio P-value
Traditional EFA/PCA -0.16051 0.07664 0.8517 0.0362
SFA c = 0.8 -0.10838 0.07626 0.8973 0.155
SFA c = 0.7 -0.09100 0.07658 0.9130 0.235
SFA c = 0.6 -0.08228 0.07673 0.9210 0.284
SFA c = 0.5 -0.07899 0.07695 0.9240 0.305
SFA c = 0.4 -0.07664 0.07714 0.9262 0.32
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Table 5.8: Autonomic Results for the OPPERA Case Control Study, c=0.7
Component 1 2 3 4 5
AvgRestingSPB 0.25 0 0 0 0
AvgRestingDPB 0.07 0 0 0 0
AvgRestingMAP 0.27 0 0 0 0
AvgRestingHR 0 0 0.15 0 0
InitialOrthoSPB 0 0 0 0 0
InitialOrthoDPB 0.03 0 0 0 0
InitialOrthoMAP 0.17 0 0 0 0
InitialOrthoHR 0 0 0 0 0
StroopColorSPBmean 0.38 0 0 0 0
StroopColorDPBmean 0.31 0 0 0 0
StroopColorMAPmean 0.44 0 0 0 0
StroopColorHRmean 0 0 0.44 0 0
StroopEmotionalSPBmean 0.37 0 0 0 0
StroopEmotionalDPBmean 0.27 0 0 0 0
StroopEmotionalMAPmean 0.43 0 0 0 0
StroopEmotionalHRmean 0 0 0.48 0 0
QST.SHRVBaseline20MinMeanHR 0 0 0.14 0 0
QST.SHRVBaseline20MinSDNN 0 0 0 0.24 0
QST.SHRVBaseline20MinRMSSD 0 0 0 0 0
HRVBaseline20minLnTP 0 0 0 0.67 0
HRVBaseline20minLnVLF 0 0 0 0.24 0
HRVBaseline20minLnLF 0 0 0 0.55 0
HRVBaseline20minLnHF 0 0 0 0.36 0
QST.SHRVOrthostatic5MinMeanHR 0 0 0.26 0 0
QST.SHRVOrthostatic5MinSDNN 0 0 0 0 0.59
QST.SHRVOrthostatic5MinRMSSD 0 0 0 0 0.39
HRVOrtho5minLnTP 0 0 0 0 0.46
HRVOrtho5minLnVLF 0 0 0 0 0.04
HRVOrtho5minLnLF 0 0 0 0 0.25
HRVOrtho5minLnHF 0 0 0 0 0.47
QST.SHRVSTROOPColor5MinMeanHR 0 0 0.47 0 0
QST.SHRVSTROOPColor5MinSDNN 0 0.58 0 0 0
QST.SHRVSTROOPColor5MinRMSSD 0 0.53 0 0 0
HRVStroopColor5minLnTP 0 0.31 0 0 0
HRVStroopColor5minLnVLF 0 0 0 0 0
HRVStroopColor5minLnLF 0 0.17 0 0 0
0 HRVStroopColor5minLnHF 0 0.27 0 0 0
QST.SHRVSTROOPEmotion5mnMeanHR 0 0 0.51 0 0
QST.SHRVSTROOPEmotion5mnSDNN 0 0.35 0 0 0
QST.SHRVSTROOPEmotion5mnRMSSD 0 0.25 0 0 0
HRVStroopEmotion5minLnTP 0 0 0 0 0
HRVStroopEmotion5minLnVLF 0 0 0 0 0
Percent Variance Explained 0.17 0.29 0.41 0.5 0.59
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Table 5.9: PCA/SFA QST Results for the Entire OPPERA Cohort, c=0.8
Component 1 2 3 4 5
Pressure Pain Threshold
Temporalis 0 0 0.45 0 0
Masseter 0 0 0.6 0 0
TMJ 0 0 0.48 0 0
Trapezius 0 0 0.39 0 0
Epicondyl 0 0 0.11 0 0
Mechanical Cutaneous Pain Threshold 0 0 0.2 0 0
Single Stimulus
256 mN Probe 0 0 0 0 0
512 mN Probe 0 0 0 0 0
After Sensation Ratings
15 s, 256 mN probe 0 0 0 1 0
15 s, 512 mN probe 0 0 0 0 0
30 s, 256 mN probe 0 0 0 0 0
30 s, 512 mN probe 0 0 0 0 0
Temporal Summation
256 mN probe 0 0 0 0 0
512 mN probe 0 0 0 0 0
Heat Pain Tolerance 0 0 0 0 0
Single Stimulus
46 0 0 0 0 0
48 0.4 0 0 0 0
50 0.48 0 0 0 0
Area Under the Curve
46 0.43 0 0 0 0
48 0.63 0 0 0 0
50 0.17 0 0 0 0
After Sensations
15 s, 46 0 0.08 0 0 0
15 s, 48 0 0.39 0 0 0
15 s, 50 0 0.3 0 0 0
30 s, 46 0 0.31 0 0 0
30 s, 48 0 0.63 0 0 0
30 s, 50 0 0.52 0 0 0
Temporal Summation: Highest Minus First Rating
46 0 0 0 0 0.39
48 0 0 0 0 0.92
50 0 0 0 0 0
Temporal Summation: Slope of Line for First 3 Ratings
46 0 0 0 0 0
48 0 0 0 0 0.08
50 0 0 0 0 0
Percent Variance Explained 0.12 0.24 0.36 0.39 0.44
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Table 5.10: PCA/SFA Autonomic Results for the OPPERA Followup Cohort, c=0.7
Component 1 2 3 4 5
AvgRestingSPB 0.27 0 0 0 0
AvgRestingDPB 0.06 0 0 0 0
AvgRestingMAP 0.27 0 0 0 0
AvgRestingHR 0 0 0.16 0 0
InitialOrthoSPB 0 0 0 0 0
InitialOrthoDPB 0.02 0 0 0 0
InitialOrthoMAP 0.18 0 0 0 0
InitialOrthoHR 0 0 0 0 0
StroopColorSPBmean 0.37 0 0 0 0
StroopColorDPBmean 0.31 0 0 0 0
StroopColorMAPmean 0.44 0 0 0 0
StroopColorHRmean 0 0 0.44 0 0
StroopEmotionalSPBmean 0.36 0 0 0 0
StroopEmotionalDPBmean 0.27 0 0 0 0
StroopEmotionalMAPmean 0.43 0 0 0 0
StroopEmotionalHRmean 0 0 0.48 0 0
QST.SHRVBaseline20MinMeanHR 0 0 0.14 0 0
QST.SHRVBaseline20MinSDNN 0 0 0 0.05 0
QST.SHRVBaseline20MinRMSSD 0 0 0 0 0
HRVBaseline20minLnTP 0 0 0 0.7 0
HRVBaseline20minLnVLF 0 0 0 0.27 0
HRVBaseline20minLnLF 0 0 0 0.56 0
HRVBaseline20minLnHF 0 0 0 0.34 0
QST.SHRVOrthostatic5MinMeanHR 0 0 0.25 0 0
QST.SHRVOrthostatic5MinSDNN 0 0 0 0 0.59
QST.SHRVOrthostatic5MinRMSSD 0 0 0 0 0.27
HRVOrtho5minLnTP 0 0 0 0 0.53
HRVOrtho5minLnVLF 0 0 0 0 0.04
HRVOrtho5minLnLF 0 0 0 0 0.25
HRVOrtho5minLnHF 0 0 0 0 0.47
QST.SHRVSTROOPColor5MinMeanHR 0 0 0.47 0 0
QST.SHRVSTROOPColor5MinSDNN 0 0.56 0 0 0
QST.SHRVSTROOPColor5MinRMSSD 0 0.44 0 0 0
HRVStroopColor5minLnTP 0 0.26 0 0 0
HRVStroopColor5minLnVLF 0 0 0 0 0
HRVStroopColor5minLnLF 0 0.11 0 0 0
HRVStroopColor5minLnHF 0 0.27 0 0 0
QST.SHRVSTROOPEmotion5mnMeanHR 0 0 0.51 0 0
QST.SHRVSTROOPEmotion5mnSDNN 0 0.44 0 0 0
QST.SHRVSTROOPEmotion5mnRMSSD 0 0.39 0 0 0
HRVStroopEmotion5minLnTP 0 0.06 0 0 0
HRVStroopEmotion5minLnVLF 0 0 0 0 0
Percent Variance Explained 0.17 0.29 0.41 0.49 0.58
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Table 5.11: Autonomic Parameter Estimates and Different Thresholds for Component
1, First-Onset TMD
Method Details Parameter Estimate Standard Error Odds Ratio P-value
SFA c = 0.8 0.14086 0.0629 1.15 0.0251
SFA c = 0.7 0.1540 0.0627 1.17 0.0140
SFA c = 0.6 0.1642 0.0626 1.18 0.0087
SFA c = 0.5 0.1682 0.0625 1.18 0.0072
SFA c = 0.4 0.1704 0.0625 1.19 0.0064
Traditional EFA/PCA 0.1649 0.0626 1.18 0.0085
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Table 5.12: PCA/SFA Psychosocial Results for the Entire OPPERA Cohort, c=0.6
Component 1 2 3 4
KOHN.Global.Score 0 0 0 0
PILL.Global.Score 0.09 0 0 0
POMS.PositiveAffectScore 0 -0.62 0 0
POMS.NegativeAffectScore 0 0 0 0
PSS.PerceivedStress 0 0.27 0 0
SCL.90R.Depression 0.5 0 0 0
SCL.90R.Somatization 0.49 0 0 0
SCL.90R.Anxiety 0.55 0 0 0
SCL.90R.Hostility 0.45 0 0 0
CSQ.Distraction 0 0 0 0.44
CSQ.IgnoringPain 0 0 0 0.48
CSQ.Distancing 0 0 0 0.47
CSQ.Coping 0 0 0 0.6
CSQ.Praying 0 0 0 0
STAIY1.StateTraitAnxiety 0 0.51 0 0
STAIY2.StateTraitAnxiety 0 0.53 0 0
PCS.Rumination 0 0 0.68 0
PCS.Magnification 0 0 0.43 0
PCS.Helplessness 0 0 0.59 0
EPQ.Escale 0 0 0 0
EPQ.Nscale 0 0 0 0
Percent Variance Explained 0.15 0.28 0.39 0.5
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Table 5.13: Psychosocial Parameter Estimates and Different Thresholds, Component 1
(Chronic)
Method Details Parameter Estimate Standard Error Odds Ratio P-value
Traditional EFA/PCA 0.49992 0.05443 ¡2e-16
SFA c = 0.7 0.35596 0.05258 1.29e-11
SFA c = 0.6 0.29673 0.03624 2.67e-16
SFA c = 0.5 0.41364 0.05211 2.05e-15
SFA c = 0.4 0.43485 0.05262 ¡2e-16
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Table 5.14: Psychosocial Parameter Estimates and Different Thresholds, Component 3
(Chronic)
Method Details Parameter Estimate Standard Error Odds Ratio P-value
Traditional EFA/PCA 0.23896 0.06946 0.000581
SFA c = 0.7 0.25626 0.06854 0.000185
SFA c = 0.6 0.24640 0.06832 0.00031
SFA c = 0.5 0.20356 0.06935 0.00333
SFA c = 0.4 0.17641 0.07025 0.012
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Table 5.15: Psychosocial Parameter Estimates and Different Thresholds, Component 4
(Chronic)
Method Details Parameter Estimate Standard Error Odds Ratio P-value
Traditional EFA/PCA -0.21275 0.07746 0.00602
SFA c = 0.7 -0.09480 0.07551 0.209
SFA c = 0.6 -0.16235 0.07676 0.0344
SFA c = 0.5 -0.17814 0.07708 0.0208
SFA c = 0.4 -0.18595 0.07722 0.016
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CHAPTER 6: CONCLUSION
In this dissertation, three methods were developed to properly analyze data from
the OPPERA study. Chapter 3 introduces a method for Cox modeling with missing
censoring indicators, which allows for estimation of hazard ratios and incidence rates,
even when a large subset of participants have uncertain event indicators. Event propabilities
are modeled via logistic regression and outcomes are imputed repeatedly using those
estimated probabilities. Implementing this method uncovered new risk factors of clinical
importance. It also illustrated that incidence rates may be underestimated if the
proposed method is not used. Incidence of TMD may be important for future studies
in orofacial pain.
This method was well received by OPPERA investigators and widely applied, e.g.
in (1). The methods paper based on Chapter 3 is in the process of submission. In its
current state, the manuscript is appropriate for submission to a journal such as Statistics
in Medicine. Additional work will be performed in hopes of proving consistency of the
estimator. If this aim is successful, we will consider a more theoretical journal. Future
work includes completing an extension that includes missing covariates (i.e. skipped
screeners), missing time, and missing censoring indicators. This will allow study of
individuals who have uncertain screener data as well as uncertain outcomes. In addition,
there were a small number (n < 20) of false negatives, i.e. participants who screened
negative but who actually had TMD. This number was too small of a sample size for
meaningful modeling and imputation. Thus we did not make any further adjustments.
In the future, the methodology could be extended to control for false negatives, or a
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sensitivity analysis could be conducted.
Chapter 4 proposes a general method to analyze intermediate phenotypes in case-
control studies. Subjects are weighted to correct for the oversampling of cases and
undersampling of controls in this sample design. Standard methods are implemented
with these weights to estimate the quantities of interest. Then bootstrapping is utilized
to estimate the standard error. The method allows for analysis of outcomes that are
currently difficult or impossible to study, such as time-to-event outcomes and sequencing
statistics.
Additional work remains before the method may be published. First, application
to haplotypes will be demonstrated. Second, the method will be applied to different
outcomes in OPPERA. Third, the simulations on sequenced data will be completed.
Fourth, the method may be applied to sequencing data from Glaxo-Smith-Klein (GSK).
Once these steps are complete, the paper should be ready to submit to a genetic journal,
such as Genetic Epidemiology.
Chapter 5 introduces a method for sparse factor analysis. Soft thresholding reduces
the magnitude of each loading in a rigorous manner rather than arbitrarily ignoring
loadings under a certain value. Sparse loadings result that are still predictive of the
underlying outcome. Implications within the OPPERA study are wide. The sparse
loadings in each domain may highlight which variables are most important for future
studies and which variables may be dropped without losing significant information. It
remains to discuss this work with the principal investigators. Additional simulations
may be produced as well.
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APPENDIX 1: SUPPLEMENTARY MATERIAL FOR CHAPTER 3
The primary objective of the OPPERA study is to identify possible risk factors
for developing first-onset TMD. See Maixner et al. (75) and Slade et al. (113) for
a more detailed description of the study. The risk factors considered in OPPERA
are classified into the following domains: sociodemographic, clinical, psychosocial,
autonomic, quantitative sensory testing (QST), and genetics. The remainder of this
section describes these OPPERA domains in more detail.
First, sociodemographic information was recorded for each OPPERA participant.
This includes age, gender, race, and OPPERA study site, as well as educational
attainment, income, and marital status. For example, TMD is more common in females
than males and in non-Hispanic whites than in other races. Details are provided in Slade
et al. (113).
Clinical risk factors refer to variables that “typically are considered in clinical
settings when evaluating patients” (86). These clinical variables may be evaluated via
physical examinations or questionnaires. Examples include headaches, back aches, pain
in other regions of the body, jaw mobility, jaw noises, and orofacial trauma. OPPERA
participants also self-reported their health history, including the presence of comorbid
pain conditions such as irritable bowel syndrome, fibromyalgia, and dysmenorrhea.
Psychosocial factors have also been shown to be associated with TMD (37). Specific
qualities related to psychosocial functioning were evaluated in OPPERA, including
general psychological function, affective distress, psychological stress, somatic awareness,
and coping/catastrophizing. Affective distress measures include state and trait anxiety
and mood. Psychological stress includes perceived stress and measures of post-traumatic
stress disorder. Somatic awareness assesses sensitivity to physical sensations. Finally,
coping/catastrophizing assesses individuals’ ability to handle pain.
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The association between TMD and the function of the autonomic nervous system
was also evaluated. Key measures of autonomic function include blood pressure, heart
rate, and heart rate variability, which were measured during the OPPERA baseline
medical examination. In previous studies, TMD was associated with higher heart rates
and lower heart rate variability, which are symptoms of dysregulation of the autonomic
nervous system. See (76) for a more detailed description of the autonomic data collected
in OPPERA.
The QST variables collected in OPPERA measure sensitivity to experimental pain.
Several measures of experimental pain sensitivity were collected, including pressure pain
thresholds measured by algometers, mechanical (pinprick) pain sensitivity, and thermal
pain sensitivity. See (46) for a more detailed description of these QST variables.
Finally, the association between TMD and selected genetic markers was evaluated.
A total of 3295 single nucleotide polymorphisms (SNP’s) were selected from genes that
are believed to be associated with pain. See (115) for more detail on how the SNP’s
were chosen and their association with TMD.
Overview of Additional Simulations
In this appendix, we provide the results of additional simulations. We investigate
the performance of the method under a variety of missing data mechanisms. We also
consider scenarios where the logistic regression model for estimating the probability of
being a case is misspecified.
Recall that we created missing censoring indicators under the following classical
missing data mechanisms of Rubin (1976):
(I) The probability of having a missing censoring indicator is independent of the
data. This is known as missing completely at random (MCAR).
(II) The probability of having a missing censoring indicator depends on an observed
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covariate. This is known as missing at random (MAR).
(III) The probability of having a missing censoring indicator depends on the censoring
indicator itself. This is known as missing not at random (MNAR).
Simulations Under MCAR
When the data were MCAR, our method had less bias on average than the complete
case method that depended on the true parameter value. Not only did our method have
adequate coverage, but it had the most narrow confidence intervals of the methods with
adequate coverage. As in other simulations, the method treating all missing indicators
as failures had poor coverage and introduced extreme bias. The complete case method
and the method that treat all missing censoring indicators as censored were valid, but
had much wider confidence intervals than our method.
However, note that it would be dangerous to apply the complete case method to the
OPPERA study. According to the OPPERA protocol, participants who do not screen
positively and are not selected as matched controls will always be censored. Only
participants who screen positively (i.e. those with Qi = 1) should potentially have
missing censoring indicators. Data that are MCAR allow participants with Qi = 0 to
have missing censoring indicators. Fitting the logistic regression model to those with
Qi = 1 only but generalizing to people with Qi = 0 may result in extreme bias, as
shown in section 6.
Additional Simulations Under MCAR
In order to more closely parallel the OPPERA study, we simulated data where we
randomly set 40% of the censoring indicators to be missing for those with Qi = 1.
(Note that our simulations assume that censoring indicators can only be missing when
Qi = 1. Without this assumption the data would not be MCAR in this scenario, since
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Qi depends on Xi2, which is observed.) This setup assumes that the probability that a
participant has a non-missing censoring indicator depends only on whether or not their
screener was positive. The logistic regression model in this case included the covariates
Xi1 and Xi2 as before, but not the time of the screener. Results are shown in Table
A1.2. All methods had a negligible amount of bias in these scenarios except for the
complete case method and the method that treated all missing indicators as failures.
In these simulations, the complete case method also displayed extreme bias and poor
coverage. This indicates that a complete case analysis would not be appropriate for a
study such as OPPERA.
Alternative Logistic Regression Models
We considered several scenarios where the logistic regression model for the probability
of being a case is misspecified. Recall that we originally modeled the probability of being
a case as
P (∆i = 1|Xi, α) = exp(α
′Xi + γVi)
1 + exp(α′Xi + γVi)
(A.1)
The original logistic model had the covariates Xi = {Xi1, Xi2} and Vi where Xi1 ∼
N(0, 2) and Xi2 ∼ N(∆i, 0.3) are mutually independent for j = 1, 2, 3 and i = 1, . . . , n.
Two alternative models were examined:
1. The first alternative model was of the form (A.1) but used the covariates X˜i =
{Xi1, Xi2, Xi3} and Vi where Xi3 ∼ N(0, 1). This scenario was to used to evaluate
the robustness of the method when an extraneous covariate is included in the
model.
2. The second alternative model was generated according to (A.1) but was fit with
the covariates X˜i = {Xi1} and Vi. In the context of OPPERA, this represents the
scenario in which we failed to include a covariate that is associated with first-onset
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TMD.
Tables A1.3 and A1.4 indicate that our method produces valid results even if a noisy
variable is added to the model or if an important variable is not included in the model.
Next, we consider the scenario where censoring indicators may be missing even
if a participant had a negative screener (i.e. Qi = 0). For each such simulation,
we randomly selected 40% of the observations to have missing censoring indicators
regardless of the value of Qi. In the first such simulation, the logistic regression model
was correctly specified when Qi = 1. (However, it will be applied to all observations
with missing censoring indicators, including those for which Qi = 0. Since the true
value of the censoring indicator is always 0 when Qi = 0, the model will be biased
for these observations.) In the two remaining simulation scenarios, the model will be
misspecified even when Qi = 1 by either adding an extra covariate or leaving out a
significant covariate as we did in the earlier simulations.
The results of these three additional simulations are shown in Tables A1.1, A1.6,
and A1.7. The model performs well in two of the three scenarios, indicating that
our methodology is robust against misspecification of the logistic regression model.
However, when an important covariate is not included in the model, the estimates
are badly biased. Empirical coverage ranged from 0% to 50%, significantly below the
nominal rate. This indicates that our method can give incorrect results if the predictive
accuracy of the logistic regression model is poor. Note that the method of Cook and
Kosorok (8) also performs poorly in this scenario. If one cannot accurately estimate
which censoring indicators are missing, it is unlikely that any method can produce valid
confidence intervals for the Cox regression coefficients.
Simulations Under MNAR
We examined two possible scenarios where the data is MNAR:
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(A) In the first, we set 30% of the censored observations and 50% of the failures to
have missing indicators.
(B) In the second, we set 20% of the censored observations and 60% of the failures to
have missing indicators.
Bias increased for all methods under both MNAR scenarios. In particular, the
complete case method consistently displayed a high amount of bias and did not achieve
the desired coverage rate. For our imputation method and the method of Cook and
Kosorok (8), bias increased and coverage decreased as the true parameter value increased.
This indicates that when the MAR assumption is violated, our method as well as the
method of Cook and Kosorok (8) may not be valid. On the other hand, even when the
data was not MAR, our method provided an improvement in terms of bias and coverage
compared to the complete case method and the method that treats all missing subjects
as failures. Moreover, the coverage probability was slightly greater for our method than
for the method of Cook and Kosorok (8).
Simulations for Poisson Regression
We performed simulations to evaluate the performance of our method when the
desired time-to-event analysis is a Poisson regression model rather than a Cox model.
Poisson models are commonly used to estimate incidence rates, which is an objective
of the OPPERA study.
The simulations were identical to those described in Section 3.4 except that the
imputed data was used to fit Poisson regression models rather than Cox proportional
hazards models. That is, we fit the data from imputations j = 1, . . . ,m to the model
log(µi) = α + βxi1 + log(Vi). (A.2)
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where µi is the expected number of cases and the offset, log(Vi), is the logarithm
of the survival time. We measured the bias, defined as βˆ minus the true value, for
β ∈ {−0.5,−1.5,−3}.
The Cook and Kosorok (8) method does not immediately generalize to Poisson
regression. Consequently, we only compared our method to the unachievable ideal of
no missing data, the complete case method, and the two ad hoc methods.
The use of Poisson regression allows us to estimate incidence rates. For each
simulation, we estimated the incidence rate based on the coefficients of the Poisson
regression model in (A.2). Specifically, estimated incidence rates for fixed values of Xi1
are given by
exp(α + βxi1) (A.3)
The bias, confidence interval width, and coverage probability of each method are shown
in Table A1.10. We also present the estimated incidence rates for each quartile of the
random variable Xi1 (i.e. the quartiles of the N(2, 1) distribution). See Table A1.11.
Our method had close to 95% coverage probability when Poisson regression was
used. None of the other methods had proper coverage for all of the simulations. Multiple
imputation yielded the least bias of all the methods besides the unacheivable ideal of
observing all data. It also produced more narrow confidence intervals than the complete
case method and the method that treats all missing censoring indicators as censored.
The bias evident in parameter estimation was compounded for incidence rates.
The complete case method and the two ad hoc methos consistently underestimated
incidence. In fact, the complete case method underestimated incidence by about 30-
200%. By contrast, our method differed from the unachievable ideal by only about
4-6%.
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Table A1.1: Simulation Results for MCAR
β Method Bias SE (Bias) Width SE (Width) Coverage*
-0.5 Full Data -0.0010 0.0006 0.1671 0.0001 0.930
Complete Case -0.0042 0.0007 0.2218 0.0001 0.956
Treat all as Censored -0.0021 0.0007 0.2212 0.0001 0.947
Treat all as Failures 0.0932 0.0005 0.1525 0.0001 0.323
Cook & Kosorok -0.0005 0.0006 0.1802 0.0002 0.943
Multiple Imputation -0.0005 0.0006 0.1713 0.0001 0.932
-1.5 Full Data -0.0008 0.0010 0.3185 0.0002 0.966
Complete Case -0.0056 0.0014 0.4261 0.0003 0.948
Treat all as Censored -0.0025 0.0014 0.4229 0.0003 0.950
Treat all as Failures 0.8277 0.0007 0.2036 0.0001 0.000
Cook & Kosorok -0.0003 0.0011 0.3512 0.0004 0.952
Multiple Imputation -0.0005 0.0011 0.3306 0.0002 0.947
-3 Full Data -0.0190 0.0025 0.7574 0.0008 0.952
Complete Case -0.0321 0.0036 1.0255 0.0016 0.942
Treat all as Censored -0.0205 0.0035 1.0070 0.0015 0.950
Treat all as Failures 2.5225 0.0009 0.2216 0.0001 0.000
Cook & Kosorok -0.0229 0.0028 0.9459 0.0024 0.953
Multiple Imputation -0.0239 0.0028 0.7961 0.0010 0.936
*: The Monte Carlo error is 0.007.
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Table A1.2: Simulation Results for MCAR
β Method Bias SE (Bias) Width SE (Width) Coverage*
-0.5 Full Data -0.0010 0.0006 0.1671 0.0001 0.930
Complete Case -0.0543 0.0008 0.2210 0.0001 0.825
Treat all as Censored -0.0021 0.0007 0.2212 0.0001 0.947
Treat all as Failures 0.0041 0.0006 0.1703 0.0001 0.929
Cook & Kosorok -0.0012 0.0006 0.1742 0.0001 0.934
Multiple Imputation -0.0012 0.0006 0.1722 0.0001 0.938
-1.5 Full Data -0.0008 0.0010 0.3185 0.0002 0.966
Complete Case -0.1329 0.0014 0.4283 0.0003 0.759
Treat all as Censored -0.0025 0.0014 0.4229 0.0003 0.950
Treat all as Failures 0.0849 0.0011 0.3147 0.0002 0.790
Cook & Kosorok -0.0006 0.0011 0.3411 0.0004 0.951
Multiple Imputation -0.0006 0.0011 0.3320 0.0002 0.957
-3 Full Data -0.0190 0.0025 0.7574 0.0008 0.952
Complete Case -0.2342 0.0037 1.0336 0.0016 0.883
Treat all as Censored -0.0205 0.0035 1.0070 0.0015 0.950
Treat all as Failures 0.6626 0.0025 0.6165 0.0006 0.047
Cook & Kosorok -0.0232 0.0028 0.8775 0.0016 0.940
Multiple Imputation -0.0240 0.0028 0.7996 0.0010 0.937
*: The Monte Carlo error is 0.007.
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Table A1.3: Results for an Extra Covariate Included in the Logistic Regression Model
β Method Bias SE (Bias) Width SE (Width) Coverage*
-0.5 Full Data -0.0017 5e-04 0.1670 1e-04 0.957
Complete Case 9e-04 7e-04 0.2156 1e-04 0.942
Treat all as Censored 0.1038 7e-04 0.2132 1e-04 0.517
Treat all as Failures 0.0010 6e-04 0.1703 1e-04 0.948
Cook & Kosorok -0.0016 6e-04 0.1741 1e-04 0.954
Multiple Imputation -0.0016 6e-04 0.1718 1e-04 0.942
-1.5 Full Data -0.0010 0.001 0.3188 2e-04 0.950
Complete Case -0.0589 0.0014 0.4332 4e-04 0.929
Treat all as Censored 0.1240 0.0014 0.4227 3e-04 0.765
Treat all as Failures 0.0665 0.001 0.3166 2e-04 0.864
Cook & Kosorok -9e-04 0.0011 0.3425 3e-04 0.945
Multiple Imputation -0.0010 0.0011 0.3313 2e-04 0.946
-3 Full Data -0.0170 0.0025 0.7586 8e-04 0.956
Complete Case -0.1892 0.0035 1.0783 0.0016 0.929
Treat all as Censored 0.1090 0.0034 1.0351 0.0014 0.907
Treat all as Failures 0.6010 0.0025 0.6275 6e-04 0.095
Cook & Kosorok -0.0184 0.0028 0.9093 0.0016 0.946
Multiple Imputation -0.0191 0.0028 0.8057 0.0012 0.941
*: The Monte Carlo error is 0.007.
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Table A1.4: Results when a Relevant Covariate is Omitted frin the Logistic Regression
Model
β Method Bias SE (Bias) Width SE (Width) Coverage*
-0.5 Full Data -0.0034 5e-04 0.1671 1e-04 0.950
Complete Case -0.0012 7e-04 0.2157 1e-04 0.943
Treat all as Censored 0.1005 7e-04 0.2133 1e-04 0.544
Treat all as Failures -8e-04 6e-04 0.1704 1e-04 0.955
Cook & Kosorok -0.0036 6e-04 0.1739 1e-04 0.951
Multiple Imputation -0.0036 6e-04 0.1721 1e-04 0.954
-1.5 Full Data -0.0055 0.001 0.3183 2e-04 0.955
Complete Case -0.0638 0.0014 0.4322 4e-04 0.925
Treat all as Censored 0.1177 0.0014 0.4218 3e-04 0.787
Treat all as Failures 0.0625 0.001 0.3161 2e-04 0.869
Cook & Kosorok -0.0054 0.0011 0.3451 4e-04 0.944
Multiple Imputation -0.0055 0.0011 0.3359 2e-04 0.954
-3 Full Data -0.0190 0.0025 0.7574 8e-04 0.952
Complete Case -0.1888 0.0038 1.0804 0.0018 0.917
Treat all as Censored 0.1134 0.0035 1.0355 0.0015 0.907
Treat all as Failures 0.5996 0.0024 0.6264 6e-04 0.080
Cook & Kosorok -0.0165 0.0029 0.8985 0.0017 0.940
Multiple Imputation -0.0186 0.0029 0.8199 0.0011 0.943
*: The Monte Carlo error is 0.007.
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Table A1.5: Results when the Logistic Regression Model is Applied to Observations
with Qi = 0
β Method Bias SE (Bias) Width SE (Width) Coverage*
-0.5 Full Data -0.0010 0.0006 0.1671 0.0001 0.930
Complete Case -0.0042 0.0007 0.2218 0.0001 0.956
Treat all as Censored -0.0021 0.0007 0.2212 0.0001 0.947
Treat all as Failures 0.0932 0.0005 0.1525 0.0001 0.323
Cook & Kosorok -0.0005 0.0006 0.1802 0.0002 0.943
Multiple Imputation -0.0005 0.0006 0.1713 0.0001 0.932
-1.5 Full Data -0.0008 0.0010 0.3185 0.0002 0.966
Complete Case -0.0056 0.0014 0.4261 0.0003 0.948
Treat all as Censored -0.0025 0.0014 0.4229 0.0003 0.950
Treat all as Failures 0.8277 0.0007 0.2036 0.0001 0.000
Cook & Kosorok -0.0003 0.0011 0.3512 0.0004 0.952
Multiple Imputation -0.0005 0.0011 0.3306 0.0002 0.947
-3 Full Data -0.0190 0.0025 0.7574 0.0008 0.952
Complete Case -0.0321 0.0036 1.0255 0.0016 0.942
Treat all as Censored -0.0205 0.0035 1.0070 0.0015 0.950
Treat all as Failures 2.5225 0.0009 0.2216 0.0001 0.000
Cook & Kosorok -0.0229 0.0028 0.9459 0.0024 0.953
Multiple Imputation -0.0239 0.0028 0.7961 0.0010 0.936
*: The Monte Carlo error is 0.007.
107
Table A1.6: Results when an Extra Covariate is Included in the Logistic Regression
Model and the Model is Applied to Observations with Qi = 0
β Method Bias SE (Bias) Width SE (Width) Coverage*
-0.5 Full Data -0.0020 5e-04 0.1671 1e-04 0.957
Complete Case -0.0026 7e-04 0.2218 1e-04 0.954
Treat all as Censored -1e-04 7e-04 0.221 1e-04 0.945
Treat all as Failures 0.0938 5e-04 0.1526 1e-04 0.328
Cook & Kosorok -4e-04 6e-04 0.1814 2e-04 0.951
Multiple Imputation -4e-04 6e-04 0.1713 1e-04 0.950
-1.5 Full Data -0.0050 0.0011 0.3187 2e-04 0.943
Complete Case -0.0077 0.0014 0.4245 4e-04 0.949
Treat all as Censored -0.0038 0.0014 0.4218 3e-04 0.947
Treat all as Failures 0.8225 7e-04 0.2040 1e-04 0.000
Cook & Kosorok -0.0041 0.0011 0.3526 4e-04 0.943
Multiple Imputation -0.0041 0.0011 0.3306 2e-04 0.939
-3 Full Data -0.0191 0.0026 0.7586 0.0008 0.950
Complete Case -0.0389 0.0035 1.0301 0.0016 0.949
Treat all as Censored -0.0276 0.0034 1.0108 0.0014 0.947
Treat all as Failures 2.5217 0.0008 0.2214 0.0001 0.000
Cook & Kosorok -0.0155 0.0029 0.9683 0.0025 0.961
Multiple Imputation -0.0156 0.0028 0.7978 0.0011 0.939
*: The Monte Carlo error is 0.007.
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Table A1.7: Results when a Relevant Covariate is not Included in the Logistic
Regression Model and the Model is Applied to Observations where Qi = 0
β Method Bias SE (Bias) Width SE (Width) Coverage*
-0.5 Full Data -0.0001 0.0006 0.1667 0.0001 0.941
Complete Case 0.0011 0.0008 0.2211 0.0001 0.939
Treat all as Censored 0.0009 0.0007 0.2205 0.0001 0.939
Treat all as Failures 0.0938 0.0005 0.1522 0.0001 0.331
Cook & Kosorok 0.0840 0.0005 0.1581 0.0001 0.484
Multiple Imputation 0.0840 0.0005 0.1551 0.0001 0.441
-1.5 Full Data -0.0046 0.0011 0.3187 0.0002 0.941
Complete Case -0.0068 0.0014 0.4242 0.0004 0.939
Treat all as Censored -0.0029 0.0014 0.4217 0.0003 0.945
Treat all as Failures 0.8236 0.0007 0.2041 0.0001 0.000
Cook & Kosorok 0.5062 0.0013 0.3936 0.0006 0.003
Multiple Imputation 0.5058 0.0013 0.2581 0.0002 0.000
-3 Full Data -0.0229 0.0026 0.7606 0.0009 0.954
Complete Case -0.0335 0.0034 1.0296 0.0016 0.965
Treat all as Censored -0.0282 0.0034 1.0132 0.0014 0.956
Treat all as Failures 2.5266 0.0008 0.2212 0.0001 0.000
Cook & Kosorok 0.8890 0.0034 1.0710 0.0026 0.191
Multiple Imputation 0.8867 0.0034 0.5424 0.0008 0.026
*: The Monte Carlo error is 0.007.
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Table A1.8: Simulation Results for MNAR, scenario A
β Method Bias SE (Bias) Width SE (Width) Coverage*
-0.5 Full Data -0.0021 0.0006 0.1671 0.0001 0.938
Complete Case -0.0755 0.0008 0.2424 0.0004 0.778
Treat all as Censored -0.0022 0.0008 0.2421 0.0001 0.942
Treat all as Failures 0.0023 0.0006 0.1705 0.0001 0.942
Cook & Kosorok -0.0054 0.0006 0.1760 0.0001 0.940
Multiple Imputation -0.0054 0.0006 0.1732 0.0001 0.943
-1.5 Full Data -0.0030 0.0011 0.3185 0.0002 0.942
Complete Case -0.1744 0.0016 0.4691 0.0004 0.717
Treat all as Censored -0.0049 0.0015 0.4623 0.0004 0.947
Treat all as Failures 0.0646 0.0011 0.3172 0.0002 0.875
Cook & Kosorok -0.0206 0.0011 0.3460 0.0004 0.921
Multiple Imputation -0.0207 0.0011 0.3362 0.0002 0.939
-3 Full Data -0.0289 0.0026 0.7611 0.0009 0.948
Complete Case -0.3308 0.0040 1.1490 0.0018 0.824
Treat all as Censored -0.0339 0.0039 1.1060 0.0016 0.935
Treat all as Failures 0.5242 0.0026 0.6487 0.0007 0.181
Cook & Kosorok -0.0737 0.0029 0.9026 0.0018 0.898
Multiple Imputation -0.0745 0.0029 0.8194 0.0011 0.940
*: The Monte Carlo error is 0.007.
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Table A1.9: Simulation Results for MNAR, scenario B
β Method Bias SE (Bias) Width SE (Width) Coverage*
-0.5 Full Data -0.0021 0.0006 0.1671 0.0001 0.938
Complete Case -0.0998 0.0009 0.2713 0.0002 0.687
Treat all as Censored -0.0016 0.0009 0.2707 0.0001 0.943
Treat all as Failures 0.0009 0.0006 0.1707 0.0001 0.943
Cook & Kosorok -0.0094 0.0006 0.1783 0.0001 0.933
Multiple Imputation -0.0095 0.0006 0.1747 0.0001 0.934
-1.5 Full Data -0.0030 0.0011 0.3185 0.0002 0.942
Complete Case -0.2278 0.0018 0.5289 0.0005 0.618
Treat all as Censored -0.0046 0.0017 0.5169 0.0004 0.958
Treat all as Failures 0.0444 0.0011 0.3201 0.0002 0.910
Cook & Kosorok -0.0398 0.0012 0.3534 0.0004 0.902
Multiple Imputation -0.0398 0.0012 0.3417 0.0002 0.920
-3 Full Data -0.0289 0.0026 0.7611 0.0009 0.948
Complete Case -0.4316 0.0046 1.3085 0.0023 0.781
Treat all as Censored -0.0464 0.0044 1.2434 0.002 0.932
Treat all as Failures 0.3661 0.0027 0.6850 0.0007 0.451
Cook & Kosorok -0.1180 0.0030 0.9425 0.0021 0.870
Multiple Imputation -0.1189 0.0030 0.8394 0.0012 0.924
*: The Monte Carlo error is 0.007.
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Table A1.10: Simulation Results for Poisson Models, MAR
β Method Bias SE (Bias) Width SE (Width) Coverage*
-0.5 Full Data -0.0036 0.0005 0.1596 0.0001 0.956
Complete Case -0.0101 0.0007 0.2067 0.0001 0.948
Treat all as Censored 0.0813 0.0007 0.2049 0.0001 0.652
Treat all as Failures -0.0002 0.0006 0.1628 0.0001 0.957
Multiple Imputation -0.0036 0.0006 0.1642 0.0001 0.959
-1.5 Full Data -0.0005 0.0010 0.2864 0.0002 0.945
Complete Case -0.1008 0.0015 0.3956 0.0004 0.829
Treat all as Censored 0.0704 0.0014 0.3883 0.0003 0.898
Treat all as Failures 0.0717 0.0010 0.2857 0.0002 0.820
Multiple Imputation 0.0006 0.0011 0.2979 0.0002 0.940
-3 Full Data -0.0184 0.0021 0.5994 0.0007 0.958
Complete Case -0.2733 0.0032 0.8710 0.0016 0.792
Treat all as Censored 0.0206 0.0030 0.8485 0.0012 0.954
Treat all as Failures 0.5232 0.0025 0.5544 0.0006 0.085
Multiple Imputation -0.0219 0.0024 0.6353 0.0009 0.940
*: The Monte Carlo error is 0.007.
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Table A1.11: Simulation Results for Incidence Rates
β Method Q1 SE Q2 SE Q3 SE
-0.5 Full Data 0.5157 0.0003 0.3671 0.0002 0.2615 0.0002
Complete Case 0.4261 0.0004 0.3019 0.0002 0.2142 0.0002
Treat all as Censored 0.2991 0.0003 0.2254 0.0002 0.1701 0.0002
Treat all as Failures 0.4949 0.0003 0.3531 0.0002 0.2521 0.0002
Multiple Imputation 0.4910 0.0003 0.3495 0.0002 0.2490 0.0002
-1.5 Full Data 0.1375 0.0001 0.0501 0.0001 0.0183 0.0000
Complete Case 0.0968 0.0001 0.0330 0.0001 0.0113 0.0000
Treat all as Censored 0.0753 0.0001 0.0288 0.0000 0.0110 0.0000
Treat all as Failures 0.1388 0.0001 0.0530 0.0001 0.0203 0.0000
Multiple Imputation 0.1309 0.0001 0.0477 0.0001 0.0174 0.0000
-3 Full Data 0.0186 0.0000 0.0025 0.0000 0.0003 0.0000
Complete Case 0.0106 0.0000 0.0012 0.0000 0.0001 0.0000
Treat all as Censored 0.0097 0.0000 0.0013 0.0000 0.0002 0.0000
Treat all as Failures 0.0301 0.0001 0.0058 0.0000 0.0011 0.0000
Multiple Imputation 0.0176 0.0000 0.0023 0.0000 0.0003 0.0000
*: Q1 denotes rates based on the lower quartile of Xi1.
*: Q2 denotes rates based on the median of Xi1.
*: Q3 denotes rates based on the upper quartile of Xi1.
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APPENDIX 2: SUPPLEMENTARY MATERIAL FOR CHAPTER 5
Results for the QST domain remained unchanged in overall interpretation for different
threshold values, ranging from 0.4 to 0.8 for all components. For the full cohort of
3443 individuals, see Tables A2.1-A2.4 and Table 5.9. For the follow-up cohort of
2737 individuals see Tables A2.6-A2.9. As expected, results are very close for the full
OPPERA dataset compared to for those with follow-up data only. No further discussion
is warranted, but tables are provided for the reader.
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Table A2.1: PCA/SFA QST Results for the Entire OPPERA Cohort, c=0.4
Component 1 2 3 4 5
Pressure Pain Threshold
Temporalis 0 0 0.42 0 0
Masseter 0 0 0.44 0 0
TMJ 0 0 0.42 0 0
Trapezius 0 0 0.41 0 0
Epicondyl 0 0 0.37 0 0
Mechanical Cutaneous Pain Threshhold 0 0 0.38 0 0
Single Stimulus
256 mN Probe 0 0 0 0.36 0
512 mN Probe 0 0 0 0.37 0
After Sensation
15 s, 256 mN probe 0 0 0 0.48 0
30 s, 256 mN probe 0 0 0 0.40 0
15 s, 512 mN probe 0 0.04 0 0.41 0
30 s, 512 mN probe 0 0.07 0 0.37 0
Temporal Summation
256 mN probe 0 0 0 0.19 0
512 mN probe 0 0 0 0 0
Heat Pain Tolerance -0.03 0 0 0 0
Single Stimulus Ratings
46 0.35 0 0 0 0
48 0.42 0 0 0 0
50 0.43 0 0 0 0
Area Under the Curve
46 0.42 0 0 0 0
48 0.45 0 0 0 0
50 0.39 0 0 0 0
After Sensations
15 s, 46 0 0.37 0 0 0
30 s, 46 0 0.40 0 0 0
15 s, 48 0 0.41 0 0 0
30 s, 48 0 0.44 0 0 0
15 s, 50 0 0.40 0 0 0
30 s, 50 0 0.42 0 0 0
Temporal Summation: Highest Minus First Rating
46 0 0 0 0 0.46
48 0 0 0 0 0.50
50 0 0 0 0 0.34
Temporal Summation: Slope of Line for First 3 Ratings
46 0 0 0 0 0.28
48 0 0 0 0 0.43
50 0 0 0 0 0.39
Percent Variance Explained 0.15 0.31 0.45 0.58 0.69
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Table A2.2: PCA/SFA QST Results for the Entire OPPERA Cohort, c=0.5
Component 1 2 3 4 5
Pressure Pain Threshold
Temporalis 0 0 0.42 0 0
Masseter 0 0 0.45 0 0
TMJ 0 0 0.43 0 0
Trapezius 0 0 0.41 0 0
Epicondyl 0 0 0.36 0 0
Mechanical Cutaneous Pain Threshold 0 0 0.37 0 0
Single Stimulus
256 mN Probe 0 0 0 0.34 0
512 mN Probe 0 0 0 0.37 0
Temporal Summation
256 mN probe 0 0 0 0.1 0
512 mN probe 0 0 0 0 0
After Sensation Ratings
15 s, 256 mN probe 0 0 0 0.52 0
15 s, 512 mN probe 0 0 0 0.42 0
30 s, 256 mN probe 0 0 0 0.4 0
30 s, 512 mN probe 0 0 0 0.35 0
Heat Pain Tolerance 0 0 0 0 0
After Sensations
15 s, 46 0 0.36 0 0 0
15 s, 48 0 0.41 0 0 0
15 s, 50 0 0.4 0 0 0
30 s, 46 0 0.4 0 0 0
30 s, 48 0 0.45 0 0 0
30 s, 50 0 0.43 0 0 0
Single Stimulus
46 0.33 0 0 0 0
48 0.42 0 0 0 0
50 0.43 0 0 0 0
Area Under the Curve
46 0.42 0 0 0 0
48 0.46 0 0 0 0
50 0.37 0 0 0 0
Temporal Summation: Highest Minus First Rating
46 0 0 0 0 0.47
48 0 0 0 0 0.53
50 0 0 0 0 0.32
Temporal Summation: Slope of Line for First 3 Ratings
46 0 0 0 0 0.24
48 0 0 0 0 0.44
50 0 0 0 0 0.38
Percent Variance Explained 0.15 0.3 0.44 0.57 0.68
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Table A2.3: PCA/SFA QST Results for the Entire OPPERA Cohort, c=0.6
Component 1 2 3 4 5
Pressure Pain Threshold
Temporalis 0 0 0.43 0 0
Masseter 0 0 0.47 0 0
TMJ 0 0 0.44 0 0
Trapezius 0 0 0.41 0 0
Epicondyl 0 0 0.34 0 0
Mechanical Cutaneous Pain Threshold 0 0 0.36 0 0
Single Stimulus
256 mN Probe 0 0 0 0.3 0
512 mN Probe 0 0 0 0.34 0
Temporal Summation
256 mN probe 0 0 0 0 0
512 mN probe 0 0 0 0 0
After Sensation Ratings
15 s, 256 mN probe 0 0 0 0.59 0
15 s, 512 mN probe 0 0 0 0.43 0
30 s, 256 mN probe 0 0 0 0.4 0
30 s, 512 mN probe 0 0 0 0.32 0
Heat Pain Tolerance 0 0 0 0 0
After Sensations
15 s, 46 0 0.34 0 0 0
15 s, 48 0 0.41 0 0 0
15 s, 50 0 0.39 0 0 0
30 s, 46 0 0.39 0 0 0
30 s, 48 0 0.46 0 0 0
30 s, 50 0 0.44 0 0 0
Single Stimulus
46 0.3 0 0 0 0
48 0.42 0 0 0 0
50 0.44 0 0 0 0
Area Under the Curve
46 0.43 0 0 0 0
48 0.48 0 0 0 0
50 0.36 0 0 0 0
Temporal Summation: Highest Minus First Rating
46 0 0 0 0 0.5
48 0 0 0 0 0.59
50 0 0 0 0 0.27
Temporal Summation: Slope of Line for First 3 Ratings
46 0 0 0 0 0.15
48 0 0 0 0 0.44
50 0 0 0 0 0.35
Percent Variance Explained 0.15 0.30 0.44 0.56 0.66
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Table A2.4: PCA/SFA QST Results for the Entire OPPERA Cohort, c=0.7
Component 1 2 3 4 5
Pressure Pain Threshold
Temporalis 0 0 0.43 0 0
Masseter 0 0 0.5 0 0
TMJ 0 0 0.45 0 0
Trapezius 0 0 0.41 0 0
Epicondyl 0 0 0.29 0 0
Mechanical Cutaneous Pain Threshold 0 0 0.33 0 0
Single Stimulus
256 mN Probe 0 0 0 0.12 0
512 mN Probe 0 0 0 0.21 0
Temporal Summation
256 mN probe 0 0 0 0 0
512 mN probe 0 0 0 0 0
After Sensation Ratings
15 s, 256 mN probe 0 0 0 0.79 0
15 s, 512 mN probe 0 0 0 0.42 0
30 s, 256 mN probe 0 0 0 0.34 0
30 s, 512 mN probe 0 0 0 0.16 0
Heat Pain Tolerance 0 0 0 0 0
After Sensations
15 s, 46 0 0.3 0 0 0
15 s, 48 0 0.41 0 0 0
15 s, 50 0 0.38 0 0 0
30 s, 46 0 0.38 0 0 0
30 s, 48 0 0.5 0 0 0
30 s, 50 0 0.46 0 0 0
Single Stimulus
46 0.22 0 0 0 0
48 0.42 0 0 0 0
50 0.45 0 0 0 0
Area Under the Curve
46 0.44 0 0 0 0
48 0.52 0 0 0 0
50 0.33 0 0 0 0
Temporal Summation: Highest Minus First Rating
46 0 0 0 0 0.52
48 0 0 0 0 0.69
50 0 0 0 0 0.09
Temporal Summation: Slope of Line for First 3 Ratings
46 0 0 0 0 0
48 0 0 0 0 0.42
50 0 0 0 0 0.25
Percent Variance Explained 0.15 0.29 0.43 0.53 0.61
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Table A2.5: PCA/SFA QST Results for the OPPERA Follow-up Cohort, c=0.4
Component 1 2 3 4 5
Pressure Pain Threshold
Temporalis 0 0 0.42 0 0
Masseter 0 0 0.44 0 0
TMJ 0 0 0.42 0 0
Trapezius 0 0 0.41 0 0
Epicondyl 0 0 0.36 0 0
Mechanical Cutaneous Pain Threshold 0 0 0.39 0 0
Single Stimulus
256 mN Probe 0 0 0 0.36 0
512 mN Probe 0 0 0 0.37 0
Temporal Summation
256 mN probe 0 0 0 0.19 0
512 mN probe 0 0 0 0 0
After Sensation Ratings
15 s, 256 mN probe 0 0 0 0.48 0
15 s, 512 mN probe 0 0.06 0 0.41 0
30 s, 256 mN probe 0 0 0 0.4 0
30 s, 512 mN probe 0 0.09 0 0.35 0
Heat Pain Tolerance -0.03 0 0 0 0
After Sensations
15 s, 46 0 0.37 0 0 0
15 s, 48 0 0.41 0 0 0
15 s, 50 0 0.4 0 0 0
30 s, 46 0 0.4 0 0 0
30 s, 48 0 0.43 0 0 0
30 s, 50 0 0.42 0 0 0
Single Stimulus
46 0.35 0 0 0 0
48 0.42 0 0 0 0
50 0.43 0 0 0 0
Area Under the Curve
46 0.42 0 0 0 0
48 0.44 0 0 0 0
50 0.38 0 0 0 0
Temporal Summation: Highest Minus First Rating
46 0 0 0 0 0.46
48 0 0 0 0 0.51
50 0 0 0 0 0.35
Temporal Summation: Slope of Line for First 3 Ratings
46 0 0 0 0 0.27
48 0 0 0 0 0.43
50 0 0 0 0 0.39
Percent Variance Explained 0.15 0.31 0.45 0.58 0.69
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Table A2.6: PCA/SFA QST Results for the OPPERA Follow-up Cohort, c=0.5
Component 1 2 3 4 5
Pressure Pain Threshold
Temporalis 0 0 0.42 0 0
Masseter 0 0 0.45 0 0
TMJ 0 0 0.43 0 0
Trapezius 0 0 0.41 0 0
Epicondyl 0 0 0.35 0 0
Mechanical Cutaneous Pain Threshold 0 0 0.38 0 0
Single Stimulus
256 mN Probe 0 0 0 0.35 0
512 mN Probe 0 0 0 0.37 0
Temporal Summation
256 mN probe 0 0 0 0.11 0
512 mN probe 0 0 0 0 0
After Sensation Ratings
15 s, 256 mN probe 0 0 0 0.52 0
15 s, 512 mN probe 0 0 0 0.42 0
30 s, 256 mN probe 0 0 0 0.41 0
30 s, 512 mN probe 0 0 0 0.34 0
Heat Pain Tolerance 0 0 0 0 0
After Sensations
15 s, 46 0 0.36 0 0 0
15 s, 48 0 0.41 0 0 0
15 s, 50 0 0.4 0 0 0
30 s, 46 0 0.4 0 0 0
30 s, 48 0 0.44 0 0 0
30 s, 50 0 0.43 0 0 0
Single Stimulus
46 0.33 0 0 0 0
48 0.42 0 0 0 0
50 0.43 0 0 0 0
Area Under the Curve
46 0.42 0 0 0 0
48 0.45 0 0 0 0
50 0.37 0 0 0 0
Temporal Summation: Highest Minus First Rating
46 0 0 0 0 0.47
48 0 0 0 0 0.54
50 0 0 0 0 0.33
Temporal Summation: Slope of Line for First 3 Ratings
46 0 0 0 0 0.22
48 0 0 0 0 0.43
50 0 0 0 0 0.38
Percent Variance Explained 0.15 0.3 0.44 0.57 0.68
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Table A2.7: PCA/SFA QST Results for the OPPERA Follow-up Cohort, c=0.6
Component 1 2 3 4 5
Pressure Pain Threshold
Temporalis 0 0 0.42 0 0
Masseter 0 0 0.46 0 0
TMJ 0 0 0.43 0 0
Trapezius 0 0 0.41 0 0
Epicondyl 0 0 0.33 0 0
Mechanical Cutaneous Pain Threshold 0 0 0.38 0 0
Single Stimulus
256 mN Probe 0 0 0 0.31 0
512 mN Probe 0 0 0 0.34 0
Temporal Summation
256 mN probe 0 0 0 0 0
512 mN probe 0 0 0 0 0
After Sensation Ratings
15 s, 256 mN probe 0 0 0 0.59 0
15 s, 512 mN probe 0 0 0 0.43 0
30 s, 256 mN probe 0 0 0 0.41 0
30 s, 512 mN probe 0 0 0 0.3 0
Heat Pain Tolerance 0 0 0 0 0
After Sensations
15 s, 46 0 0.34 0 0 0
15 s, 48 0 0.41 0 0 0
15 s, 50 0 0.4 0 0 0
30 s, 46 0 0.39 0 0 0
30 s, 48 0 0.46 0 0 0
30 s, 50 0 0.44 0 0 0
Single Stimulus
46 0.3 0 0 0 0
48 0.43 0 0 0 0
50 0.44 0 0 0 0
Area Under the Curve
46 0.43 0 0 0 0
48 0.47 0 0 0 0
50 0.35 0 0 0 0
Temporal Summation: Highest Minus First Rating
46 0 0 0 0 0.49
48 0 0 0 0 0.59
50 0 0 0 0 0.28
Temporal Summation: Slope of Line for First 3 Ratings
46 0 0 0 0 0.12
48 0 0 0 0 0.44
50 0 0 0 0 0.36
Percent Variance Explained 0.15 0.3 0.44 0.56 0.66
121
Table A2.8: PCA/SFA QST Results for the OPPERA Follow-up Cohort, c=0.7
Component 1 2 3 4 5
Pressure Pain Threshold
Temporalis 0 0 0.43 0 0
Masseter 0 0 0.5 0 0
TMJ 0 0 0.44 0 0
Trapezius 0 0 0.41 0 0
Epicondyl 0 0 0.28 0 0
Mechanical Cutaneous Pain Threshold 0 0 0.35 0 0
Single Stimulus
256 mN Probe 0 0 0 0.12 0
512 mN Probe 0 0 0 0.2 0
Temporal Summation
256 mN probe 0 0 0 0 0
512 mN probe 0 0 0 0 0
After Sensation Ratings
15 s, 256 mN probe 0 0 0 0.8 0
15 s, 512 mN probe 0 0 0 0.41 0
30 s, 256 mN probe 0 0 0 0.35 0
30 s, 512 mN probe 0 0 0 0.09 0
Heat Pain Tolerance 0 0 0 0 0
After Sensations
15 s, 46 0 0.29 0 0 0
15 s, 48 0 0.41 0 0 0
15 s, 50 0 0.39 0 0 0
30 s, 46 0 0.38 0 0 0
30 s, 48 0 0.49 0 0 0
30 s, 50 0 0.46 0 0 0
Single Stimulus
46 0.23 0 0 0 0
48 0.44 0 0 0 0
50 0.46 0 0 0 0
Area Under the Curve
46 0.43 0 0 0 0
48 0.5 0 0 0 0
50 0.32 0 0 0 0
Temporal Summation: Highest Minus First Rating
46 0 0 0 0 0.51
48 0 0 0 0 0.7
50 0 0 0 0 0.11
Temporal Summation: Slope of Line for First 3 Ratings
46 0 0 0 0 0
48 0 0 0 0 0.41
50 0 0 0 0 0.26
Percent Variance Explained 0.15 0.29 0.43 0.52 0.61
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Table A2.9: PCA/SFA QST Results for the OPPERA Follow-up Cohort, c=0.8
Component 1 2 3 4 5
Pressure Pain Threshold
Temporalis 0 0 0.44 0 0
Masseter 0 0 0.6 0 0
TMJ 0 0 0.47 0 0
Trapezius 0 0 0.39 0 0
Epicondyl 0 0 0.09 0 0
Mechanical Cutaneous Pain Threshold 0 0 0.26 0 0
Single Stimulus
256 mN Probe 0 0 0 0 0
512 mN Probe 0 0 0 0 0
Temporal Summation
256 mN probe 0 0 0 0 0
512 mN probe 0 0 0 0 0
After Sensation Ratings
15 s, 256 mN probe 0 0 0 1 0
15 s, 512 mN probe 0 0 0 0 0
30 s, 256 mN probe 0 0 0 0 0
30 s, 512 mN probe 0 0 0 0 0
Heat Pain Tolerance 0 0 0 0 0
After Sensations
15 s, 46 0 0.06 0 0 0
15 s, 48 0 0.37 0 0 0
15 s, 50 0 0.34 0 0 0
30 s, 46 0 0.31 0 0 0
30 s, 48 0 0.61 0 0 0
30 s, 50 0 0.52 0 0 0
Single Stimulus
46 0 0 0 0 0
0 48 0.44 0 0 0 0
50 0.49 0 0 0 0
Area Under the Curve
46 0.43 0 0 0 0
48 0.6 0 0 0 0
50 0.14 0 0 0 0
Temporal Summation: Highest Minus First Rating
46 0 0 0 0 0.32
48 0 0 0 0 0.95
50 0 0 0 0 0
Temporal Summation: Slope of Line for First 3 Ratings
46 0 0 0 0 0
48 0 0 0 0 0
50 0 0 0 0 0
Percent Variance Explained 0.12 0.24 0.37 0.4 0.44
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Table A2.10: PCA/SFA Autonomic Results for the OPPERA Followup Cohort, c=0.4
Component 1 2 3 4 5
AvgRestingSPB 0.29 0 0 0 0
AvgRestingDPB 0.22 0 0 0 0
AvgRestingMAP 0.29 0 0 0 0
AvgRestingHR 0 0 0.3 0 0
InitialOrthoSPB 0.18 0 0 0 0
InitialOrthoDPB 0.2 0 0 0 0
InitialOrthoMAP 0.26 0 0 0 0
InitialOrthoHR 0 0 0.2 0 0
StroopColorSPBmean 0.33 0 0 0 0
StroopColorDPBmean 0.31 0 0 0 0
StroopColorMAPmean 0.35 0 0 0 0
StroopColorHRmean 0 0 0.4 0 0
StroopEmotionalSPBmean 0.33 0 0 0 0
StroopEmotionalDPBmean 0.29 0 0 0 0
StroopEmotionalMAPmean 0.35 0 0 0 0
StroopEmotionalHRmean 0 0 0.41 0 0
QST.SHRVBaseline20MinMeanHR 0 0 0.3 0 0
QST.SHRVBaseline20MinSDNN 0 0 0 0.34 0
QST.SHRVBaseline20MinRMSSD 0 0 0 0.12 0
HRVBaseline20minLnTP 0 0 0 0.53 0
HRVBaseline20minLnVLF 0 0 0 0.41 0
HRVBaseline20minLnLF 0 0 0 0.49 0
HRVBaseline20minLnHF 0 0 0 0.42 0
QST.SHRVOrthostatic5MinMeanHR 0 0 0.33 0 0
QST.SHRVOrthostatic5MinSDNN 0 0 0 0 0.47
QST.SHRVOrthostatic5MinRMSSD 0 0 0 0 0.38
HRVOrtho5minLnTP 0 0 0 0 0.45
HRVOrtho5minLnVLF 0 0 0 0 0.33
HRVOrtho5minLnLF 0 0 0 0 0.38
HRVOrtho5minLnHF 0 0 0 0 0.43
QST.SHRVSTROOPColor5MinMeanHR 0 0 0.41 0 0
QST.SHRVSTROOPColor5MinSDNN 0 0.42 0 0 0
QST.SHRVSTROOPColor5MinRMSSD 0 0.38 0 0 0
HRVStroopColor5minLnTP 0 0.32 0 0 0
HRVStroopColor5minLnVLF 0 0.18 0 0 0
HRVStroopColor5minLnLF 0 0.28 0 0 0
HRVStroopColor5minLnHF 0 0.33 0 0 0
QST.SHRVSTROOPEmotion5mnMeanHR 0 0 0.42 0 0
QST.SHRVSTROOPEmotion5mnSDNN 0 0.38 0 0 0
QST.SHRVSTROOPEmotion5mnRMSSD 0 0.36 0 0 0
HRVStroopEmotion5minLnTP 0 0.26 0 0 0
HRVStroopEmotion5minLnVLF 0 0.13 0 0 0
Percent Variance Explained 0.2 0.36 0.51 0.61 0.72
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Table A2.11: PCA/SFA Autonomic Results for the OPPERA Followup Cohort, c=0.5
Component 1 2 3 4 5
AvgRestingSPB 0.29 0 0 0 0
AvgRestingDPB 0.2 0 0 0 0
AvgRestingMAP 0.29 0 0 0 0
AvgRestingHR 0 0 0.28 0 0
InitialOrthoSPB 0.15 0 0 0 0
InitialOrthoDPB 0.18 0 0 0 0
InitialOrthoMAP 0.25 0 0 0 0
InitialOrthoHR 0 0 0.15 0 0
StroopColorSPBmean 0.34 0 0 0 0
StroopColorDPBmean 0.31 0 0 0 0
StroopColorMAPmean 0.37 0 0 0 0
StroopColorHRmean 0 0 0.41 0 0
StroopEmotionalSPBmean 0.33 0 0 0 0
StroopEmotionalDPBmean 0.29 0 0 0 0
StroopEmotionalMAPmean 0.36 0 0 0 0
StroopEmotionalHRmean 0 0 0.42 0 0
QST.SHRVBaseline20MinMeanHR 0 0 0.28 0 0
QST.SHRVBaseline20MinSDNN 0 0 0 0.3 0
QST.SHRVBaseline20MinRMSSD 0 0 0 0.01 0
HRVBaseline20minLnTP 0 0 0 0.57 0
HRVBaseline20minLnVLF 0 0 0 0.39 0
HRVBaseline20minLnLF 0 0 0 0.51 0
HRVBaseline20minLnHF 0 0 0 0.42 0
QST.SHRVOrthostatic5MinMeanHR 0 0 0.32 0 0
QST.SHRVOrthostatic5MinSDNN 0 0 0 0 0.48
QST.SHRVOrthostatic5MinRMSSD 0 0 0 0 0.37
HRVOrtho5minLnTP 0 0 0 0 0.46
HRVOrtho5minLnVLF 0 0 0 0 0.29
HRVOrtho5minLnLF 0 0 0 0 0.37
HRVOrtho5minLnHF 0 0 0 0 0.44
QST.SHRVSTROOPColor5MinMeanHR 0 0 0.42 0 0
QST.SHRVSTROOPColor5MinSDNN 0 0.44 0 0 0
QST.SHRVSTROOPColor5MinRMSSD 0 0.39 0 0 0
HRVStroopColor5minLnTP 0 0.32 0 0 0
HRVStroopColor5minLnVLF 0 0.13 0 0 0
HRVStroopColor5minLnLF 0 0.27 0 0 0
HRVStroopColor5minLnHF 0 0.33 0 0 0
QST.SHRVSTROOPEmotion5mnMeanHR 0 0 0.44 0 0
QST.SHRVSTROOPEmotion5mnSDNN 0 0.39 0 0 0
QST.SHRVSTROOPEmotion5mnRMSSD 0 0.37 0 0 0
HRVStroopEmotion5minLnTP 0 0.24 0 0 0
HRVStroopEmotion5minLnVLF 0 0.07 0 0 0
Percent Variance Explained 0.2 0.36 0.5 0.59 0.7
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Table A2.12: PCA/SFA Autonomic Results for the OPPERA Followup Cohort, c=0.6
Component 1 2 3 4 5
AvgRestingSPB 0.29 0 0 0 0
AvgRestingDPB 0.16 0 0 0 0
AvgRestingMAP 0.29 0 0 0 0
AvgRestingHR 0 0 0.25 0 0
InitialOrthoSPB 0.09 0 0 0 0
InitialOrthoDPB 0.13 0 0 0 0
InitialOrthoMAP 0.23 0 0 0 0
InitialOrthoHR 0 0 0.06 0 0
StroopColorSPBmean 0.35 0 0 0 0
StroopColorDPBmean 0.31 0 0 0 0
StroopColorMAPmean 0.4 0 0 0 0
StroopColorHRmean 0 0 0.42 0 0
StroopEmotionalSPBmean 0.35 0 0 0 0
StroopEmotionalDPBmean 0.29 0 0 0 0
StroopEmotionalMAPmean 0.39 0 0 0 0
StroopEmotionalHRmean 0 0 0.44 0 0
QST.SHRVBaseline20MinMeanHR 0 0 0.24 0 0
QST.SHRVBaseline20MinSDNN 0 0 0 0.23 0
QST.SHRVBaseline20MinRMSSD 0 0 0 0 0
HRVBaseline20minLnTP 0 0 0 0.61 0
HRVBaseline20minLnVLF 0 0 0 0.36 0
HRVBaseline20minLnLF 0 0 0 0.53 0
HRVBaseline20minLnHF 0 0 0 0.4 0
QST.SHRVOrthostatic5MinMeanHR 0 0 0.3 0 0
QST.SHRVOrthostatic5MinSDNN 0 0 0 0 0.52
QST.SHRVOrthostatic5MinRMSSD 0 0 0 0 0.35
HRVOrtho5minLnTP 0 0 0 0 0.49
HRVOrtho5minLnVLF 0 0 0 0 0.23
HRVOrtho5minLnLF 0 0 0 0 0.34
HRVOrtho5minLnHF 0 0 0 0 0.45
QST.SHRVSTROOPColor5MinMeanHR 0 0 0.44 0 0
QST.SHRVSTROOPColor5MinSDNN 0 0.48 0 0 0
QST.SHRVSTROOPColor5MinRMSSD 0 0.41 0 0 0
HRVStroopColor5minLnTP 0 0.31 0 0 0
HRVStroopColor5minLnVLF 0 0.02 0 0 0
HRVStroopColor5minLnLF 0 0.23 0 0 0
HRVStroopColor5minLnHF 0 0.32 0 0 0
QST.SHRVSTROOPEmotion5mnMeanHR 0 0 0.46 0 0
QST.SHRVSTROOPEmotion5mnSDNN 0 0.41 0 0 0
QST.SHRVSTROOPEmotion5mnRMSSD 0 0.38 0 0 0
HRVStroopEmotion5minLnTP 0 0.2 0 0 0
HRVStroopEmotion5minLnVLF 0 0 0 0 0
Percent Variance Explained 0.19 0.33 0.47 0.56 0.67
126
Table A2.13: PCA/SFA Autonomic Results for the OPPERA Followup Cohort, c=0.8
Component 1 2 3 4 5
AvgRestingSPB 0.17 0 0 0 0
AvgRestingDPB 0 0 0 0 0
AvgRestingMAP 0.18 0 0 0 0
AvgRestingHR 0 0 0 0 0
InitialOrthoSPB 0 0 0 0 0
InitialOrthoDPB 0 0 0 0 0
InitialOrthoMAP 0 0 0 0 0
InitialOrthoHR 0 0 0 0 0
StroopColorSPBmean 0.39 0 0 0 0
StroopColorDPBmean 0.27 0 0 0 0
StroopColorMAPmean 0.53 0 0 0 0
StroopColorHRmean 0 0 0.43 0 0
StroopEmotionalSPBmean 0.37 0 0 0 0
StroopEmotionalDPBmean 0.18 0 0 0 0
StroopEmotionalMAPmean 0.51 0 0 0 0
StroopEmotionalHRmean 0 0 0.5 0 0
QST.SHRVBaseline20MinMeanHR 0 0 0 0 0
QST.SHRVBaseline20MinSDNN 0 0 0 0 0
QST.SHRVBaseline20MinRMSSD 0 0 0 0 0
HRVBaseline20minLnTP 0 0 0 0.86 0
HRVBaseline20minLnVLF 0 0 0 0 0
HRVBaseline20minLnLF 0 0 0 0.51 0
HRVBaseline20minLnHF 0 0 0 0 0
QST.SHRVOrthostatic5MinMeanHR 0 0 0 0 0
QST.SHRVOrthostatic5MinSDNN 0 0 0 0 0.79
QST.SHRVOrthostatic5MinRMSSD 0 0 0 0 0
HRVOrtho5minLnTP 0 0 0 0 0.54
HRVOrtho5minLnVLF 0 0 0 0 0
HRVOrtho5minLnLF 0 0 0 0 0
HRVOrtho5minLnHF 0 0 0 0 0.29
QST.SHRVSTROOPColor5MinMeanHR 0 0 0.48 0 0
QST.SHRVSTROOPColor5MinSDNN 0 0.76 0 0 0
QST.SHRVSTROOPColor5MinRMSSD 0 0.42 0 0 0
HRVStroopColor5minLnTP 0 0 0 0 0
HRVStroopColor5minLnVLF 0 0 0 0 0
HRVStroopColor5minLnLF 0 0 0 0 0
HRVStroopColor5minLnHF 0 0 0 0 0
QST.SHRVSTROOPEmotion5mnMeanHR 0 0 0.58 0 0
QST.SHRVSTROOPEmotion5mnSDNN 0 0.42 0 0 0
QST.SHRVSTROOPEmotion5mnRMSSD 0 0.27 0 0 0
HRVStroopEmotion5minLnTP 0 0 0 0 0
HRVStroopEmotion5minLnVLF 0 0 0 0 0
Percent Variance Explained 0.14 0.21 0.3 0.34 0.4
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Table A2.14: PCA/SFA QST Results for Cases, c=0.4
Component 1 2 3 4 5
Pressure Pain Threshhold
Temporalis 0 0 0 0.47 0
Masseter 0 0 0 0.5 0
TMJ 0 0 0 0.5 0
Trapezius 0 0 0 0.4 0
Epicondyl 0 0 0 0.36 0
Mechanical Cutaneous Pain Threshold 0 0 0 0 0
Single Stimulus
256 mN Probe 0 0 0 0 0.54
512 mN Probe 0 0 0 0 0.54
Temporal Summation
256 mN probe 0 0 0 0 0
512 mN probe 0 0.07 0 0 0
After Sensation Ratings
15 s, 256 mN probe 0.12 0 0 0 0.4
15 s, 512 mN probe 0.15 0 0 0 0.32
30 s, 256 mN probe 0.16 0 0 0 0.29
30 s, 512 mN probe 0.21 0 0 0 0.27
Heat Pain Tolerance 0 -0.05 0 0 0
Single Stimulus
46 0 0.28 -0.06 0 0
48 0 0.36 -0.09 0 0
50 0 0.42 0 0 0
Area Under the Curve
46 0 0.42 0 0 0
48 0 0.48 0 0 0
50 0 0.44 0 0 0
After Sensations
15 s, 46 0.37 0 0 0 0
15 s, 48 0.38 0 0 0 0
15 s, 50 0.34 0 0 0 0
30 s, 46 0.39 0 0 0 0
30 s, 48 0.42 0 0 0 0
30 s, 50 0.41 0 0 0 0
Temporal Summation: Highest Minus First Rating
46 0 0 0.42 0 0
48 0 0 0.48 0 0
50 0 -0.02 0.32 0 0
Temporal Summation: Slope of Line for First 3 Ratings
46 0 0 0.32 0 0
48 0 0 0.45 0 0
50 0 0 0.41 0 0
Percent Variance Explained 0.2 0.35 0.48 0.6 0.69
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Table A2.15: Autonomic Results for the OPPERA Case Control Study, c=0.4
Component 1 2 3 4 5
AvgRestingSPB 0.29 0 0 0 0
AvgRestingDPB 0.22 0 0 0 0
AvgRestingMAP 0.29 0 0 0 0
AvgRestingHR 0 0 0.3 0 0
InitialOrthoSPB 0.18 0 0 0 0
InitialOrthoDPB 0.21 0 0 0 0
InitialOrthoMAP 0.26 0 0 0 0
InitialOrthoHR 0 0 0.21 0 0
StroopColorSPBmean 0.33 0 0 0 0
StroopColorDPBmean 0.31 0 0 0 0
StroopColorMAPmean 0.35 0 0 0 0
StroopColorHRmean 0 0 0.4 0 0
StroopEmotionalSPBmean 0.33 0 0 0 0
StroopEmotionalDPBmean 0.29 0 0 0 0
StroopEmotionalMAPmean 0.35 0 0 0 0
StroopEmotionalHRmean 0 0 0.41 0 0
QST.SHRVBaseline20MinMeanHR 0 0 0.3 0 0
QST.SHRVBaseline20MinSDNN 0 0 0 0.38 0
QST.SHRVBaseline20MinRMSSD 0 0 0 0.18 0
HRVBaseline20minLnTP 0 0 0 0.52 0
HRVBaseline20minLnVLF 0 0 0 0.38 0
HRVBaseline20minLnLF 0 0 0 0.48 0
HRVBaseline20minLnHF 0 0 0 0.42 0
QST.SHRVOrthostatic5MinMeanHR 0 0 0.34 0 0
QST.SHRVOrthostatic5MinSDNN 0 0 0 0 0.47
QST.SHRVOrthostatic5MinRMSSD 0 0 0 0 0.41
HRVOrtho5minLnTP 0 0 0 0 0.43
HRVOrtho5minLnVLF 0 0 0 0 0.31
HRVOrtho5minLnLF 0 0 0 0 0.37
HRVOrtho5minLnHF 0 0 0 0 0.44
QST.SHRVSTROOPColor5MinMeanHR 0 0 0.41 0 0
QST.SHRVSTROOPColor5MinSDNN 0 0.42 0 0 0
QST.SHRVSTROOPColor5MinRMSSD 0 0.4 0 0 0
HRVStroopColor5minLnTP 0 0.34 0 0 0
HRVStroopColor5minLnVLF 0 0.2 0 0 0
HRVStroopColor5minLnLF 0 0.3 0 0 0
HRVStroopColor5minLnHF 0 0.33 0 0 0
QST.SHRVSTROOPEmotion5mnMeanHR 0 0 0.42 0 0
QST.SHRVSTROOPEmotion5mnSDNN 0 0.35 0 0 0
QST.SHRVSTROOPEmotion5mnRMSSD 0 0.32 0 0 0
HRVStroopEmotion5minLnTP 0 0.25 0 0 0
HRVStroopEmotion5minLnVLF 0 0.12 0 0 0
Percent Variance Explained 0.2 0.36 0.51 0.61 0.72
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Table A2.16: Autonomic Results for the OPPERA Case Control Study, c=0.5
Component 1 2 3 4 5
AvgRestingSPB 0.28 0 0 0 0
AvgRestingDPB 0.2 0 0 0 0
AvgRestingMAP 0.29 0 0 0 0
AvgRestingHR 0 0 0.28 0 0
InitialOrthoSPB 0.14 0 0 0 0
InitialOrthoDPB 0.18 0 0 0 0
InitialOrthoMAP 0.25 0 0 0 0
InitialOrthoHR 0 0 0.17 0 0
StroopColorSPBmean 0.34 0 0 0 0
StroopColorDPBmean 0.31 0 0 0 0
StroopColorMAPmean 0.37 0 0 0 0
StroopColorHRmean 0 0 0.4 0 0
StroopEmotionalSPBmean 0.34 0 0 0 0
StroopEmotionalDPBmean 0.29 0 0 0 0
StroopEmotionalMAPmean 0.36 0 0 0 0
StroopEmotionalHRmean 0 0 0.42 0 0
QST.SHRVBaseline20MinMeanHR 0 0 0.28 0 0
QST.SHRVBaseline20MinSDNN 0 0 0 0.37 0
QST.SHRVBaseline20MinRMSSD 0 0 0 0.11 0
HRVBaseline20minLnTP 0 0 0 0.55 0
HRVBaseline20minLnVLF 0 0 0 0.37 0
HRVBaseline20minLnLF 0 0 0 0.49 0
HRVBaseline20minLnHF 0 0 0 0.42 0
QST.SHRVOrthostatic5MinMeanHR 0 0 0.33 0 0
QST.SHRVOrthostatic5MinSDNN 0 0 0 0 0.49
QST.SHRVOrthostatic5MinRMSSD 0 0 0 0 0.41
HRVOrtho5minLnTP 0 0 0 0 0.44
HRVOrtho5minLnVLF 0 0 0 0 0.28
HRVOrtho5minLnLF 0 0 0 0 0.36
HRVOrtho5minLnHF 0 0 0 0 0.44
QST.SHRVSTROOPColor5MinMeanHR 0 0 0.42 0 0
QST.SHRVSTROOPColor5MinSDNN 0 0.45 0 0 0
QST.SHRVSTROOPColor5MinRMSSD 0 0.43 0 0 0
HRVStroopColor5minLnTP 0 0.34 0 0 0
HRVStroopColor5minLnVLF 0 0.16 0 0 0
HRVStroopColor5minLnLF 0 0.29 0 0 0
HRVStroopColor5minLnHF 0 0.33 0 0 0
QST.SHRVSTROOPEmotion5mnMeanHR 0 0 0.44 0 0
QST.SHRVSTROOPEmotion5mnSDNN 0 0.36 0 0 0
QST.SHRVSTROOPEmotion5mnRMSSD 0 0.32 0 0 0
HRVStroopEmotion5minLnTP 0 0.22 0 0 0
HRVStroopEmotion5minLnVLF 0 0.05 0 0 0
Percent Variance Explained 0.2 0.35 0.5 0.6 0.71
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Table A2.17: Autonomic Results for the OPPERA Case Control Study, c=0.6
Component 1 2 3 4 5
AvgRestingSPB 0.28 0 0 0 0
AvgRestingDPB 0.16 0 0 0 0
AvgRestingMAP 0.29 0 0 0 0
AvgRestingHR 0 0 0.25 0 0
InitialOrthoSPB 0.08 0 0 0 0
InitialOrthoDPB 0.14 0 0 0 0
InitialOrthoMAP 0.22 0 0 0 0
InitialOrthoHR 0 0 0.08 0 0
StroopColorSPBmean 0.36 0 0 0 0
StroopColorDPBmean 0.31 0 0 0 0
StroopColorMAPmean 0.4 0 0 0 0
StroopColorHRmean 0 0 0.42 0 0
StroopEmotionalSPBmean 0.35 0 0 0 0
StroopEmotionalDPBmean 0.29 0 0 0 0
StroopEmotionalMAPmean 0.39 0 0 0 0
StroopEmotionalHRmean 0 0 0.44 0 0
QST.SHRVBaseline20MinMeanHR 0 0 0.24 0 0
QST.SHRVBaseline20MinSDNN 0 0 0 0.33 0
QST.SHRVBaseline20MinRMSSD 0 0 0 0 0
HRVBaseline20minLnTP 0 0 0 0.59 0
HRVBaseline20minLnVLF 0 0 0 0.34 0
HRVBaseline20minLnLF 0 0 0 0.51 0
HRVBaseline20minLnHF 0 0 0 0.41 0
QST.SHRVOrthostatic5MinMeanHR 0 0 0.31 0 0
QST.SHRVOrthostatic5MinSDNN 0 0 0 0 0.52
QST.SHRVOrthostatic5MinRMSSD 0 0 0 0 0.41
HRVOrtho5minLnTP 0 0 0 0 0.45
HRVOrtho5minLnVLF 0 0 0 0 0.21
HRVOrtho5minLnLF 0 0 0 0 0.33
HRVOrtho5minLnHF 0 0 0 0 0.45
QST.SHRVSTROOPColor5MinMeanHR 0 0 0.44 0 0
QST.SHRVSTROOPColor5MinSDNN 0 0.49 0 0 0
QST.SHRVSTROOPColor5MinRMSSD 0 0.46 0 0 0
HRVStroopColor5minLnTP 0 0.34 0 0 0
HRVStroopColor5minLnVLF 0 0.07 0 0 0
HRVStroopColor5minLnLF 0 0.26 0 0 0
HRVStroopColor5minLnHF 0 0.32 0 0 0
QST.SHRVSTROOPEmotion5mnMeanHR 0 0 0.46 0 0
QST.SHRVSTROOPEmotion5mnSDNN 0 0.36 0 0 0
QST.SHRVSTROOPEmotion5mnRMSSD 0 0.31 0 0 0
HRVStroopEmotion5minLnTP 0 0.16 0 0 0
HRVStroopEmotion5minLnVLF 0 0 0 0 0
Percent Variance Explained 0.19 0.33 0.47 0.56 0.67
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Table A2.18: Autonomic Results for the OPPERA Case Control Study, c=0.8
Component 1 2 3 4 5
AvgRestingSPB 0.14 0 0 0 0
AvgRestingDPB 0 0 0 0 0
AvgRestingMAP 0.17 0 0 0 0
AvgRestingHR 0 0 0 0 0
InitialOrthoSPB 0 0 0 0 0
InitialOrthoDPB 0 0 0 0 0
InitialOrthoMAP 0 0 0 0 0
InitialOrthoHR 0 0 0 0 0
StroopColorSPBmean 0.4 0 0 0 0
StroopColorDPBmean 0.26 0 0 0 0
StroopColorMAPmean 0.54 0 0 0 0
StroopColorHRmean 0 0 0.42 0 0
StroopEmotionalSPBmean 0.38 0 0 0 0
StroopEmotionalDPBmean 0.18 0 0 0 0
StroopEmotionalMAPmean 0.51 0 0 0 0
StroopEmotionalHRmean 0 0 0.51 0 0
QST.SHRVBaseline20MinMeanHR 0 0 0 0 0
QST.SHRVBaseline20MinSDNN 0 0 0 0 0
QST.SHRVBaseline20MinRMSSD 0 0 0 0 0
HRVBaseline20minLnTP 0 0 0 0.84 0
HRVBaseline20minLnVLF 0 0 0 0 0
HRVBaseline20minLnLF 0 0 0 0.53 0
HRVBaseline20minLnHF 0 0 0 0.08 0
QST.SHRVOrthostatic5MinMeanHR 0 0 0.03 0 0
QST.SHRVOrthostatic5MinSDNN 0 0 0 0 0.8
QST.SHRVOrthostatic5MinRMSSD 0 0 0 0 0.17
HRVOrtho5minLnTP 0 0 0 0 0.39
HRVOrtho5minLnVLF 0 0 0 0 0
HRVOrtho5minLnLF 0 0 0 0 0
HRVOrtho5minLnHF 0 0 0 0 0.42
QST.SHRVSTROOPColor5MinMeanHR 0 0 0.49 0 0
QST.SHRVSTROOPColor5MinSDNN 0 0.77 0 0 0
QST.SHRVSTROOPColor5MinRMSSD 0 0.62 0 0 0
HRVStroopColor5minLnTP 0 0.03 0 0 0
HRVStroopColor5minLnVLF 0 0 0 0 0
HRVStroopColor5minLnLF 0 0 0 0 0
HRVStroopColor5minLnHF 0 0 0 0 0
QST.SHRVSTROOPEmotion5mnMeanHR 0 0 0.57 0 0
QST.SHRVSTROOPEmotion5mnSDNN 0 0.13 0 0 0
QST.SHRVSTROOPEmotion5mnRMSSD 0 0 0 0 0
HRVStroopEmotion5minLnTP 0 0 0 0 0
HRVStroopEmotion5minLnVLF 0 0 0 0 0
Percent Variance Explained 0.14 0.19 0.28 0.33 0.39
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Table A2.19: PCA/SFA Psychosocial Results for the Entire OPPERA Cohort, c=0.4
Component 1 2 3 4
KOHN.Global.Score 0 0 0.12 0
PILL.Global.Score 0.28 0 0 0
POMS.PositiveAffectScore 0 -0.52 0 0
POMS.NegativeAffectScore 0.11 0.23 0 0
PSS.PerceivedStress 0 0.39 0 0
SCL.90R.Depression 0.48 0 0 0
SCL.90R.Somatization 0.47 0 0 0
SCL.90R.Anxiety 0.5 0 0 0
SCL.90R.Hostility 0.45 0 0 0
CSQ.Distraction 0 0 0 0.48
CSQ.IgnoringPain 0 0 0 0.49
CSQ.Distancing 0 0 0 0.49
CSQ.Coping 0 0 0 0.54
CSQ.Praying 0 0 0.21 0
STAIY1.StateTraitAnxiety 0 0.48 0 0
STAIY2.StateTraitAnxiety 0.04 0.48 0 0
PCS.Rumination 0 0 0.61 0
PCS.Magnification 0 0 0.5 0
PCS.Helplessness 0 0 0.57 0
EPQ.Escale 0 -0.08 0 0
EPQ.Nscale 0 0.24 0 0
Percent Variance Explained 0.17 0.34 0.46 0.57
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Table A2.20: PCA/SFA Psychosocial Results for the Entire OPPERA Cohort, c=0.5
Component 1 2 3 4
KOHN.Global.Score 0 0 0 0
PILL.Global.Score 0.22 0 0 0
POMS.PositiveAffectScore 0 -0.56 0 0
POMS.NegativeAffectScore 0 0.14 0 0
PSS.PerceivedStress 0 0.36 0 0
SCL.90R.Depression 0.49 0 0 0
SCL.90R.Somatization 0.48 0 0 0
SCL.90R.Anxiety 0.52 0 0 0
SCL.90R.Hostility 0.45 0 0 0
CSQ.Distraction 0 0 0 0.46
CSQ.IgnoringPain 0 0 0 0.49
CSQ.Distancing 0 0 0 0.48
CSQ.Coping 0 0 0 0.56
CSQ.Praying 0 0 0.08 0
STAIY1.StateTraitAnxiety 0 0.5 0 0
STAIY2.StateTraitAnxiety 0 0.51 0 0
PCS.Rumination 0 0 0.65 0
PCS.Magnification 0 0 0.49 0
PCS.Helplessness 0 0 0.58 0
EPQ.Escale 0 0 0 0
EPQ.Nscale 0 0.15 0 0
Percent Variance Explained 0.16 0.31 0.43 0.54
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Table A2.21: PCA/SFA Psychosocial Results for the Entire OPPERA Cohort, c=0.7
Component 1 2 3 4
KOHN.Global.Score 0 0 0 0
PILL.Global.Score 0 0 0 0
POMS.PositiveAffectScore 0 -0.76 0 0
POMS.NegativeAffectScore 0 0 0 0
PSS.PerceivedStress 0 0 0 0
SCL.90R.Depression 0.5 0 0 0
SCL.90R.Somatization 0.48 0 0 0
SCL.90R.Anxiety 0.61 0 0 0
SCL.90R.Hostility 0.39 0 0 0
CSQ.Distraction 0 0 0 0.21
CSQ.IgnoringPain 0 0 0 0.38
CSQ.Distancing 0 0 0 0.35
CSQ.Coping 0 0 0 0.83
CSQ.Praying 0 0 0 0
STAIY1.StateTraitAnxiety 0 0.43 0 0
STAIY2.StateTraitAnxiety 0 0.48 0 0
PCS.Rumination 0 0 0.78 0
PCS.Magnification 0 0 0.25 0
PCS.Helplessness 0 0 0.57 0
EPQ.Escale 0 0 0 0
EPQ.Nscale 0 0 0 0
Percent Variance Explained 0.14 0.24 0.35 0.44
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Table A2.22: PCA/SFA Psychosocial Results for the Entire OPPERA Cohort, c=0.4
to 0.55
Component 1 2 3 4
KOHN.Global.Score 0 0 0 0
PILL.Global.Score 0.28 0 0 0
POMS.PositiveAffectScore 0 -0.54 0 0
POMS.NegativeAffectScore 0.11 0.2 0 0
PSS.PerceivedStress 0 0.38 0 0
SCL.90R.Depression 0.48 0 0 0
SCL.90R.Somatization 0.47 0 0 0
SCL.90R.Anxiety 0.5 0 0 0
SCL.90R.Hostility 0.45 0 0 0
CSQ.Distraction 0 0 0 0.45
CSQ.IgnoringPain 0 0 0 0.49
CSQ.Distancing 0 0 0 0.48
CSQ.Coping 0 0 0 0.57
CSQ.Praying 0 0 0.08 0
STAIY1.StateTraitAnxiety 0 0.49 0 0
STAIY2.StateTraitAnxiety 0.04 0.5 0 0
PCS.Rumination 0 0 0.65 0
PCS.Magnification 0 0 0.49 0
PCS.Helplessness 0 0 0.58 0
EPQ.Escale 0 -0.01 0 0
EPQ.Nscale 0 0.2 0 0
Percent Variance Explained 0.17 0.33 0.45 0.55
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Table A2.23: PCA/SFA Psychosocial Results for the Entire OPPERA Cohort, c=0.6
to 0.45
Component 1 2 3 4
KOHN.Global.Score 0 0 0 0
PILL.Global.Score 0.09 0 0 0
POMS.PositiveAffectScore 0 -0.59 0 0
POMS.NegativeAffectScore 0 0.04 0 0
PSS.PerceivedStress 0 0.33 0 0
SCL.90R.Depression 0.5 0 0 0
SCL.90R.Somatization 0.49 0 0 0
SCL.90R.Anxiety 0.55 0 0 0
SCL.90R.Hostility 0.45 0 0 0
CSQ.Distraction 0 0 0 0.47
CSQ.IgnoringPain 0 0 0 0.49
CSQ.Distancing 0 0 0 0.49
CSQ.Coping 0 0 0 0.55
CSQ.Praying 0 0 0.08 0
STAIY1.StateTraitAnxiety 0 0.51 0 0
STAIY2.StateTraitAnxiety 0 0.52 0 0
PCS.Rumination 0 0 0.65 0
PCS.Magnification 0 0 0.49 0
PCS.Helplessness 0 0 0.58 0
EPQ.Escale 0 0 0 0
EPQ.Nscale 0 0.05 0 0
Percent Variance Explained 0.15 0.29 0.41 0.51
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Table A2.24: PCA/SFA Psychosocial Results for the Entire OPPERA Cohort, c=0.7
to 0.4
Component 1 2 3 4
KOHN.Global.Score 0 0 0 0
PILL.Global.Score 0 0 0 0
POMS.PositiveAffectScore 0 -0.62 0 0
POMS.NegativeAffectScore 0 0 0 0
PSS.PerceivedStress 0 0.27 0 0
SCL.90R.Depression 0.5 0 0 0
SCL.90R.Somatization 0.48 0 0 0
SCL.90R.Anxiety 0.61 0 0 0
SCL.90R.Hostility 0.39 0 0 0
CSQ.Distraction 0 0 0 0.48
CSQ.IgnoringPain 0 0 0 0.49
CSQ.Distancing 0 0 0 0.49
CSQ.Coping 0 0 0 0.54
CSQ.Praying 0 0 0.08 0
STAIY1.StateTraitAnxiety 0 0.51 0 0
STAIY2.StateTraitAnxiety 0 0.53 0 0
PCS.Rumination 0 0 0.65 0
PCS.Magnification 0 0 0.49 0
PCS.Helplessness 0 0 0.58 0
EPQ.Escale 0 0 0 0
EPQ.Nscale 0 0 0 0
Percent Variance Explained 0.14 0.27 0.39 0.49
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